Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3149
Encontrada(s) 32 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Efecto de la actividad física, la obesidad y el sueño en la calidad de vida relacionada con la salud en Individuos con Síndrome Metabólico, Effect of physical activity, obesity and sleep on health-related quality of life in individuals with Metabolic Syndrome

  • Marcos Delgado, Alba
218 p., [ES] Introducción La calidad de vida relacionada con la salud (CVRS) se ha convertido en un parámetro indispensable para la salud pública, pudiendo estimar la carga de enfermedad global en las poblaciones, siendo un buen predictor de mortalidad. Debido al aumento en la prevalencia del síndrome metabólico (SMet) en la población resulta imprescindible averiguar cuál es la relación entre el SMet y la CVRS. Por este motivo, el objetivo principal de la presente tesis doctoral es estimar la CVRS en adultos que padecen SMet y los factores relacionados que influyen en la misma. Metodología Se utilizó la información disponible del estudio PREDIMED-Plus, un ensayo clínico aleatorizado multicéntrico, que recoge los datos sobre CVRS mediante el cuestionario SF-36, así como medidas antropométricas, nivel de actividad física y duración de sueño mediante acelerometría. Se realizó un análisis descriptivo transversal de la CVRS. Mediante modelos de regresión lineal ajustados por potenciales factores confusores, se evaluó la asociación entre la CVRS, el nivel de actividad física, el grado de obesidad y la duración del sueño, al comienzo del estudio y al año de seguimiento. Además, se realizaron modelos de regresión logística para averiguar si la actividad física, el índice de masa corporal (IMC) y la duración del sueño predicen cambios clínicamente significativos en la CVRS. Resultados Nuestros resultados reflejan que el aumento en la actividad física conlleva un incremento en las puntuaciones medias de la CVRS. En las mujeres, se encontraron hasta 10 puntos de diferencia entre la actividad física ligera y la moderada-vigorosa en la función física, rol físico, vitalidad, función social y rol emocional. Además, aquellos sujetos que mejoraron sus niveles de actividad física a lo largo del año de seguimiento, tuvieron un 91% de posibilidades de mejora clínicamente significativa de su componente agregado físico (PCS), respecto a aquellos que se mantuvieron inactivos durante un año (OR = 1,91; IC 95%: 1,23-2,96). En cuanto al grado de obesidad, cuanto mayor es el IMC, menores son las puntuaciones medias en las esferas físicas. Sin embargo, un IMC >30kg/m2, predice una mejora de dichas esferas a un año y son aquellos sujetos que pierden peso a lo largo del año los que más probabilidades tienen de mejorar su CVRS, respecto a aquellos que no modificaron su IMC (PCS OR = 1,85; IC 95% = 1,43-2,40). Se observa que los valores extremos en la duración de sueño de noche (<6h/>9h) afectan negativamente a la PCS. También, se ha encontrado una correlación entre dormir la siesta y la mejora del componente agregado mental (MCS) en aquellos individuos con un sueño nocturno corto (<7h) (Coeficiente β = 6,3 (1,3-11,3) p= 0,01). Conclusiones Nuestros resultados ponen de manifiesto que el SMets afecta negativamente en las esferas físicas de la CVRS. El nivel de actividad física, el IMC y la duración del sueño son factores relacionados que influyen en la misma. Se sugiere que una mejora en estos factores provoca una mejoría de la CVRS en individuos que padecen SMets. No obstante, se precisan más ensayos clínicos para evaluar estas asociaciones., [EN] Introduction Health-related quality of life (HRQoL) has become an essential parameter for public health, given its ability to estimate the global burden of disease in populations makes it a good predictor of mortality. Due to the increased prevalence of metabolic syndrome (MetS) in the population, it is vital to discern the relationship between MetS and HRQoL. As such, the main objective of this doctoral thesis is to estimate HRQoL in adults with MetS and the related factors that influence it. Methods Available information was used from the PREDIMED-Plus study, a multicenter randomized clinical trial that collects data on HRQoL using the SF-36 questionnaire, anthropometric measurements, level of physical activity and sleep duration using accelerometry. A cross-sectional descriptive analysis of HRQoL was performed. Through linear regression models adjusted for potential confounding factors, the association between HRQoL, level of physical activity, degree of obesity, and sleep duration was evaluated at the start of the study and at a one-year follow-up. Additionally, logistic regression models were fit to discern whether physical activity, body mass index (BMI), and sleep duration predict clinically significant changes in HRQoL. Results Our results reflect that increased physical activity leads to an increase in the mean HRQoL scores. In women, up to a 10-point difference was found between light and moderate-to-vigorous physical activity in physical function, physical role, vitality, social function, and emotional role. Furthermore, subjects who improved their physical activity levels throughout the follow-up year had a 91% chance of clinically significant improvement in their physical aggregate component (PCS), compared to those who remained inactive during that year (OR = 1.91; 95% CI: 1.23-2.96). In terms of obesity, the higher the BMI, the lower the average scores in physical areas. However, a BMI >30kg/m2 predicts an improvement in these areas at one year and subjects who lose weight throughout the year are more likely to improve their HRQoL, compared to those whose BMI was unchanged (PCS OR = 1.85, 95% CI = 1.43-2.40). We observed that extreme values in nightly sleep duration (<6h/>9h) negatively affect the PCS. A correlation was also found between napping and improving the physical aggregate component (MCS) in individuals with a short night's sleep (<7h) (Coefficient β = 6.3 (1.3-11.3) p= 0.01). Conclusions Our results show that MetS negatively affects the physical domains of HRQoL and physical activity level, BMI and sleep duration are related factors that influence it. Results suggest that improving these factors leads to an improved HRQoL in individuals with MetS. However, more clinical trials are needed to evaluate these associations.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Efecto de la ingesta de polifenoles en biomarcadores y riesgo cardiovascular, Effect of polyphenol intake on biomarkers and cardiovascular risk

  • Rubín García, María
174 p., [ES] Introducción La enfermedad cardiovascular es la principal causa de muerte en todo el mundo y, a pesar de las estrategias preventivas llevadas a cabo, continúa siendo un problema de salud pública. La dieta mediterránea ha demostrado numerosos beneficios cardiosaludables dada su riqueza en moléculas antioxidantes y antiinflamatorias y, muy especialmente, en polifenoles. Estos compuestos bioactivos han mostrado beneficios a nivel cardiovascular debido a sus propiedades antitrombóticas, antiinflamatorias y antiagregantes. Sin embargo, el estudio de su potencial en humanos es limitado. Dado el gran número de compuestos que existen, y, por ende, sus variadas biodisponibilidades y mecanismos de acción, aún hay muchos puntos que necesitan ser esclarecidos. Por este motivo, el objetivo principal de la presente tesis doctoral es evaluar la asociación entre el consumo de polifenoles, y el riesgo y biomarcadores de riesgo cardiovascular (RCV). Metodología Se utilizó la información disponible de 6.633 participantes del estudio PREDIMED-Plus, un ensayo clínico aleatorizado multicéntrico, que recopiló información sobre hábitos alimentarios y estilos de vida, así como muestras sanguíneas para análisis bioquímicos. El consumo de polifenoles se estimó utilizando los datos de consumo de alimentos del cuestionario semicuantitativo de frecuencia alimentaria de 143 ítems y el contenido de polifenoles de cada alimento contenido en la base de datos Phenol-Explorer. Los consumos estimados se ajustaron por la ingesta total de energía de acuerdo al método de residuales. Mediante modelos de regresión lineal multivariante, se evaluó la asociación entre la ingesta de polifenoles y el RCV (estimado mediante ecuaciones de riesgo). Además, se evaluó la asociación entre la ingesta de polifenoles y, el ácido úrico (mediante regresión lineal multivariante) y, mediante modelos de regresión de Cox con un tiempo de seguimiento constante (t=1) se estimó los Prevalence Ratio de la hiperuricemia. Por otro lado, se establecieron patrones de consumo de polifenoles mediante análisis factorial y análisis clúster, comparando ambos métodos y relacionando la adherencia a cada patrón con el RCV estimado. Todos los análisis se realizaron para hombres y mujeres por separado, además de en la población total. Resultados La ingesta total de polifenoles (βQ5vs.Q1= 0,10, IC 95%: 0,04 a 0,17) y flavonoides (βQ5vs.Q1= 0,17, IC 95%: 0,10 a 0,24) se asoció directa y significativamente con una mejor salud cardiovascular óptima (Life’s Simple 7). Se encontraron asociaciones inversas entre el consumo de la clase otros polifenoles y, el RCV estimado mediante Framingham (βQ5vs.Q1= -1,22%, IC 95%: -2,37 a -0,07) y SCORE (βQ5vs.Q1=-0,32, IC 95%: -2,37 a -0,07). En las mujeres, las asociaciones entre el consumo de polifenoles y todas las ecuaciones de riesgo, tienden a ser protectoras. La ingesta de ácidos fenólicos (βQ5vs.Q1= -0,17, IC 95%: -0,27 a -0,06), ácidos hidroxicinámicos (βQ5vs.Q1= -0,19, IC 95%: -0,3 a -0,09), alquilmetoxifenoles (βQ5vs.Q1= 0,2, IC 95%: -0,31 a -0. 1) y metoxifenoles (βQ5vs.Q1= -0,24, IC 95%: -0,34 a -0,13) -0,24, IC 95%: -0,34 a -0,13) mostró una asociación inversa con los niveles de ácido úrico en suero y, la hiperuricemia (PRQ5vs.Q1=0,82, IC 95%:0,71-0,95; PRQ5vs.Q1=0,82, IC 95%:0,71-0,95; PRQ5vs.Q1=0,80, IC 95%:0,70-0,92 y PR=0,79, IC 95%:0,69-0,91, respectivamente). Los patrones de polifenoles revelaron diferencias entre hombres y mujeres, así como en su asociación con el RCV. Respecto a aquellos derivados del análisis factorial: para el total de la muestra, y los hombres, el patrón 3 (aceitunas y aceite de oliva) se asoció positivamente con el RCV, también presentaron, mayor prevalencia de diabetes y mayores consumos de sodio. El patrón 4 formado por el café en todos los grupos, también se asoció con mayor RCV. En cuanto al análisis clúster, el clúster 2 en el total y en hombres, caracterizados por consumo de polifenoles del café y las aceitunas y aceite de oliva, también mostraron mayor RCV. Conclusiones La clase otros polifenoles mostró asociaciones inversas con el riesgo cardiovascular estimado, encontrándose resultados similares con las ecuaciones de Framingham, Framingham-REGICOR y Life’s Simple 7 (después de eliminar el componente de dieta) y diferentes con la SCORE, pero los predictores que se incluyen en esta herramienta son escasos. Una mayor ingesta subclases de polifenoles presentes en el café: ácidos hidroxicinámicos, alquilmetoxifenoles y metoxifenoles se asoció de forma inversa a los niveles de ácido úrico y la hiperuricemia. Encontramos diferencias en los patrones de ingesta de polifenoles entre hombres y mujeres, y en sus asociaciones con la RCV. Estas diferencias de sexo pueden explicarse por el hecho de que llevan estilos de vida diferentes, ya que un patrón no se refiere sólo a los hábitos dietéticos. Además, los sujetos que presentaban un mayor riesgo al inicio del estudio podrían sentirse más motivados para mejorar su hábito dietético (causalidad inversa). Nuestros hallazgos añaden nuevos conocimientos en el estudio de los compuestos fenólicos, destacando la importancia de analizarlos por sexo y de estudiar los determinantes de las elecciones alimentarias y los patrones dietéticos en relación con la percepción de riesgo y los estilos de vida específicos., [EN] Introduction Cardiovascular disease is the leading cause of death worldwide and, despite preventive strategies, continues to be a public health problem. The Mediterranean diet has demonstrated numerous benefits in this regard given its richness in antioxidant and anti-inflammatory molecules, and most especially, in polyphenols. These bioactive compounds have shown cardiovascular benefits due to their antithrombotic, anti-inflammatory and antiplatelet properties. However, the study of their potential in humans is limited. Given the large number of compounds that exist and, therefore, their varied bioavailability and mechanisms of action, there are still many points that need to be clarified. For this reason, the main objective of this doctoral thesis is to evaluate the association between polyphenol intake and cardiovascular risk (CVR) and biomarkers. Methods The information available from 6,633 participants in the PREDIMED-Plus study was used, it is a multicenter randomized clinical trial, which collected information on dietary habits and lifestyles, as well as blood samples for biochemical analysis. Polyphenol intakes were estimated using food consumption data from the 143-item semi-quantitative food frequency questionnaire and the polyphenol content of each food contained in the Phenol-Explorer database. Estimated intakes were adjusted for total energy intake according to the residuals method. The association between polyphenol intake and CVR (estimated using risk equations) was evaluated using multivariate linear regression models. In addition, the association between polyphenol intake and uric acid was evaluated (using multivariate linear regression) and, using Cox regression models with a constant follow-up time (t=1), the prevalence ratio of hyperuricemia was estimated. On the other hand, polyphenol consumption patterns were established by factor analysis and cluster analysis, comparing both methods and relating adherence to each pattern with the estimated CVR. All analyses were performed for men and women separately, as well as in the total population. Results Total polyphenol (βQ5vs.Q1= 0.10, 95% CI: 0.04 to 0.17) and flavonoid (βQ5vs.Q1= 0.17, 95% CI: 0.10 to 0.24) intakes were directly and significantly associated with improved optimal cardiovascular health (Life's Simple 7). Inverse associations were found between other polyphenols class intake and, CVR estimated by Framingham (βQ5vs.Q1= -1.22%, 95% CI: -2.37 to -0.07) and SCORE (βQ5vs.Q1=-0.32, 95% CI: -2.37 to -0.07). In women, the associations between polyphenol intake and all risk equations tended to be protective. The intake of phenolic acids (βQ5vs.Q1= -0.17, 95% CI: -0.27 to -0.06), hydroxycinnamic acids (βQ5vs.Q1= -0.19, 95% CI: -0.3 to -0.09), alkylmethoxyphenols (βQ5vs.Q1= 0.2, 95% CI: -0.31 to -0. 1) and methoxyphenols (βQ5vs.Q1= -0.24, 95% CI -0.34 to -0.13) showed an inverse association with serum uric acid levels and, hyperuricemia (PRQ5vs.Q1=0.82, 95% CI:0.71-0.95; PRQ5vs.Q1=0.82, 95% CI:0.71-0.95; PRQ5vs.Q1=0.80, 95% CI:0.70-0.92 and PRQ5vs.Q1=0.79, 95% CI:0.69-0.91, respectively). The polyphenol patterns revealed differences between men and women, as well as, in their association with CVR. Regarding those derived from the factorial analysis: for the total sample and the men, pattern 3 (olives and olive oil poyphenols) was positively associated with CVR, they also had a higher prevalence of diabetes and higher sodium intake. Pattern 4, formed by coffee polyphenols in all groups, was also associated with higher CVR. As for the cluster analysis, cluster 2 in the total and in men, characterized by consumption of coffee polyphenols and olives and olive oil, also showed higher CVR. Conclusions The other polyphenols class showed inverse associations with estimated cardiovascular risk, finding similar results with the Framingham, Framingham-REGICOR and Life's Simple 7 equations (after eliminating the diet component), and different with the SCORE, but predictors included in this scale are scarce. Higher intakes of polyphenols present in coffee: hydroxycinnamic acids, alkylmethoxyphenols, and methoxyphenols, were inversely associated with serum uric acid levels and hyperuricemia. We found differences in polyphenol intake patterns between men and women, and in their associations with CVR. These sex differences may be explained by the fact that they lead different lifestyles, since a pattern does not refer only to dietary habits. Moreover, subjects who were at higher risk at baseline might be more motivated to improve their dietary habit (reverse causality). Our findings add new insights in the study of phenolic compounds, highlighting the importance of analyzing them by sex and studying the determinants of food choices and dietary patterns in relation to risk perception and specific lifestyles.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

  • Payo Serafín, Tania
  • Méndez Blanco, Carolina
  • Fernández Palanca, Paula
  • Martínez Geijo, Jennifer
  • Reviejo, María
  • Ortiz de Urbina, Juan José
  • González Gallego, Javier
  • García Marín, José Juan
  • Mauriz Gutiérrez, José Luis
  • San Miguel de Vega, Beatriz
[EN]Although the treatment landscape has rapidly evolved over the last years, hepatocellular carcinoma (HCC) is one of the most lethal cancers. With recent advances, both immunotherapy and tyrosine kinase inhibitors (TKIs)-based chemotherapy constitute the standard treatment for advanced HCC. A systematic search of randomized clinical trials employing TKIs was performed in 17 databases, obtaining 25 studies evaluating the prognosis, tumor response, and presence of adverse events (AEs) related to TKIs in HCC. Overall effect sizes were estimated for the hazard ratios (HR) and odds ratios (OR) with 95% confidence interval (CI), either extracted or calculated with the Parmar method, employing STATA 16. Heterogeneity was assessed by Chi-square-based Q-test and inconsistency (I2) statistic; source of heterogeneity by meta-regression and subgroup analysis; and publication bias by funnel plot asymmetry and Egger's test. The research protocol was registered in PROSPERO (CRD42023397263). Meta-analysis revealed a correlation between survival and tumor response parameters and TKI treatment vs. placebo, despite detecting high heterogeneity. Combined TKI treatment showed a significantly better objective response rate (ORR) with no heterogeneity, whereas publication bias was only detected with time to progression (TTP). Few gastrointestinal and neurological disorders were associated with TKI treatment vs. placebo or with combined treatment. However, a higher number of serious AEs were related to TKI treatment vs. sorafenib alone. Results show positive clinical benefits from TKI treatment, supporting the approval and maintenance of TKI-based therapy for advanced HCC, while establishing appropriate strategies to maximize efficacy and minimize toxicity., SI, Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat Mesquida, Margalida
  • Álvarez Álvarez, Laura
  • Rubín García, María
  • Martínez González, Miguel Ángel
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Goday, Albert
  • Martínez, J. Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • Lopez Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra Majem, Lluís
  • Riquelme Gallego, Blanca
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayón Orea, Carmen
  • Guillem Saiz, Patricia
  • Valle Hita, Cristina
  • Cabanes, Robert
  • Abete, Itziar
  • Goicolea Güemez, Leire
  • Gómez Gracia, Enrique
  • Tercero Maciá, Cristina
  • Colom, Antoni
  • García Ríos, Antonio
  • Castro Barquero, Sara
  • Fernández García, José C.
  • Santos Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío
  • Khoury, Nadine
  • Castañer, Olga
  • Zulet, María Ángeles
  • Vaquero Luna, Jessica
  • Bes-Rastrollo, Maira
  • Heras Delgado, Sara de las
  • Ciurana, Ramón
  • Martín Sánchez, Vicente
  • Tur, Josep A.
  • Bouzas, Cristina
[EN] Background Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims To assess the association between MetS severity and amount of carbon dioxide ( CO2) emitted in an adult population. Design Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. Trial registration ISRCTN, ISRCT N8989 8870. Registered 05 September 2013., SI, We thank all PREDIMED-Plus participants and investigators. CIBEROBN, CIBERESP, and CIBERDEM are initiatives of the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) food companies donated extra-virgin olive oil. The Almond Board of California (Modesto, CA), American Pistachio Growers (Fresno, CA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA) donated nuts for the PREDIMED-Plus pilot study., Funding This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGEN grant. J.S-S is partially supported by ICREA under the ICREA Academia programme. C.B. was granted by Juan de la Cierva grant. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication., info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01120/ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS, info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01522//ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

  • Fernández Tussy, Pablo
  • Rodríguez Agudo, Rubén
  • Fernández Ramos, David
  • Barbier Torres, Lucía
  • Zubiete Franco, Imanol
  • Davalillo, Sergio López de
  • Herráez, Elisa
  • Goikoetxea Usandizaga, Naroa
  • Lachiondo Ortega, Sofía
  • Simón, Jorge
  • Lopitz Otsoa, Fernando
  • Gutiérrez de Juan, Virginia
  • McCain, Misti V.
  • Perugorría, María J.
  • Mabe, Jon
  • Navasa Mayo, Nicolás
  • Rodrigues, Cecilia M. P.
  • Fabregat, Isabel
  • Boix, Loreto
  • Sapena, Víctor
  • Anguita, Juan
  • Lu, Shelly C.
  • Mato, José M.
  • Banales, Jesus M.
  • Villa, Erica
  • Reeves, Helen L.
  • Bruix, Jordi
  • Reig, María
  • Marín, José J. G.
  • Delgado, Teresa C.
  • Martínez Chantar, María L.
[EN]Dysregulation of miRNAs is a hallmark of cancer, modulating oncogenes, tumor suppressors, and drug responsiveness. The multi-kinase inhibitor sorafenib is one of the first-line drugs for advanced hepatocellular carcinoma (HCC), although the outcome for treated patients is heterogeneous. The identification of predictive biomarkers and targets of sorafenib efficacy are sorely needed. Thus, selected top upregulated miRNAs from the C19MC cluster were analyzed in different hepatoma cell lines compared to immortalized liver human cells, THLE-2 as control. MiR-518d-5p showed the most consistent upregulation among them. Thus, miR-518d-5p was measured in liver tumor/non-tumor samples of two distinct cohorts of HCC patients (n = 16 and n = 20, respectively). Circulating miR-518d-5p was measured in an independent cohort of HCC patients receiving sorafenib treatment (n = 100), where miR-518d-5p was analyzed in relation to treatment duration and patient’s overall survival. In vitro and in vivo studies were performed in human hepatoma BCLC3 and Huh7 cells to analyze the effect of miR-518d-5p inhibition/overexpression during the response to sorafenib. Compared with healthy individuals, miR-518d-5p levels were higher in hepatic and serum samples from HCC patients (n = 16) and in an additional cohort of tumor/non-tumor paired samples (n = 20). MiR-518d-5p, through the inhibition of c-Jun and its mitochondrial target PUMA, desensitized human hepatoma cells and mouse xenograft to sorafenib-induced apoptosis. Finally, serum miR-518d-5p was assessed in 100 patients with HCC of different etiologies and BCLC-stage treated with sorafenib. In BCLC-C patients, higher serum miR-518d-5p at diagnosis was associated with shorter sorafenib treatment duration and survival. Hence, hepatic miR-518d-5p modulates sorafenib resistance in HCC through inhibition of c-Jun/PUMA-induced apoptosis. Circulating miR-518d-5p emerges as a potential lack of response biomarker to sorafenib in BCLC-C HCC patients., SI, This work was supported by grants from NIH (US Department of Health and Human services) R01CA172086 (to S.C.L., J.M.M. and M.L.M.-C.) and P01CA233452 (to S.C.L.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C), MINECO: SAF2017-87301-R, SAF2014-52097-R, RTI2018-096759-A-100, SAF2016-75197-R and SAF2015-64149-R, integrated in the Plan Estatal de Investigación Cientifica y Técnica e Innovación 2017-2020 cofounded by FEDER funds/Development Fund—a way to build Europe (to M.L.M.-C., J.M.M., T.C.D., J.J.G.M., and I.F., respectively), Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain: PI16/00598 and PI19/00819 (to J.J.G.M.), PI15/01132 and PI18/01075 (to J.M.B.), PI14/00399 and PI17/00022 (to M.J.P.), PI18/0358 (to M.R.), BIOEF (Basque Foundation for Innovation and Health Research): EITB Maratoia BIO15/CA/014 and BIO15/CA/016/BD (to M.L.M.-C and J.M.B., respectively); Mitotherapeutix (to M.L.M.-C), Consejería de Educación, Junta de Castilla y León: SA063P17 (J.J.G.M.), Asociación Española Contra el Cáncer (T.C. D, P.F.-T., and M.L.M-C), Basque Government Postdoctoral Program (P.F.-T.), Daniel Alagille award from EASL (to T.C.D.), Asociación Española contra el Cáncer, Canceres raros (M.L.M.-C., J.M.B., and J.J.G.M.), La Caixa Foundation (to M.L.M.-C. and J.M.B.), Ayudas Fundación BBVA a equipos de Investigación Científica 2018 (to M.L.M.-C.), Fondo Europeo de Desarrollo Regional’ (FEDER) (to J.M.B.); CIBERehd, Spain (to J.M.B.); IKERBASQUE, Basque foundation for Science, Spain (to J.M.B.), Department of Health of the Basque Country (2017111010) (to J.M.B.), Euskadi RIS3 (2019222054, 2020333010) (to J.M.B.); Department of Industry of the Basque Country (J.M.B.: Elkartek: KK-2020/00008) (to J.M.B.), Ayudas para apoyar grupos de investigación del sistema Universitario Vasco IT971, Instituto de Salud Carlos III PI18/00768 (J.B.), AECC PI044031 (J.B.), Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement 2014 SGR 605 (J.B.), WCR (AICR) 16-0026 (J.B.), Programma di ricerca Regione-Università 2007–2009 and 2011–2012, Regione Emilia- Romagna (E.V.).
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Prospective association of changes in (poly)phenol intake, body weight and physical activity with inflammatory profile

  • Rubín García, María
  • Vitelli Storelli, Facundo Ezequiel
  • Álvarez Álvarez, Laura
  • Fitó, Montserrat
  • Vázquez Ruiz, Zenaida
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Serra-Majem, Lluis
  • Wärnberg, Julia
  • Romaguera, Dora
  • Estruch, Ramón
  • Pintó, Xavier
  • Martínez, José Alfredo
  • Vázquez, Clotilde
  • Vidal, Josep
  • Tur, Josep A.
  • Alonso Gómez, Ángel M.
  • Ros, Emilio
  • Vioque, Jesús
  • López Miranda, José
  • Bueno Cavanillas, Aurora
  • Tinahones, Francisco J.
  • Lapetra, José
  • Daimiel, Lidia
  • Delgado Rodríguez, Miguel
  • Matía Martín, Pilar
  • Babio, Nancy
  • Schröder, Helmut
  • Lamuela Raventós, Rosa M.
  • Martín Sánchez, Vicente
  • Zamora Ros, Raúl
[EN] Backgrounds and aim: To prospectively evaluate the associations between changes in (poly)phenol intake, body weight(BW), and physical activity(PA) with changes in an inflammatory score after 1-year. Methods and results: This is a prospective observational analysis involving 484 participants from the PREDIMED-Plus with available inflammatory measurements. (Poly)phenol intake was estimated using a validated semi-quantitative food frequency questionnaire and the Phenol-Explorer database. An inflammatory score was calculated based on 8 blood biomarkers (IL-6, IL-8, IL-18, MCP-1, C-peptide, hs-CRP, leptin, and RANTES). The association between BW, PA, (poly)phenol intake and inflammatory score was evaluated using structural equations. Mediation analyses were performed to assess the relationship between change in (poly)phenol intake and inflammatory score was mediated by the change in BW. A higher increase in total (poly)phenol intake was related to a decrease in the inflammatory score (β = −0.005mg/1000 Kcal; CI95 % = -0.100,0.000) along with a decrease in BW (β = −0.006mg/1000 Kcal; CI95 % = -0.010,-0.003). Increased PA was associated with a lower inflammatory score (β = −0.129MET-min/d; CI95 % = −0.238,-0.021) and BW (β = −0.248MET-min/d; CI95 % = -0.343,-0.152). Finally, a decrease in BW was associated with a decrease in the inflammatory score (β = 0.240 kg; CI95 % = 0.155,0.325). Mediation analyses revealed that changes in BW explained 22 % of the overall association between changes in (poly)phenol intake and inflammatory score. Conclusions: An inverse association between changes in (poly)phenol intake and inflammatory status was observed, with BW playing a significant mediating role, emphasising the impact of BW reduction on inflammation reduction, SI, This work was supported by the Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigaci´on para la Salud (FIS), which is cofounded by the European Regional Development Fund (2 coordinated FIS projects [led by J.S.-S. and J.V.] funded by the following grant codes: PI13/00673, PI13/00492, PI13/00272, PI13/ 01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/ 01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/ 00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/ 00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/ 00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/ 01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/ 01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/ 01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/ 01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/ 00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Eu- ropean Research Council (Advanced Research Grant 2013–2018, grant number 340918); Recercaixa (2013ACUP00194); Consejería de Salud de la Junta de Andalucía (PI0458/2013); and a SEMERGEN grant. CIBERobn (Centros de Investigaci´on Biom´edica en Red: Obesidad y Nutrici´on), CIBEResp (Centros de Investigaci´on Biom´edica en Red: Epidemiologia y Salud Publica), and CIBERdem (Centros de Inves- tigaci´on Biom´edica en Red: Diabetes y Enfermedades Metab´olicas aso- ciadas) are initiatives of Carlos III Health Institute, Madrid, Spain. We thank CERCA Program/Generalitat de Catalunya for the institutional support to IDIBELL and IISPV, and PROMETEO 21/2021 from the Generalitat Valenciana. RZ-R was supported by the “Miguel Servet II” (CPII20/00009) program from the Instituto de Salud Carlos III (Co- funded by European Social Fund (ESF) investing in your future). J.S.-S. is partially supported by the ICREA Academia program. None of the funding sources took part in the design, collection, analysis or inter- pretation of the data, or in the decision to submit the manuscript for publication. The remaining authors have no disclosures to report
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Exposure to a mixture of arsenic species and growth indicators in 6–12-year-old children from the cycles 2007–2020 NHANES

  • García Villarino, Miguel
  • Fernández Iglesias, Rocío
  • García, Ana Victoria
  • Villa Fernández, Elsa
  • Fernández Arce, Lucía
  • Riaño Galán, Isolina
  • Lambert, Carmen
  • Martín Sánchez, Vicente
  • Karagas, Margaret R.
  • Delgado Álvarez, Elías
  • Fernández Somoano, Ana
  • Signes Pastor, Antonio José
[EN] Background: Exposure to arsenic (As) and its metabolites can affect normal growth in children, but the combine effects at simultaneous low-level exposures, remain uncertain. Hence, this study aims to analyze how the combined effects of As and its metabolites can impact growth indicators in 1,792 US children aged 6–12 years, from the NHANES. Methods: Levels of arsenic species in urine were measured using HPLC coupled with ICP-DRC-MS during the 2007–2020 NHANES cycles. The sum of iAs ([AsIII + AsV]), MMA, and DMA was used as a biomarker of internal iAs exposure (∑As), and methylation efficiency was assessed using the primary and secondary methylation indices (PMI, SMI). Linear regression and BKMR models were applied to identify adverse effects, nonlinear associations, interactions, and combined effects. Results: Median concentrations of MMA, DMA, iAs, and ∑As were 0.56 μg/L, 4.07 μg/L, 1.33 μg/L, and 6.40 μg/L, respectively. In the linear regression analyses, higher urinary concentrations of MMA were associated with reductions in several growth indicators. Specifically, each interquartile range (IQR) increase in MMA concentration was linked to decreases of −0.18 (95 % CI: −0.29, −0.06) in Body Mass Index (BMI) Z-score, −0.18 (95 % CI: −0.29, −0.06) in Weight Z-score, and −0.01 (95 % CI: −0.02, −0.01) in Waist circumference/Height ratio. Additionally, higher DMA concentrations were negatively associated with Height Z-score, with a reduction of −0.08 (95 % CI: −0.15, −0.01). In the BKMR analysis, DMA consistently emerged as the dominant contributor across multiple outcomes, showing the highest Posterior Inclusion Probabilities (PIPs) for indicators such as BMI Z-score and Waist circumference/Height ratio. While MMA exhibited notable PIPs in certain models, its influence was generally weaker than that of DMA. Conclusion: Childhood exposure to a mixture of arsenic species, even at low levels, appears to influence growth indicators and adversely affect physical development in children enrolled in NHANES, SI, This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI19/01162 and co-funded by the European Union and Universidad de Oviedo. This study was also funded by grants from CIDEGENT/2020/050 (Antonio J. Signes-Pastor); P01ES022832, RD83544201, and R25CA134286 (Margaret R. Karagas)
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Sarcopenic Obesity and Longitudinal Trajectories on Cognitive Performance and Subtle Cognitive Impairment Over 6 Years in Older Adults

  • Vázquez Lorente, Héctor
  • Paz Graniel, Indira
  • Margara Escudero, Hernando J.
  • Martínez González, Miguel Ángel
  • Romaguera, Dora
  • Martínez Urbistondo, Diego
  • Estruch, Ramón
  • Martín Sánchez, Vicente
  • Vidal, Josep
  • Fitó, Montserrat
  • Goñi, Nuria
  • Chaplin, Alice
  • Zulet, María Ángeles
  • Sacanella, Emilio
  • Paz Fernández, José Antonio de
  • Altés, Andreu
  • García Gavilán, Jesús Francisco
  • Konieczna, Jadwiga
  • Martínez, J. Alfredo
  • Salas Salvadó, Jordi
[EN] Background: Sarcopenic obesity has been suggested as a potential risk factor for cognitive decline; however, few prospective studies have been conducted to test this hypothesis. We aimed to assess the relationship between baseline sarcopenic obesity and 6-year trajectories of cognitive performance and subtle cognitive impairment in older adults. Methods: This longitudinal study comprised 1097 older adults aged 55–75 years (mean [SD] age, 65.3 [4.9] years; 506 females [46.1%] and 591 males [53.9%]) exhibiting baseline overweight/obesity and metabolic syndrome. Baseline lower-limb muscle strength was determined by the validated 30-s Chair Stand Test. Baseline total body weight, fat mass percentage and appendicular lean mass were obtained through dual-energy x-ray absorptiometry scans. Baseline sarcopenic obesity (n = 364 [33.2%]) was subsequently defined based on the new European Society for Clinical Nutrition and Metabolism and the European Association for the Study of Obesity consensus criteria. Cognitive performance was assessed at baseline, 2, 4 and 6 years of follow-up through five composite scores derived from a comprehensive battery of eight validated neuropsychological tests, encompassing global cognitive function, general cognitive function, executive function, attention and language. Subtle cognitive impairment was defined for those z-scores 0.5 standard deviations below the mean for each cognitive performance composite score at baseline. Linear and logistic two-level mixed models including lost to follow-up participants were fitted as main analyses. Complete case analyses were additionally performed. Results: After adjusting for multiple covariates, main analyses showed that, compared to older adults without sarcopenic obesity, those with sarcopenic obesity showed a higher decline in global cognitive function (between-group difference, −1.0 [95% CI, −2.2 to 0.2] after 6 years; overall p = 0.048) and general cognitive function (between-group difference, −2.5 [95% CI, −4.4 to 0.5] after 6 years; overall p = 0.028) and had a higher risk of subtle global cognitive function impairment (between-group difference, 2.3 [95% CI, 0.9 to 5.6] after 6 years; overall p = 0.038) over 6 years of follow-up. Associations remained consistent in the complete case analysis and attenuated when comparing those participants with baseline sarcopenic obesity with those only presenting sarcopenia, obesity or overweight. Of note, participants with baseline sarcopenia or obesity, compared to the absence of these conditions, showed no relationship with cognitive performance and subtle cognitive impairment over 6 years of follow-up. Conclusions: Sarcopenic obesity may be considered a potential independent risk factor for cognitive decline over the long term that warrants further evaluation in clinical settings, SI, This study was supported by the official Spanish Institutions for FundingScientific Biomedical Research, CIBER Fisiopatología de la Obesidad yNutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), throughthe Fondo de Investigación para la Salud (FIS), which is co-funded bythe European Regional Development Fund (six coordinated FIS proj-ects led by J.S.-S. and J.V., including the following projects: PI13/00673,PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184,PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618,PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972,PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094,PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120,PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827,PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926,PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017,PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138,PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158and PI23/00220); the Especial Action Project entitled: Implementación yevaluación de una intervención intensiva sobre la actividad física CohortePREDIMED-Plus grant to J.S.-S.; the European Research Council(Advanced Research Grant 2014–2019; agreement #340918) grantedto M.A.M.-G.; the Agencia Catalana de Recerca i Universitats, AGAUR(2021SGR00336 to J.S.-S; the Recercaixa (number 2013ACUP00194) grantto J.S.-S.; grants from the Consejería de Salud de la Junta de Andalucía(PI0458/2013, PS0358/2016 and PI0137/2018); the PROMETEO/21/2021and the AICO/2021/347 grants from the Generalitat Valenciana; theMINECO (CNS2022–135862) grant to D.R. and the Horizon 2020 PRIMEstudy (Prevention and Remediation of Insulin Multimorbidity in Europe;grant agreement #847879). J.K. received funding from ISCIII, throughthe Miguel Servet Project (CP24/00089), co-funded by the EuropeanUnion. H.V.-L. was funded by a research grant from the Agència de Gestiód‘Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV- 01).H.J.M.-E holds a ContratoPre-doctoral de Formacion en Investigacion en Salud (PFIS FI24/00038)funded by the ISCIII. None of the funding sources took part in the design,collection, analysis, interpretation of the data or writing of the report orin the decision to submit the manuscript for publication. J.S.-S., senior au-thor, gratefully acknowledges the financial support by ICREA under theICREA Academia program.Ethics StatementThe study protocol was approved by the Research Ethics Committees ofall recruiting centres. In addition, all participants signed an informedconsent form upon entry into the study.Conflicts of InterestThe authors declare no conflicts of interest.Data Availability StatementData described in the manuscript, codebook and analytic code will bemade available upon request pending application and approval of thePREDIMED-Plus Steering Committee. There are restrictions on theavailability of data for the PREDIMED-Plus trial, due to the signed con-sent agreements around data sharing, which only allow access to exter-nal researchers for studies following the project purposes. Requestorswishing to access the PREDIMED-Plus trial data used in this study canmake a request to the PREDIMED-Plus trial Steering Committee chair:jordi.salas@urv.cat. The request will then be passed to members of thePREDIMED-Plus Steering Committee for deliberation
Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación Artículo científico (JournalArticle)

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector

  • Aad, G.
  • Barreiro Alonso, Fernando
  • Batlamous, S.
  • Collado Soto, P.
  • Cueto, A.
  • Peso Malagón, José del
  • Glasman Kuguel, Claudia Beatriz
  • Pascual Dominguez, L.
  • Principe Martin, M. A.
  • Terrón Cuadrado, Juan
  • The Atlas Collaboration
Artículo escrito por un elevado número de autores. Solo se referencia el que aparece en primer lugar, el nombre del grupo de colaboración, si hubiere, y los autores pertenecientes a la UAM, A search for the dimuon decay of the Higgs boson is presented based on (Formula presented) collision data recorded by ATLAS during Run 3 of the Large Hadron Collider, corresponding to an integrated luminosity of (Formula presented) at (Formula presented). To enhance the sensitivity, the results are combined with those from Run 2. An excess of events over the background is observed with a significance of (Formula presented) ((Formula presented) expected). The best-fit signal strength is (Formula presented). This result provides evidence for the (Formula presented) decay with ATLAS data and offers a direct probe of the Higgs-boson Yukawa coupling to second-generation fermions, We thank CERN for the very successful operation of the LHC and its injectors, as well as the support staff at CERN and at our institutions worldwide without whom ATLAS could not be operated efficiently. The crucial computing support from all WLCG partners is acknowledged gratefully, in particular from CERN, the ATLAS Tier-1 facilities at TRIUMF/SFU (Canada), NDGF (Denmark, Norway, Sweden), CC-IN2P3 (France), KIT/ GridKA (Germany), INFN-CNAF (Italy), NL-T1 (Netherlands), PIC (Spain), RAL (UK) and BNL (USA), the Tier-2 facilities worldwide and large non-WLCG resource providers. Major contributors of computing resources are listed in Ref. [53].We gratefully acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; BMWFW and FWF, Austria; ANAS, Azerbaijan; CNPq and FAPESP, Brazil; NSERC, NRC and CFI, Canada; CERN; ANID, Chile; CAS, MOST and NSFC, China; Minciencias, Colombia; MEYS CR, Czech Republic; DNRF and DNSRC, Denmark; IN2P3-CNRS and CEA-DRF/IRFU, France; SRNSFG, Georgia; BMFTR, HGF and MPG, Germany; GSRI, Greece; RGC and Hong Kong SAR, China; ICHEP and Academy of Sciences and Humanities, Israel; INFN, Italy; MEXT and JSPS, Japan; CNRST, Morocco; NWO, Netherlands; RCN, Norway; MNiSW, Poland; FCT, Portugal; MNE/IFA, Romania; MSTDI, Serbia; MSSR, Slovakia; ARIS and MVZI, Slovenia; DSI/NRF, South Africa; MICIU/AEI, Spain; SRC and Wallenberg Foundation, Sweden; SERI, SNSF and Cantons of Bern and Geneva, Switzerland; NSTC, Taipei; TENMAK, Türkiye; STFC/UKRI, United Kingdom; DOE and NSF, USA. Individual groups and members have received support from BCKDF, CANARIE, CRC and DRAC, Canada; CERN-CZ, FORTE and PRIMUS, Czech Republic; COST, ERC, ERDF, Horizon 2020, ICSC-NextGenerationEU and Marie Skłodowska-Curie Actions, European Union; Investissements d’Avenir Labex, Investissements d’Avenir Idex and ANR, France; DFG and AvH Foundation, Germany; Herakleitos, Thales and Aristeia programmes co-financed by EU-ESF and the Greek NSRF, Greece; BSF-NSF and MINERVA, Israel; NCN and NAWA, Poland; La Caixa Banking Foundation, CERCA Programme Generalitat de Catalunya and PROMETEO and GenT Programmes Generalitat Valenciana, Spain; Göran Gustafssons Stiftelse, Sweden; The Royal Society and Leverhulme Trust, United Kingdom. In addition, individual members wish to acknowledge support from CERN: European Organization for Nuclear Research (CERN DOCT); Chile: Agencia Nacional de Investigación y Desarrollo (FONDECYT 1230812, FONDECYT 1240864, Fondecyt 3240661); China: ChineseMinistry of Science and Technology (MOST-2023YFA1605700, MOST- 2023YFA1609300), National Natural Science Foundation of China (NSFC—12175119, NSFC 12275265); Czech Republic: Czech Science Foundation (GACR—24- 11373S), Ministry of Education Youth and Sports (ERCCZ- LL2327, FORTE CZ.02.01.01/00/22_008/0004632), PRIMUS Research Programme (PRIMUS/21/SCI/017); EU: H2020 European Research Council (ERC— 101002463); European Union: European Research Council (BARD No. 101116429, ERC—948254, ERC 101089007), European Regional Development Fund (SMASH COFUND 101081355, SLO ERDF), Horizon 2020 Framework Programme (MUCCA—CHIST-ERA-19-XAI-00), European Union, Future Artificial Intelligence Research (FAIR-NextGenerationEU PE00000013), Italian Center for High Performance Computing, Big Data and Quantum Computing (ICSC, NextGenerationEU); France: Agence Nationale de la Recherche (ANR-21-CE31-0022, ANR- 22-EDIR-0002); Germany: Baden-Württemberg Stiftung (BW Stiftung-Postdoc Eliteprogramme), Deutsche Forschungsgemeinschaft (DFG—469666862, DFG—CR 312/5-2); China: Research Grants Council (GRF); Italy: Istituto Nazionale di Fisica Nucleare (ICSC, NextGenerationEU), Ministero dell’Universit`a e della Ricerca (NextGenEU 153D23001490006 M4C2.1.1, NextGenEU I53D23000820006 M4C2.1.1, NextGenEU I53D23001490006 M4C2.1.1, SOE2024_0000023); Japan: Japan Society for the Promotion of Science (JSPSKAKENHI JP22H01227, JSPS KAKENHI JP22H04944, JSPS KAKENHI JP22KK0227, JSPS KAKENHI JP24K23939, JSPS KAKENHI JP24KK0251, JSPS KAKENHI JP25H00650, JSPS KAKENHI JP25H01291, JSPS KAKENHI JP25K01023); Norway: Research Council of Norway (RCN-314472); Poland: Ministry of Science and Higher Education (IDUB AGH, POB8, D4 no 9722), Polish National Science Centre (NCN 2021/42/E/ST2/00350, NCN OPUS 2023/51/B/ST2/02507, NCN OPUS nr 2022/47/B/ ST2/03059,NCNUMO-2019/34/E/ST2/00393,UMO-2022/ 47/O/ST2/00148, UMO-2023/49/B/ST2/04085, UMO- 2023/51/B/ST2/00920, UMO-2024/53/N/ST2/00869); Portugal: Foundation for Science and Technology (FCT); Spain: Ministry of Science and Innovation (MCIN and NextGenEU PCI2022-135018-2, MICIN & FEDER PID2021-125273NB, RYC2019-028510-I, RYC2020- 030254-I, RYC2021-031273-I, RYC2022-038164-I); Sweden: Carl Trygger Foundation (Carl Trygger Foundation CTS 22∶2312), Swedish Research Council (Swedish Research Council 2023-04654, VR 2021-03651, VR 2022-03845, VR 2022-04683, VR 2023-03403, VR 2024-05451), Knut and Alice Wallenberg Foundation (KAW 2018.0458, KAW 2022.0358, KAW 2023.0366); Switzerland: Swiss National Science Foundation (SNSF— PCEFP2_194658); United Kingdom: Royal Society (NIFR1- 231091); USA: U.S. Department of Energy (ECA DEAC02- 76SF00515), Neubauer Family Foundation
Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación Artículo científico (JournalArticle)

Constraining off-shell Higgs boson production and the Higgs boson total width using WW → ℓνℓν final states with the ATLAS detector

  • Aad, G.
  • The Atlas Collaboration
  • Barreiro Alonso, Fernando
  • Batlamous, S.
  • Collado Soto, P.
  • Cueto, A.
  • Peso Malagón, José del
  • Glasman Kuguel, Claudia Beatriz
  • Pascual Dominguez, L.
  • Principe Martin, M.A.
  • Terrón Cuadrado, Juan
Artículo escrito por un elevado número de autores. Solo se referencia el que aparece en primer lugar, el nombre del grupo de colaboración, si hubiere, y los autores pertenecientes a la UAM, A measurement of off-shell Higgs boson production is performed in the 𝐻∗ → 𝑊𝑊 channel. The measurement uses a proton–proton collision dataset with an integrated luminosity of 140 fb−1 collected at a centre-of-mass energy of 13 TeV by the ATLAS detector at the Large Hadron Collider. Final states in which both 𝑊 bosons decay leptonically are targeted, and events are categorised based on the flavour of the final-state leptons, the jet multiplicity, and the output of neural network-based classifiers. The data are found to be compatible with the Standard Model expectation. An observed (expected) upper bound on the 95% symmetric confidence level interval is set on the rate of off-shell Higgs boson production at a value of 3.4 (4.4) times the Standard Model prediction. These results are combined with the results from the measurement of on-shell Higgs boson production in the same final states to obtain an observed (expected) upper bound at 95% confidence level on the Higgs boson total width of 13.1 (17.3) MeV, We thank CERN for the very successful operation of the LHC and its injectors, as well as the support staff at CERN and at our institutions worldwide without whom ATLAS could not be operated efficiently. The crucial computing support from all WLCG partners is acknowl-edged gratefully, in particular from CERN, the ATLAS Tier-1 facilities at TRIUMF/SFU (Canada), NDGF (Denmark, Norway, Sweden), CC-IN2P3 (France), KIT/GridKA (Germany), INFN-CNAF (Italy), NL-T1 (Nether-lands), PIC (Spain), RAL (UK) and BNL (USA), the Tier-2 facilities world-wide and large non-WLCG resource providers. Major contributors of computing resources are listed in Ref. [110]. We gratefully acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; BMWFW and FWF, Austria; ANAS, Azerbaijan; CNPq and FAPESP, Brazil; NSERC, NRC and CFI, Canada; CERN; ANID, Chile; CAS, MOST and NSFC, China; Minciencias, Colombia; MEYS CR, Czech Republic; DNRF and DNSRC, Denmark; IN2P3-CNRS and CEA-DRF/IRFU, France; SRNSFG, Georgia; BMFTR, HGF and MPG, Germany; GSRI, Greece; RGC and Hong Kong SAR, China; ICHEP and Academy of Sciences and Humanities, Israel; INFN, Italy; MEXT and JSPS, Japan; CNRST, Morocco; NWO, Netherlands; RCN, Norway; MNiSW, Poland; FCT, Portugal; MNE/IFA, Romania; MSTDI, Serbia; MSSR, Slovakia; ARIS and MVZI, Slovenia; DSI/NRF, South Africa; MICIU/AEI, Spain; SRC and Wallenberg Foundation, Sweden; SERI, SNSF and Cantons of Bern and Geneva, Switzerland; NSTC, Taipei; TENMAK, Türkiye; STFC/UKRI, United Kingdom; DOE and NSF, United States of America. Individual groups and members have received support from BCKDF, CANARIE, CRC and DRAC, Canada; CERN-CZ, FORTE and PRIMUS, Czech Republic; COST, ERC, ERDF, Horizon 2020, ICSC-NextGenerationEU and Marie Skłodowska-Curie Actions, European Union; Investissements d’Avenir Labex, Investissements d’Avenir Idex and ANR, France; DFG and AvH Foundation, Germany; Herakleitos, Thales and Aristeia programmes co-financed by EU-ESF and the Greek NSRF, Greece; BSF-NSF and MINERVA, Israel; NCN and NAWA, Poland; La Caixa Banking Foundation, CERCA Programme Generalitat de Catalunya and PROMETEO and GenT Programmes Generalitat Valen-ciana, Spain; Göran Gustafssons Stiftelse, Sweden; The Royal Society and Leverhulme Trust, United Kingdom. In addition, individual members wish to acknowledge support from Armenia: Yerevan Physics Institute (FAPERJ); CERN: European Organization for Nuclear Research (CERN DOCT); Chile: Agencia Nacional de Investigación y Desarrollo (FONDECYT 1230812, FONDE-CYT 1240864); China: Chinese Ministry of Science and Technology (MOST-2023YFA1605700, MOST-2023YFA1609300), National Natural Science Foundation of China (NSFC - 12175119, NSFC 12275265); Czech Republic: Czech Science Foundation (GACR - 24-11373S), Ministry of Education Youth and Sports (ERC-CZ-LL2327, FORTE CZ.02.01.01/00/22_008/0004632), PRIMUS Research Programme (PRIMUS/21/SCI/017); EU: H2020 European Research Council (ERC - 101002463); European Union: European Research Council (BARD No. 101116429, ERC - 948254, ERC 101089007), European Regional Devel-opment Fund (SMASH COFUND 101081355, SLO ERDF), Horizon 2020 Framework Programme (MUCCA - CHIST-ERA-19-XAI-00), European Union, Future Artificial Intelligence Research (FAIR-NextGenerationEU PE00000013), Horizon 2020 (EuroHPC - EHPC-DEV-2024D11-051), Italian Center for High Performance Computing, Big Data and Quantum Computing (ICSC, NextGenerationEU); France: Agence Nationale de la Recherche (ANR-21-CE31-0022, ANR-22-EDIR-0002); Germany: Baden-Württemberg Stiftung (BW Stiftung-Postdoc Eliteprogramme),Deutsche Forschungsgemeinschaft (DFG - 469666862, DFG - CR 312/5-2); China: Research Grants Council (GRF); Italy: Istituto Nazionale di Fisica Nucleare (ICSC, NextGenerationEU), Ministero dell’Università e della Ricerca (NextGenEU 153D23001490006 M4C2.1.1, NextGenEU I53D23000820006 M4C2.1.1, NextGenEU I53D23001490006 M4C2.1.1); Japan: Japan Society for the Promotion of Science (JSPS KAKENHI JP22H01227, JSPS KAKENHI JP22H04944, JSPS KAKENHI JP22KK0227, JSPS KAKENHI JP23KK0245, JSPS KAKENHI JP24K23939); Norway: Research Council of Norway (RCN-314472); Poland: Ministry of Science and Higher Education (IDUB AGH, POB8, D4 no 9722), Polish National Science Centre (NCN 2021/42/E/ST2/00350, NCN OPUS 2023/51/B/ST2/02507, NCN OPUS nr 2022/47/B/ST2/03059, NCN UMO-2019/34/E/ST2/00393, UMO-2022/47/O/ST2/00148, UMO-2023/49/B/ST2/04085, UMO-2023/51/B/ST2/00920, UMO-2024/53/N/ST2/00869); Portugal: Foundation for Science and Technology (FCT); Spain: Generalitat Va-lenciana (Artemisa, FEDER, IDIFEDER/2018/048), Ministry of Science and Innovation (MCIN & NextGenEU PCI2022-135018-2, MICIN & FEDER PID2021-125273NB, RYC2019-028510-I, RYC2020-030254-I, RYC2021-031273-I, RYC2022-038164-I); Sweden: Carl Trygger Foun-dation (Carl Trygger Foundation CTS 22:2312), Swedish Research Council (Swedish Research Council 2023-04654, VR 2021-03651, VR 2022-03845, VR 2022-04683, VR 2023-03403, VR 2024-05451), Knut and Alice Wallenberg Foundation (KAW 2018.0458, KAW 2022.0358, KAW 2023.0366); Switzerland: Swiss National Science Foundation (SNSF - PCEFP2_194658); United Kingdom: Leverhulme Trust (Leverhulme Trust RPG-2020-004), Royal Society (NIF-R1-231091); United States of America: U.S. Department of Energy (ECA DE-AC02-76SF00515), Neubauer Family Foundation
Docta Complutense
Publicación Artículo científico (JournalArticle)

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

  • Ayala Díaz, Rosa María
  • Martínez López, Joaquín
This phase Ib, non-randomized, open-label study evaluates the safety and tolerability of ruxolitinib in combination with nilotinib and prednisone in patients with naïve or ruxolitinib-resistant myelofibrosis (MF). A total of 15 patients with primary or secondary MF received the study treatment; 13 patients had received prior ruxolitinib treatment (86.7%). Eight patients completed seven cycles (53.3%) and six patients completed twelve cycles of treatment (40%). All the patients experienced at least one adverse event (AE) during the study (the most common AEs were hyperglycemia, asthenia, and thrombocytopenia), and 14 patients registered at least one treatment-related AE (the most common treatment-related AEs were hyperglycemia (22.2%; three grade 3 cases). Five treatment-related serious AEs (SAEs) were reported in two patients (13.3%). No deaths were registered throughout the study. No dose-limiting toxicity was observed. Four out of fifteen (27%) patients experienced a 100% spleen size reduction at Cycle 7, and two additional patients achieved a >50% spleen size reduction, representing an overall response rate of 40% at Cycle 7. In conclusion, the tolerability of this combination was acceptable, and hyperglycemia was the most frequent treatment-related AE. Ruxolitinib in combination with nilotinib and prednisone showed relevant clinical activity in patients with MF. This trial was registered with EudraCT Number 2016-005214-21.
Docta Complutense
Publicación Artículo científico (JournalArticle)

A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers

  • Hernández Lorenzo, Laura
  • Gil‐Moreno, Maria José
  • Ortega‐Madueño, Isabel
  • Cárdenas Fernández, María Cruz
  • Diez‐Cirarda, María
  • Delgado Álvarez, Alfonso
  • Palacios‐Sarmiento, Marta
  • Matías-Guiu Guía, Jorge
  • Corrochano Sánchez, Silvia
  • Ayala Rodrigo, José Luis
  • Matias-Guiu Antem, Jordi
Aims: The AT(N) classification system not only improved the biological characteriza-tion of Alzheimer's disease (AD) but also raised challenges for its clinical application. Unbiased, data-driven techniques such as clustering may help optimize it, rendering informative categories on biomarkers' values. Methods: We compared the diagnostic and prognostic abilities of CSF biomarkers clustering results against their AT(N) classification. We studied clinical (patients from our center) and research (Alzheimer's Disease Neuroimaging Initiative) cohorts. The studied CSF biomarkers included Aβ(1– 42), Aβ(1– 42 ) /Aβ(1– 40) ratio, tTau, and pTau. Results: The optimal solution yielded three clusters in both cohorts, significantly dif-ferent in diagnosis, AT(N) classification, values distribution, and survival. We defined these three CSF groups as (i) non-defined or unrelated to AD, (ii) early stages and/or more delayed risk of conversion to dementia, and (iii) more severe cognitive impair-ment subjects with faster progression to dementia. Conclusion: We propose this data-driven three- group classification as a meaningful and straightforward approach to evaluating the risk of conversion to dementia, com-plementary to the AT(N) system classification.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Antipsychotic medication influences the discriminative value of acylethanolamides as biomarkers of substance use disorder

  • Herrera-Imbroda, Jesús
  • Flores-López, María
  • Requena-Ocaña, Nerea
  • Araos, Pedro
  • Ropero, Jessica
  • García Marchena, Nuria
  • Bordallo, Antonio
  • Suarez, Juan
  • Pavón-Morón, Francisco Javier
  • Serrano, Antonia
  • Mayoral, Fermín
  • Rodríguez De Fonseca, Fernando Antonio
Plasma acylethanolamides (NAEs), including the endocannabinoid anandamide (AEA), have been proposed as circulating biomarkers of substance use disorders. However, the concentration of these lipid transmitters might be influenced by the use of drugs prescribed for either the treatment of addiction or the associated psychiatric co-morbidities such as psychosis. As an example, neuroleptics, used for attenuation of psychotic symptoms and sedation, might theoretically interfere with the monoamine-mediated production of NAEs, obstructing the interpretation of plasma NAEsasclinical biomarkers. To solve the lack of information on the impact of neuroleptics on the concentration of NAEs, we evaluated the concentrations of NAEs in a control group and compared them to those present in (a) substance use disorders (SUD) patients that are not prescribed with neuroleptics, and (b) SUD patients (both alcohol use disorder and cocaine use disorder patients) using neuroleptics. The results demonstrate that SUD patients exhibited greater concentrations of NAEsthan the control population, affecting all species with the exception of stearoylethanolamide (SEA) and palmitoleoylethanolamide (POEA). Neuroleptic treatment enhanced the concentrations of NAEs, especially those of AEA, linoleoylethanolamide (LEA), and oleoylethanolamide (OEA). This effect of neuroleptic treatment was observed independently of the drug addiction that motivated the demand for treatment (either alcohol or cocaine). This study remarks the need to control the current use of psychotropic medication as a potential confounding variable when considering the use of NAEsasbiomarkers in SUD.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Candida genotyping of blood culture isolates from patients admitted to 16 hospitals in Madrid: genotype spreading during the COVID-19 pandemic driven by fluconazole-resistant C. parapsilosis

  • Díaz García, Judith
  • Gómez, Ana
  • Machado, Marina
  • Alcalá, Luis
  • Reigadas Ramírez, Elena Manuela
  • Sánchez Carrillo, Carlos
  • Pérez Ayala, Ana
  • Gómez García De La Pedrosa, María Elia
  • González Romo, Fernando
  • Cuétara, María Soledad
  • García Esteban, Coral
  • Quiles Melero, Inmaculada
  • Zurita, Nelly Daniela
  • Muñoz Algarra, María
  • Durán Valle, María Teresa
  • Sánchez García, Aída
  • Muñoz García, Patricia Carmen
  • Escribano Subías, María Pilar
  • Guinea, Jesús
Background: Candidaemia and invasive candidiasis are typically hospital-acquired. Genotyping isolates from patients admitted to different hospitals may be helpful in tracking clones spreading across hospitals, especially those showing antifungal resistance. Methods: We characterized Candida clusters by studying Candida isolates (C. albicans, n = 1041; C. parapsilosis, n = 354, and C. tropicalis, n = 125) from blood cultures (53.8%) and intra-abdominal samples (46.2%) collected as part of the CANDIMAD (Candida in Madrid) study in Madrid (2019–2021). Species-specific microsatellite markers were used to define the genotypes of Candida spp. found in a single patient (singleton) or several patients (cluster) from a single hospital (intra-hospital cluster) or different hospitals (widespread cluster). Results: We found 83 clusters, of which 20 were intra-hospital, 49 were widespread, and 14 were intra-hospital and widespread. Some intra-hospital clusters were first detected before the onset of the COVID-19 pandemic, but the number of clusters increased during the pandemic, especially for C. parapsilosis. The proportion of widespread clusters was significantly higher for genotypes found in both compartments than those exclusively found in either the blood cultures or intra-abdominal samples. Most C. albicans- and C. tropicalis-resistant genotypes were singleton and presented exclusively in either blood cultures or intra-abdominal samples. Fluconazole-resistant C. parapsilosis isolates belonged to intra-hospital clusters harboring either the Y132F or G458S ERG11p substitutions; the dominant genotype was also widespread. Conclusions: the number of clusters—and patients involved—increased during the COVID-19 pandemic mainly due to the emergence of fluconazole-resistant C. parapsilosis genotypes.
Docta Complutense
Publicación Capítulo o parte de un libro (BookPart)

Fronteras, patrimonios, escalas: la cooperación transfronteriza como política escalar. El caso de la Raya

  • Lois Barrio, María Dolores
Los programas de cooperación transfronteriza de la Unión Europea han transformado las zonas fronterizas internas de la UE en escenarios para explorar prácticas y procesos de patrimonialización de las fronteras, en relación con la construcción de la Europeidad. En estos programas, las fronteras se reconstruyen como elementos patrimoniales orientados al consumo turístico, en un escenario donde múltiples actores institucionales y no institucionales negocian constantemente la imaginación patrimonial de la frontera. El objetivo de este trabajo es aproximarnos a las narrativas escalares que se proyectan y exhiben en los lugares patrimoniales, eventos, y documentos promocionales de las fronteras internas de la UE. El texto se centra en una región transfronteriza de la Raya, denominada BIN-SAL (Beira Interior Norte, Portugal y Salamanca, España), desde donde reflexionaremos en torno a las múltiples escalas y agencias de patrimonialización fronteriza, y sobre las diferentes tramas de la imaginación espacial europea.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Biblia e identidad en la pintura mexicana a través de dos ejemplos del siglo XIX, Bible and Identity in the Mexiccan Paintings of the 19th Century

  • Seijas De Los Ríos Zarzosa, Guadalupe
A mediados del siglo XIX la Real Academia de San Carlos, el equivalente en la capital mexicana a la Real Academia de Bellas Artes de San Fernando, experimentó un fuerte impulso de renovación gracias, entre otras medidas, a la contratación de prestigiosos profesores. Pelegrín Clavé influyó notablemente en la elección de temas bíblicos por parte de los alumnos, escogiéndose pasajes especialmente significativos a la luz del contexto político mexicano de confrontación entre conservadores y liberales. El análisis de La Sagrada Familia de Samuel Flores (1857) y Cautividad de los hebreos en Babilonia de Joaquín Ramírez (1858). nos permitirá mostrar la identificación que establecieron los artistas entre los temas bíblicos y la realidad de su tiempo, haciendo de la Biblia un texto vivo y significativo en la conformación y expresión de la identidad del nacionalismo conservador mexicano., In the mid-nineteenth century the Real Academia de San Carlos located in Mexican capital, similar to the Real Academia de Bellas Artes de San Fernando in Madrid, experienced a deep renewal thanks, among other reasons, to the hiring of world-renowned scholars. Pelegrín Clavé had a notable influence in the use of biblical topics by the students, choosing passages especially significant in light of the Mexican confrontation between conservatives and liberals. Through the analysis of The Holy Family of Samuel Flores (1857) and Joaquin ́s Ramírez Captivity of the Hebrews in Babylon (1858), this paper will show the identification that the artists established between biblical episodes and the reality of their time, making the Bible a living and meaningful text to conform and express the identity of Mexican conservative nationalism
Docta Complutense
Publicación Artículo científico (JournalArticle)

Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables

  • Wicke, Pablo Delgado
  • Fernández de Córdoba Oñate, Sara
  • Roy Vallejo, Emilia
  • Alegría Carrasco, Estibaliz
  • Rodríguez Serrano, Diego A.
  • Lamana Domínguez, Amalia
  • Montes, Nuria
  • Nicolao Gómez, Ana
  • Carracedo Rodríguez, Rosa
  • Marcos Jiménez, Ana
  • Díaz Fernández, Paula
  • Galván Román, José M.
  • Rabes Rodríguez, Laura
  • Sanz Alba, Marta
  • Álvarez Rodríguez, Jesús
  • Villa Martí, Almudena
  • Rodríguez Franco, Carlos
  • Villapalos García, Gonzalo
  • Zubiaur, Pablo
  • Abad Santos, Francisco
  • De los Santos, Ignacio
  • Pérez Gomáriz, Rosa María
  • García Vicuña, Rosario
  • Muñoz Calleja, Cecilia
  • González Álvaro, Isidoro
  • Fernández Ruiz, Elena
  • Suárez Fernández, Carmen
  • Barrios, Ana
  • Sanz, Jesús
  • Casado, Pedro
  • Gutiérrez, Ángela
  • Bautista, Azucena
  • Hernández, Pilar
  • Ruiz Giménez, Nuria
  • Moyano, Berta
  • Gil, Paloma
  • Delgado, María Jesús
  • Parra, Pedro
  • Sánchez, Beatriz
  • Sáez, Carmen
  • Fernández Rico, Marta
  • Arévalo Román, Cristina
  • Ciudad, Marianela
  • Castañeda, Santos
  • Llorente, Irene
  • Tomero, Eva G.
  • García Castañeda, Noelia
  • Uriarte, Miren
  • Cardeñoso, Laura
  • Fontán García-Rodrigo, Leticia
  • Domingo García, Diego
  • Alarcón Cavero, Teresa
  • Semiglia Chong, María Auxiliadora
  • Gutiérrez Cobos, Ainhoa
  • Zurita Cruz, Nelly D.
  • Sánchez Madrid, Francisco
  • Martín Gayo, Enrique
  • Sánchez Cerrillo, Ildefonso
  • Martínez Fleta, Pedro
  • López Sanz, Celia
  • Gabrie, Ligia
  • Del Campo Guerola, Luciana
  • Tejedor, Reyes
  • Ancochea, Julio
  • García Castillo, Elena
  • Ávalos, Elena
  • Sánchez Azofra, Ana
  • Alonso, Tamara
  • Cisneros, Carolina
  • Valenzuela, Claudia
  • García Pérez, Francisco J.
  • Girón, Rosa M.
  • Aspa, Javier
  • Marcos, Celeste
  • Socorro Churruca, M. del Perpetuo
  • Zamora, Enrique
  • Martínez, Adrián
  • Barrio Mayo, Mar
  • Henares Espi, Rosalina
  • Méndez, Rosa
  • Arribas, David
  • Chicot Llano, Marta
  • González, Begoña
  • Quicios, Begoña
  • Patiño, Pablo
  • Trigueros, Marina
  • Dominguez Peña, Cristina
  • Jiménez Jiménez, David
  • Villamayor, Pablo
  • Canabal, Alfonso
  • De la Cámara, Rafael
  • Ortiz, Javier
  • Iturrate, Isabel
The characteristics of the host are crucial in the final outcome of COVID-19. Herein, the influence of genetic and clinical variants in COVID-19 severity was investigated in a total of 1350 patients. Twenty-one single nucleotide polymorphisms of genes involved in SARS-CoV-2 sensing as Toll-like-Receptor 7, antiviral immunity as the type I interferon signalling pathway (TYK2, STAT1, STAT4, OAS1, SOCS) and the vasoactive intestinal peptide and its receptors (VIP/VIPR1,2) were studied. To analyse the association between polymorphisms and severity, a model adjusted by age, sex and different comorbidities was generated by ordinal logistic regression. The genotypes rs8108236-AA (OR 0.12 [95% CI 0.02–0.53]; p = 0.007) and rs280519-AG (OR 0.74 [95% CI 0.56–0.99]; p = 0.03) in TYK2, and rs688136-CC (OR 0.7 [95% CI 0.5–0.99]; p = 0.046) in VIP, were associated with lower severity; in contrast, rs3853839-GG in TLR7 (OR 1.44 [95% CI 1.07–1.94]; p = 0.016), rs280500-AG (OR 1.33 [95% CI 0.97–1.82]; p = 0.078) in TYK2 and rs1131454-AA in OAS1 (OR 1.29 [95% CI 0.95–1.75]; p = 0.110) were associated with higher severity. Therefore, these variants could influence the risk of severe COVID-19.
Docta Complutense
Publicación Artículo científico (JournalArticle)

BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury

  • Saiz, M. L.
  • Lozano-Chamizo, L.
  • Florez, A. B.
  • Marciello, Marzia
  • Diaz-Bulnes, P.
  • Corte-Iglesias, V.
  • Bernet, C. R.
  • Rodrigues-Diez, R. R.
  • Martin-Martin, C.
  • Rodriguez-Santamaria, M.
  • Fernandez-Vega, I.
  • Rodriguez, R. M.
  • Diaz-Corte, C.
  • Suarez-Alvarez, B.
  • Filice, Marco
  • Lopez-Larrea, C.
Targeting epigenetic mechanisms has emerged as a potential therapeutic approach for the treatment of kidney diseases. Specifically, inhibiting the bromodomain and extra-terminal (BET) domain proteins using the small molecule inhibitor JQ1 has shown promise in preclinical models of acute kidney injury (AKI) and chronic kidney disease (CKD). However, its clinical translation faces challenges due to issues with poor pharmacokinetics and side effects. Here, we developed engineered liposomes loaded with JQ1 with the aim of enhancing kidney drug delivery and reducing the required minimum effective dose by leveraging cargo protection. These liposomes efficiently encapsulated JQ1 in both the membrane and core, demonstrating superior therapeutic efficacy compared to freely delivered JQ1 in a mouse model of kidney ischemia-reperfusion injury. JQ1-loaded liposomes (JQ1-NPs) effectively targeted the kidneys and only one administration, one-hour after injury, was enough to decrease the immune cell (neutrophils and monocytes) infiltration to the kidney—an early and pivotal step to prevent damage progression. By inhibiting BRD4, JQ1-NPs suppress the transcription of pro-inflammatory genes, such as cytokines (il-6) and chemokines (ccl2, ccl5). This success not only improved early the kidney function, as evidenced by decreased serum levels of BUN and creatinine in JQ1-NPs-treated mice, along with reduced tissue expression of the damage marker, NGAL, but also halted the production of extracellular matrix proteins (Fsp-1, Fn-1, α-SMA and Col1a1) and the fibrosis development. In summary, this work presents a promising nanotherapeutic strategy for AKI treatment and its progression and provides new insights into renal drug delivery.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The challenge of managing threatened invasive species at a continental scale

  • Baquero Noriega, Rocío Aranzazu
  • Oficialdegui, Francisco Javier
  • Ayllón Fernández, Daniel
  • Gómez Nicola, María Gracia
The European Union's (EU) environmental legislation establishes common measures to prevent the entry and spread of invasive non-native species and to minimize their impacts. However, species that are native to at least one member state but non-native and potentially invasive in others (NPIS) are in limbo because they are neither legally regulated at the EU level nor in most member states. We used the Communication and Information Resource Centre for Administrations, Businesses and Citizens (CIRCABC) raw data on NPIS (317 taxa) to analyze their distribution across the EU and identify which biogeographical regions are the main sources of invasions. We additionally evaluated the conservation challenge posed by NPIS that are threatened within their native ranges. We performed a pairwise analysis summarizing the number of species that are native to a given member state but non-native to another and vice versa. Although distribution patterns of NPIS varied across taxa groups, overall, southern and central EU countries were both donors and recipients of NPIS. Eastern countries were mainly a source, and western and northern countries mostly received NPIS. Around 27% of NPIS were threatened in some of their EU native ranges, which is a challenge for conservation and management because some of them have serious negative effects on European biodiversity, but hitherto remain outside the scope of the EU regulation of invasive non-native species. This highlights an unresolved paradox because efforts to manage species as invasive conflict with efforts to protect them as threatened within the same territory.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Stability of long-sustained oscillations induced by electron tunneling

  • Tabanera Bravo, Jorge
  • Vigneau, Florian
  • Monsel, Juliette
  • Aggarwal, Kushagra
  • Bresque, Lea
  • Fedele, Federico
  • Cerisola, Federico
  • Briggs, G. A. D.
  • Anders, Janet
  • Auffèves, Alexia
  • Rodríguez Parrondo, Juan Manuel
  • Ares, Natalia
Self-oscillations are the result of an efficient mechanism generating periodic motion from a constant power source. In quantum devices, these oscillations may arise due to the interaction between single electron dynamics and mechanical motion. We show that, due to the complexity of this mechanism, these self-oscillations may irrupt, vanish, or exhibit a bistable behavior causing hysteresis cycles. We observe these hysteresis cycles and characterize the stability of different regimes in both single- and double-quantum-dot configurations. In particular cases, we find these oscillations stable for over 20 s, many orders of magnitude above electronic and mechanical characteristic timescales, revealing the robustness of the mechanism at play.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Seeding or planting to revegetate the world's degraded land: systematic review and experimentation to address methodological issues

  • Leverkus, Alexandro B
  • Lázaro-González, Alba
  • Andivia Muñoz, Enrique
  • Castro, Jorge
  • Jiménez, María Noelia
  • Navarro, Francisco B
Revegetation is key to achieve the goals of the UN Decade on Ecosystem Restoration. For many situations and plant species, selecting direct seeding or planting can define revegetation success. However, there is no clarity about when one method should be preferred over the other, partly driven by methodological difficulties that preclude avoiding bias during experimentation. To move the debate forward, (1) we propose a systematic review of the studies that compare seeding and planting, including how they have handled bias; and (2) we describe an ongoing experiment that tests different ways to handle bias when comparing seeding with planting.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Relationship between the feeling of emptiness and suicide reattempt: Conclusions from cross-sectional and longitudinal analyses

  • Pemau Gurumeta, Andrés
  • Marín Martín, Carolina
  • De La-Torre Luque, Alejandro Francisco
  • Ayad Ahmed, Wala
  • López Villatoro, José Manuel
  • Fernández Rodrigues, Verónica
  • Mola Cárdenes, Pablo
  • Carrasco Perera, José Luis
  • Díaz Marsa, Marina Francisca
Introduction: The feeling of emptiness is a complex subjective experience considered relevant in the suicidal process, acting as a risk factor for suicide ideation, attempts and even reattempts. However, empirical studies are still scarce. Objectives: This study has three objectives: to compare emptiness levels in healthy people and those with suicide attempts; to compare the emptiness level between people with a single suicide attempt and multiple suicide attempts at baseline; and to study emptiness as a risk factor for the appearance of new suicidal attempts after an index one. Methodology: In the study, 382 healthy controls and 58 participants with a recent suicide attempt (in the past 15 days) participated. All completed the feeling of emptiness scale (FES). Information was also collected on sociodemographic characteristics and history of suicide attempts. First, the control sample scores were compared with those of the clinical sample. Later, the single attempt and reattempt groups (any amount greater than one attempt at baseline) were compared. Finally, the clinical sample was followed for 1 year and 3 months (through clinical records). Survival analysis was performed. Results: The clinical group obtained higher scores across the FES subscales, even when controlling for other relevant variables (p < 0.01). When comparing people with one versus several attempts, differences were also observed in all subscales except one, the reattempt group getting higher scores (p < 0.05). Regarding the survival analysis, the feeling of emptiness was significantly associated with the risk of reattempt (HR = 1.04; p < 0.05). All people who reattempted during follow-up belonged to the reattempt group at baseline. Conclusions: People who have attempted suicide present higher emptiness scores. Furthermore, emptiness appears to significantly predict the occurrence of new attempts at follow-up. The feeling of emptiness may be associated with the lack of vital meaning and disconnection from others, fundamental aspects of the ideation-to-action suicide models. Including emptiness in suicide assessments could increase clinicians' predictive ability.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The mediating role of reflective functioning in the association between childhood trauma and suicide attempt

  • Andreo Jover, J.
  • De La-Torre Luque, Alejandro Francisco
  • Díaz Marsa, Marina Francisca
  • Fernández Rodrigues, Verónica
  • Pemau Gurumeta, Andrés
  • Diaz Carracedo, Patricia Cristina
  • Saiz González, María Dolores
  • Ayad Ahmed, Wala
  • Carrasco Perera, José Luis
Background: Childhood trauma is intimately related with suicidal behaviour. Patients who have suffered childhood trauma develop impaired Reflective Functioning (RF), which refers to the capacity to understand ourselves and others in terms of intentional mental states. An improvement in RF has been associated with a reduction in suicidal attempts, but the mediating role of RF between childhood trauma and suicidal behaviour has not been addressed so far. Objective: We aim to examine the potential mediating effect of RF among childhood trauma and suicide attempts. Method: We included 748 patients who had attempted suicide at least once. They were asked to complete the Reflective Functioning Questionnaire (RFQ-8), the Columbia-Suicide Severity Rating scale (CSSRS), and the Childhood Trauma Questionnaire-Short Form (CTQ-SF). We conducted linear regressions by simple mediating model to examine the role of RF in the indirect association between childhood trauma and the number of suicide attempts. Results: Our results show significant indirect effects through hypo and hypermentalizing between Emotional Abuse (EA) and Sexual Abuse (SA) in childhood and the number of suicide attempts in lifetime. These results indicate that ineffective RF significantly mediates the association between childhood trauma and suicidality. Conclusion: This is the first study supporting the mediational role of RF in the relationship between EA and SA, and the number of suicide attempt in lifetime. These findings have important implications for reducing suicide rates and preventing future re-attempts. Further studies analysing this mediating role and focusing efforts on increasing RF-based interventions are required.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Frequent Parasitism of Apis mellifera by Trypanosomatids in Geographically Isolated Areas with Restricted Beekeeping Movements

  • Aguado López, Daniel
  • Bartolomé, Carolina
  • Lopes, Ana Rita
  • Henriques, Dora
  • Segura, Sara Kafafi
  • Maside, Xulio
  • Pinto, M. Alice
  • Higes, Mariano
  • Martín Hernández, Raquel
Trypanosomatids form a group of high prevalence protozoa that parasitise honey bees, with Lotmaria passim as the predominant species worldwide. However, the knowledge about the ecology of trypanosomatids in isolated areas is limited. The Portuguese archipelagos of Madeira and Azores provide an interesting setting to investigate these parasites because of their geographic isolation, and because they harbour honey bee populations devoid of two major enemies: Varroa destructor and Nosema ceranae. Hence, a total of 661 honey bee colonies from Madeira and the Azores were analysed using different molecular techniques, through which we found a high prevalence of trypanosomatids despite the isolation of these islands. L. passim was the predominant species and, in most colonies, was the only one found, even on islands free of V. destructor and/or N. ceranae with severe restrictions on colony movements to prevent the spread of them. However, islands with V. destructor had a significantly higher prevalence of L. passim and, conversely, islands with N. ceranae did not shown any significant correlation with the trypanosomatid. Crithidia bombi was detected in Madeira and on three islands of the Azores, almost always coincident with L. passim. By contrast, Crithidia mellificae was not detected in any sample. A high-throughput sequencing analysis distinguished two main haplotypes of L. passim, which accounted for 98% of the total sequence reads. This work suggests that L. passim and C. bombi are parasites that have been associated with honey bees predating the spread of V. destructor and N. ceranae.
Docta Complutense
Publicación Contribución de congreso (ConferenceOutput)

Abordaje de las úlceras venosas de pacientes incluidos en un ensayo clínico

  • Herraiz Ahijado, Borja Jesús
  • Folguera Álvarez, María Del Carmen
  • Mori Vara, Pilar
  • Rodriguez Vegue, Mónica
  • Lopez Sanchez, Rocio
  • Muñoz Caballero, Eva Rocio
  • Navarro Mallén, Beatriz
  • Hita Urias, María José
  • Peláez Raposo, Belen
Describe el abordaje de las úlceras venosas de pacientes incluidos en ensayo clínico aleatorio, cuyo objetivo es evaluar la efectividad de una intervención educativa estructurada en ejercicio físico como tratamiento coadyuvante del tratamiento habitual, en la cicatrización de las úlceras venosas en atención primaria. Comunicación oral.
Docta Complutense
Publicación Artículo científico (JournalArticle)

C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer’s disease targeting tauopathies

  • Arribas, Raquel L.
  • Viejo, Lucía
  • Bravo, Isaac
  • Martínez, Minerva
  • Ramos Alonso, Eva
  • Romero Martínez, Manuel Alejandro
  • García-Frutos, Eva María
  • Janssens, Veerle
  • Montiel, Carmen
  • De Los Ríos, Cristobal
Protein phosphatase 2A (PP2A) is an important Ser/Thr phosphatase that participates in the regulation of multiple cellular processes. This implies that any deficient activity of PP2A is the responsible of severe pathologies. For instance, one of the main histopathological features of Alzheimer’s disease is neurofibrillary tangles, which are mainly comprised by hyperphosphorylated forms of tau protein. This altered rate of tau phosphorylation has been correlated with PP2A depression AD patients. With the goal of preventing PP2A inactivation in neurodegeneration scenarios, we have aimed to design, synthesize and evaluate new ligands of PP2A capable of preventing its inhibition. To achieve this goal, the new PP2A ligands present structural similarities with the central fragment C19–C27 of the well-established PP2A inhibitor okadaic acid (OA). Indeed, this central moiety of OA does not exert inhibitory actions. Hence, these compounds lack PP2A-inhibiting structural motifs but, in contrast, compete with PP2A inhibitors, thus recovering phosphatase activity. Proving this hypothesis, most compounds showed a good neuroprotective profile in neurodegeneration models related to PP2A impairment, highlighting derivative 10, named ITH12711, as the most promising one. This compound (1) restored in vitro and cellular PP2A catalytic activity, measured on a phospho-peptide substrate and by western-blot analyses, (2) proved good brain penetration measured by PAMPA, and (3) prevented LPS-induced memory impairment of mice in the object recognition test. Thus, the promising outcomes of the compound 10 validate our rational approach to design new PP2A-activating drugs based on OA central fragment.
Docta Complutense
Publicación Artículo científico (JournalArticle)

On the generality of measuring ultrabroad-band ultrashort laser pulses with the d-scan technique using ensembles of dielectric nano- and microparticles

  • Pérez Benito, Óscar
  • Cabrera Granado, Eduardo
  • García Martín, Susana
  • García González, Esther
  • Weigand Talavera, Rosa María
We demonstrate that temporal characterization of ultrabroadband laser pulses (∼ 7 fs) through the d-scan technique can be implemented using ensembles of SHG micro and/or nanocrystals independently of their crystal size and/or composition. The experimental results have been supported by numerical simulations based on the Finite-Difference-Time-Domain (FDTD) algorithm. Both, experiment and simulations show that, in spite of the low optical quality of the samples and the unavoidable appearance of incoherent light, the technique is robust and allows to measure ultrashort laser pulses using clusters of randomly distributed and piled-up polar micro- and nanocrystals.
Docta Complutense
Publicación Artículo científico (JournalArticle)

An immuno-fragile profile is associated with mortality risk in patients with chronic kidney disease

  • Ceprián, Noemí
  • Martínez De Toda Cabeza, Irene
  • Jara Caro, Paula
  • Yuste, Claudia
  • Valera Arévalo, Gemma
  • González de Pablos, Ignacio
  • Figuer, Andrea
  • Alique, Matilde
  • Ramírez, Rafael
  • Morales Ruiz, Enrique
  • Carracedo, Julia
Background/Objectives: Patients with chronic kidney disease (CKD) face higher risks of infections, poor vaccine responses, and cardiovascular diseases, leading to increased morbidity and mortality due to immune dysfunction and frailty. This study aims to evaluate immune status and frailty in CKD patients across different treatments, examine the influence of frailty on immune status, and link these factors to mortality. Methods: A total of 174 participants were included (end-stage renal disease, ESRD n = 40; hemodialysis, HD n = 40; peritoneal dialysis, n = 36; kidney transplant patients, n = 40; healthy subjects n = 18). Immunophenotyping of lymphocyte and monocyte subpopulations was performed, and frailty was assessed using the Edmonton Frail Scale. Principal component analysis (PCA) integrated immune and frailty variables to define an “immuno-fragile profile,” and survival was monitored for up to six years. Results: CKD patients, especially those on HD, showed decreased lymphocyte counts and proinflammatory monocyte subpopulations with increased expression of costimulatory molecules B7.2/CD86 and ICAM-1/CD54). Frailty was most prevalent in HD patients (53%), with notable sex differences. PCA identified three components—lymphocyte counts, monocyte co-stimulatory expression, and frailty—that together explained 70% of the variance. Survival analysis revealed that patients with lower lymphocyte counts and higher frailty scores had increased mortality risk, especially in the HD and ESRD groups. Cox regression confirmed that the immuno-fragile profile independently predictedmortality. Conclusions: The integration of immune alterations and frailty defines an immuno-fragile profile strongly associated with mortality in CKD patients, which may serve as a robust prognostic tool to improve risk stratification and guide personalized interventions in clinical practice.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Design, development, and optimization of in situ-forming implants for intra-articular delivery of celecoxib in osteoarthritis

  • Cunalema, Carmen
  • Kargin, Sena
  • Flores, Xcaret
  • Celis, Ana C.
  • Fraguas Sánchez, Ana Isabel
  • Fernández Carballido, Ana María
Osteoarthritis (OA) is a prevalent chronic joint disease characterized by pain, swelling, and physical disability. Its management includes the use of anti-inflammatory drugs, including intra-articular corticosteroids and oral NSAIDs such as COX-2 selective inhibitors like Celecoxib (CXB). The intra-articular administration of corticosteroids is highly effective. However, long-term corticosteroid use causes cartilage degradation, whereas oral CXB is associated with cardiovascular toxicity. The intra-articular CXB delivery may reduce systemic exposure, yet rapid joint clearance limits its utility. Therefore, this study aimed to design, develop, and optimize intraarticular in situ forming implants of CXB (CXB-ISFI) to provide controlled drug release over 6–8 weeks for the treatment of OA and overcome rapid joint elimination and enable sustained local drug exposure. The DoE approach based on a two-level factorial experimental design was used to optimize a CXB-ISFI formulation with a suitable release profile, evaluating the effect of solvent and polymer type, polymer concentration and CXB content. The type of solvent and the polymer concentration showed a significant influence on CXB release during the initial phase (%Q2). In contrast, the polymer type was a significant factor for the late phase (%Q60). All these factors had a significant impact on dissolution efficiency at 60 days (%DE60). The optimized formulation, prepared with 150 mg of PLGA and DMSO, at a polymer concentration of 50% and a CXB content of 20% showed a controlled drug release over 8 weeks with a minimized burst effect. It exhibited good injectability through a 21G needle and no signs of toxicity in the HET-CAM assay. These findings indicate its suitability for intra-articular administration and its potential use in the treatment of OA as an alternative to intra-articular corticosteroids.
Docta Complutense
Publicación Artículo científico (JournalArticle)

New mechanisms involved in the development of cardiovascular disease in chronic kidney disease

  • Figuer, Andrea
  • Alique, Matilde
  • Valera Arévalo, Gemma
  • Serroukh, Nadia
  • Ceprían, Noemí
  • De Sequera Ortiz, Patricia
  • Morales Ruiz, Enrique
  • Carracedo Añón, Julia María
  • Ramírez, Rafael
  • Bodega, Guillermo
Chronic kidney disease (CKD) is a pathology with a high worldwide incidence and an upward trend affecting the elderly. When CKD is very advanced, the use of renal replacement therapies is required to prolong its life (dialysis or kidney transplantation). Although dialysis improves many complications of CKD, the disease does not reverse completely. These patients present an increase in oxidative stress, chronic inflammation and the release of extracellular vesicles (EVs), which cause endothelial damage and the development of different cardiovascular diseases (CVD). CKD patients develop premature diseases associated with advanced age, such as CVD. EVs play an essential role in developing CVD in patients with CKD since their number increases in plasma and their content is modified. The EVs of patients with CKD cause endothelial dysfunction, senescence and vascular calcification. In addition, miRNAs free or transported in EVs together with other components carried in these EVs promote endothelial dysfunction, thrombotic and vascular calcification in CKD, among other effects. This review describes the classic factors and focuses on the role of new mechanisms involved in the development of CVD associated with CKD, emphasizing the role of EVs in the development of cardiovascular pathologies in the context of CKD. Moreover, the review summarized the EVs’ role as diagnostic and therapeutic tools, acting on EV release or content to avoid the development of CVD in CKD patients
Docta Complutense
Publicación Artículo científico (JournalArticle)

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

  • Tapia Galisteo, Antonio
  • Aguilar Sopeña, Óscar
  • Narbona Corral, Javier
  • Lacadena García-Gallo, Francisco Javier
  • Roda Navarro, Pedro
  • Sanz, Laura
Retargeting of T lymphocytes toward cancer cells by bispecific antibodies has demonstrated its therapeutic potential, with one such antibody approved for the treatment of acute lymphoblastic leukemia (blinatumomab) and several other in clinical trials. However, improvement of their efficacy and selectivity for solid tumors is still required. Here, we describe a novel tandem T-cell recruiting trispecific antibody for the treatment of colorectal cancer (CRC). This construct, termed trispecific T-cell engager (TriTE), consists of a CD3-specific single-chain Fv (scFv) flanked by anti-epidermal growth factor receptor (EGFR) and anti-epithelial cell adhesion molecule (EpCAM) single-domain V antibodies. The TriTE was well expressed in mammalian and yeast cells, bound the cognate antigens of the three parental antibodies, and enabled the specific cytolysis of EGFR- and/or EpCAM-expressing cancer cells, without inducing T cell activation and cytoxicity against double-negative (EGFREpCAM) cancer cells. Bivalent bispecific targeting of double-positive HCT116 cells by TriTE improved potency up to 100-fold compared to single-positive cells and significantly prolonged survival . In addition, it was less efficient at killing single-positive target cells than the corresponding bispecific controls, leading to potentially enhanced tumor specificity. Moreover, dual targeting of two tumor-associated antigens may contribute toward preventing the tumor escape by antigen loss caused by selective pressures from conventional single-targeting T-cell engagers, and may help to overcome antigenic heterogeneity.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Risk factors for suicide reattempt: a systematic review and meta-analysis

  • Pemau Gurumeta, Andrés
  • Marín Martín, Carolina
  • Díaz Marsa, Marina Francisca
  • De La-Torre Luque, Alejandro Francisco
  • Ayad Ahmed, Wala
  • González Pinto, Ana
  • Garrido Torres, Nathalia
  • Garrido Sanchez, Lucia
  • Roberto, Natalia
  • Lopez Peña, Purificacion
  • Mar Barrutia, Lorea
  • Grande, Iria
  • Guinovart, Marti
  • Hernandez Calle, Daniel
  • Jimenez Treviño, Luis
  • Lopez Sola, Clara
  • Mediavilla, Roberto
  • Perez Aranda, Adrian
  • Ruiz Veguilla, Miguel
  • Seijo Zazo, Elisa
  • Toll, Alba
  • Elices, Matilde
  • Perez Sola, Victor
  • Ayuso Mateos, Jose Luis
  • SURVIVE Consortium
Background Suicide is one of the main external causes of death worldwide. People who have already attempted suicide are at high risk of new suicidal behavior. However, there is a lack of information on the risk factors that facilitate the appearance of reattempts. The aim of this study was to calculate the risk of suicide reattempt in the presence of suicidal history and psychosocial risk factors and to estimate the effect of each individual risk factor. Methods This systematic review and meta-analysis were conducted following the PRISMA-2020 guidelines. Studies on suicide reattempt that measured risk factors were searched from inception to 2022. The risk factors studied were those directly related to suicide history: history of suicide prior to the index attempt, and those that mediate the transition from suicidal ideation to attempt (alcohol or drug misuse, impulsivity, trauma, and non-suicidal self-injury). Results The initial search resulted in 11 905 articles. Of these, 34 articles were selected for this meta-analysis, jointly presenting 52 different effect sizes. The pooled effect size across the risk factors was significant (OR 2.16). Reattempt risk may be increased in presence of any of the following risk factors: previous history, active suicidal ideation, trauma, alcohol misuse, and drug misuse. However, impulsivity, and non-suicidal self-injury did not show a significant effect on reattempt. Conclusion Most of the risk factors traditionally associated with suicide are also relevant when talking about suicide reattempts. Knowing the traits that define reattempters can help develop better preventive and intervention plans.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease

  • Delgado Álvarez, Alfonso
  • Delgado Alonso, Cristina
  • Goudsmit, Miriam
  • García-Ramos García, María Del Rocío
  • Gil Moreno, María José
  • Valles Salgado, María
  • Díez Cirarda, María
  • Zamarrón Cassinello, María Dolores
  • Matías-Guiu Guía, Jorge
  • Matias-Guiu Antem, Jordi
Objective: The Cross-Cultural Dementia (CCD) is a new screening tool to evaluate cognitive impairment based on a cross-cultural perspective to reduce the bias of education, and language and cultural differences. We aimed to evaluate the diagnostic properties of the CCD in Spaniards for the assessment of patients with Alzheimer’s disease in mild cognitive impairment (AD-MCI) and mild dementia stages (AD-D) and patients with mild cognitive impairment associated with Parkinson’s disease (PD-MCI). Methods: Sixty participants with AD (50% MCI) and thirty with PD-MCI were enrolled. Each clinical group was compared against a healthy control group (HC) with the same number of participants and no significant differences in age, education, and sex. A comprehensive neuropsychological test battery and CCD were completed. Intergroup comparisons, ROC curves, and cut-off scores were calculated for the study of diagnostic properties. Results: Intergroup differences were found in accordance with the cognitive profile of each clinical condition. Memory measures (Objects test) were especially relevant for the classification between AD and HC. Memory and executive function scores (Sun-Moon and Dots tests) were useful in the case of PD-MCI and HC. Furthermore, CCD described differences in executive functions and speed scores comparing AD-MCI and PD-MCI. Correlations between standardized neuropsychological tests and CCD measures supported the convergent validity of the test. Conclusion: CCD showed good discrimination properties and cut-off scores for dementia and extended its application to a sample of prodromal stages of AD and PD with mild cognitive impairment.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Zoonotic potential of urban wildlife faeces, assessed through metabarcoding

  • Cabodevilla, Xabier
  • Malo, Juan E.
  • Aguirre de Cárcer, Daniel
  • Zurdo, Julia
  • Chaboy Cansado, Rubén
  • Rastrojo, Alberto
  • García, Francisco J.
  • Traba, Juan
Monitoring zoonoses in urban environments is of great relevance, where the incidence of certain pathogens may be higher and where population density makes the spread of any contagious disease more likely. In this study we applied a metabarcoding approach to study potentially zoonotic pathogens in faecal samples of 9 urban vertebrate species. We applied this methodology with two objectives. Firstly, to obtain information on potential pathogens present in the urban fauna of a large European city (Madrid, Spain) and to determine which are their main reservoirs. In addition, we tested for differences in the prevalence of these potential pathogens between urban and rural European rabbits, used as ubiquitous species. Additionally, based on the results obtained, we evaluated the effectiveness of metabarcoding as a tool for monitoring potential pathogen. Our results revealed the presence of potentially zoonotic bacterial genera in all studied host species, 10 of these genera with zoonotic species of mandatory monitoring in the European Union. Based on these results, urban birds (especially house sparrows and pigeons) and bats are the species posing the greatest potential risk, with Campylobacter and Listeria genera in birds and of Chlamydia and Vibrio cholerae in bats as most relevant pathogens. This information highlights the risk associated with fresh faeces from urban wildlife. In addition, we detected Campylobacter in >50 % of the urban rabbit samples, while we only detected it in 11 % of the rural rabbit samples. We found that urban rabbits have a higher prevalence of some pathogens relative to rural rabbits, which could indicate increased risk of pathogen transmission to humans. Finally, our results showed that metabarcoding can be an useful tool to quickly obtain a first screening of potentially zoonotic organisms, necessary information to target the monitoring efforts on the most relevant pathogens and host species.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The role of the dopamine system in post-stroke mood disorders in newborn rats.

  • Villa, M
  • Martinez Vega, M
  • del Pozo, A
  • Muneta Arrate, I
  • Gómez Soria, A
  • Muguruza, C
  • de Hoz Rivera, M
  • Romero, A
  • Silva, L
  • Callado, L F
  • Casarejos, M J
  • Martínez Orgado, José Antonio
Post-stroke mood disorders (PSMD) affect disease prognosis in adults. Adult rodent models underlie the importance of the dopamine (DA) system in PSMD pathophysiology. There are no studies on PSMD after neonatal stroke. We induced neonatal stroke in 7-day-old (P7) rats by temporal left middle cerebral artery occlusion (MCAO). Performance in the tail suspension test (TST) at P14 and the forced swimming test (FST) and open field test (OFT) at P37 were studied to assess PSMD. DA neuron density in the ventral tegmental area, brain DA concentration and DA transporter (DAT) expression as well as D2 receptor (D2R) expression and G-protein functional coupling were also studied. MCAO animals revealed depressive-like symptoms at P14 associated with decreased DA concentration and reduced DA neuron population and DAT expression. At P37, MCAO rats showed hyperactive behavior associated with increased DA concentration, normalization of DA neuron density and decreased DAT expression. MCAO did not modify D2R expression but reduced D2R functionality at P37. MCAO-induced depressive-like symptoms were reversed by the DA reuptake inhibitor GBR-12909. In conclusion, MCAO in newborn rats induced depressive-like symptoms and hyperactive behavior in the medium and long term, respectively, that were associated with alterations in the DA system.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Targeting cow's milk allergy using hypoallergenic protein-polyphenol formulas: A proof of concept

  • Victoria Gil, M.
  • Gutiérrez Díaz, Gloria
  • Higuero, Nieves
  • Palma, Esther
  • Fernández Rivera, Nuria
  • Parrón Ballesteros, Jorge
  • Betancor, Diana
  • Pastor Vargas, Carlos
  • Cintas, Pedro
  • Delgado Adamez, Jonathan
Cow's milk allergy caused by a hypersensitivity to milk proteins has increased over the last years. Hypoallergenic responses can be induced by altering the structure of such proteins with chemical modifiers; this paper is about the creation of edible matrices based on polyphenols from orange peel. Some compounds were able to significantly lower the IgE binding from β-lactoglobulin allergic serum in sensitized patients. Such effects could also be observed for casein allergic serum in patients sensitized to both proteins. A certain inter-individual variability is observed, although polyphenols do actually induce salient structural changes. This indicates that molecular modifications aimed at oral treatments against food allergy may or may not correlate with reduced allergenicity, and hence the necessity for serum monitoring through immunological assays. Overall, the results are promising enough to validate the polyphenol-fortified approach. In addition, this study highlights the upgrading of vegetable waste, consistent with a circular economy in food chemistry.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Brain metabolism response to intrahospital transfers in neurocritical ill patients and the impact of microdialysis probe location

  • Pedrosa, Leire|||0000-0002-1852-4975
  • Hoyos, Jhon
  • Reyes, Luís
  • Mosteiro, Alejandra|||0000-0001-7170-0635
  • Zattera, Luigi
  • Topczewski, Tthomaz
  • Rodríguez-Hernández, Ana|||0000-0002-2992-2557
  • Amaro, Sergio|||0009-0008-9728-3823
  • Torné, Ramon|||0000-0001-7932-2528
  • Enseñat, Joaquim|||0000-0002-5812-0991
Intrahospital transfer (IHT), a routine in the management of neurocritical patients requiring imaging or interventions, might affect brain metabolism. Studies about IHT effects using microdialysis (MD) have produced conflicting results. In these studies, only the most damaged hemisphere was monitored, and those may not reflect the impact of IHT on overall brain metabolism, nor do they address differences between the hemispheres. Herein we aimed to quantify the effect of IHT on brain metabolism by monitoring both hemispheres with bilateral MD. In this study, 27 patients with severe brain injury (10 traumatic brain injury and 17 subarachnoid hemorrhage patients) were included, with a total of 67 IHT. Glucose, glycerol, pyruvate and lactate were measured by MD in both hemispheres for 10 h pre- and post-IHT. Alterations in metabolite levels after IHT were observed on both hemispheres; although these changes were more marked in hemisphere A (most damaged) than B (less damaged). Our results suggest that brain metabolism is altered after an IHT of neurocritical ill patients particularly but not limited to the damaged hemisphere. Bilateral monitorization may be more sensitive than unilateral monitorization for detecting metabolic disturbances not directly related to the course of the disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

  • de Lazzari, Elisa|||0000-0003-2614-6545
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Tiraboschi, Juan Manuel|||0000-0002-0073-873X
  • Ribera, Esteban|||0000-0002-3752-8808
  • Abdulghani, Nadia
  • Alba, Verónica|||0000-0002-5925-9573
  • Fernández-Arroyo, Salvador
  • Vilades, Consuelo
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Gatell, José Mª|||0000-0002-4705-3244
  • Blanco Arévalo, José Luis|||0000-0003-2010-2744
  • Vidal, Francesc|||0000-0002-6692-6186
  • Rull, Anna|||0000-0002-8907-7754
  • Martínez, Esteban|||0000-0002-6911-8846
Introduction: The DOLAM trial revealed that switching from triple antiretroviral therapy (three-drug regimen; 3DR) to dolutegravir plus lamivudine (two-drug regimen; 2DR) was virologically non-inferior to continuing 3DR after 48weeks of follow-up. Weight increased with 2DR relative to 3DR but it did not impact on metabolic parameters. Methods: Multiomics plasma profile was performed to gain further insight into whether this therapy switch might affect specific biological pathways. DOLAM (EudraCT 201500027435) is a Phase 4, randomized, open-label, non-inferiority trial in which virologically suppressed persons with HIV treated with 3DR were assigned (1:1) to switch to 2DR or to continue 3DR for 48weeks. Untargeted proteomics, metabolomics and lipidomics analyses were performed at baseline and at 48eeks. Univariate and multivariate analyses were performed to identify changes in key molecules between both therapy arms. Results: Switching from 3DR to 2DR showed a multiomic impact on circulating plasma concentration of N-acetylmuramoyl-L-alanine amidase (Q96PD5), insulin-like growth factor-binding protein 3 (A6XND0), alanine and triglyceride (TG) (48:0). Correlation analyses identified an association among the up-regulation of these four molecules in persons treated with 2DR. Conclusions: Untargeted multiomics profiling studies identified molecular changes potentially associated with inflammation immune pathways, and with lipid and glucose metabolism. Although these changes could be associated with potential metabolic or cardiovascular consequences, their clinical significance remains uncertain. Further work is needed to confirm these findings and to assess their long-term clinical consequences.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Latorre, Irene|||0000-0001-8159-2455
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Martínez-Planas, Aina
  • Minguell Domingo, Laura
  • Vallmanya, Teresa
  • Méndez Hernández, Maria|||0000-0001-5697-2763
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Baquero-Artigao, Fernando|||0000-0002-6903-3826
  • Rodríguez-Molino, Paula
  • Guillén-Martín, Sara
  • Toro Rueda, Carlos
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Sabriá, Josefina
  • Santos, José Ramón|||0000-0002-0886-7114
  • Puig, Jordi|||0000-0002-4075-0346
  • Domínguez-Álvarez, Marisol
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Altet, Neus
  • Galea, Yolanda
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • García-García, Esther
  • Bach Griera, Marc|||0000-0001-9845-7225
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Julián, Esther|||0000-0002-6558-3978
  • Torrelles, Jordi B.|||0000-0001-7702-5941
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Domínguez, José|||0000-0001-7888-0309
Background: Diagnosis of nontuberculous mycobacteria (NTM) infections remains a challenge. In this study, we describe the evaluation of an immunological NTM-interferon (IFN)-γ release assay (IGRA) that we developed using glycopeptidolipids (GPLs) as NTM-specific antigens. Methods: We tested the NTM-IGRA in 99 samples from pediatric patients. Seventy-five were patients with lymphadenitis: 25 were NTM confirmed, 45 were of unknown etiology but compatible with mycobacterial infection and 5 had lymphadenitis caused by an etiologic agent other than NTM. The remaining 24 samples were from control individuals without lymphadenitis (latently infected with M.Tuberculosis, uninfected controls and active tuberculosis patients). Peripheral blood mononuclear cells were stimulated overnight with GPLs. Detection of IFN-γ producing cells was evaluated by enzyme-linked immunospot assay. Results: NTM culture-confirmed lymphadenitis patient samples had a significantly higher response to GPLs than the patients with lymphadenitis of unknown etiology but compatible with mycobacterial infection (P < 0.001) and lymphadenitis not caused by NTM (P < 0.01). We analyzed the response against GPLs in samples from unknown etiology lymphadenitis but compatible with mycobacterial infection cases according to the tuberculin skin test (TST) response, and although not statistically significant, those with a TST ≥5 mm had a higher response to GPLs when compared with the TST <5 mm group. Conclusions: Stimulation with GPLs yielded promising results in detecting NTM infection in pediatric patients with lymphadenitis. Our results indicate that the test could be useful to guide the diagnosis of pediatric lymphadenitis. This new NTM-IGRA could improve the clinical handling of NTM-infected patients and avoid unnecessary misdiagnosis and treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Corticosterone administration immediately after peripuberty stress exposure does not prevent protracted stress-induced behavioral alterations

  • Perez-Caballero, Laura|||0000-0002-2315-2213
  • Guillot de Suduiraut, Isabelle
  • Romero, Leire R.|||0009-0005-0733-7161
  • Grosse, Jocelyn
  • Sandi, Carmen|||0000-0001-7713-8321
  • Andero Galí, Raül|||0000-0003-3641-8903
Stress-related disorders are commonly associated with abnormalities in hypothalamic-pituitary-adrenal (HPA) axis activity. Preliminary studies with cortisol administration in the aftermath of trauma suggest that this HPA axis hormone can potentially prevent maladaptive behavioral and biological stress responses. However, the efficacy of glucocorticoid administration during the peripuberty period has not been tested yet, although this lifetime is a critical time window in brain development and is highly sensitive to the harmful effects of stress. To further examine the short and long-lasting impact of glucocorticoids treatment given during the post-peripubertal stress period, the present study utilized a rat model of peripubertal stress-induced psychopathology and animals were subjected to a battery of tests to assess anxiety-like behaviors, exploratory behavior and reactivity to novelty at late adolescence and sociability, anhedonia and stress coping behaviors at adulthood. All the experiments were performed in males and females to evaluate the potential behavioral sex differences. Overall, our results demonstrated that rats exposed to peripubertal stress show decreased sociability in adulthood without differences in anxiety and depression-like behaviors. Moreover, this study shows that the administration of corticosterone after stress exposure at peripuberty does not prevent stress-induced behavioral alterations. However, we observed that some stress-induced behavioural alterations and corticosterone responses are sex-specific. Thus, the data obtained highlight that delineating sex differences in stress-related studies may ultimately contribute to the development of effective therapeutic interventions for each sex.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A novel biomimetic nanoplasmonic sensor for rapid and accurate evaluation of checkpoint inhibitor immunotherapy

  • Batool, Razia|||0000-0001-6864-5655
  • Soler Aznar, Maria|||0000-0001-7232-2277
  • Singh, Rukmani|||0000-0002-7562-7217
  • Lechuga, Laura M.|||0000-0001-5187-5358
Immune checkpoint inhibitors (ICIs) emerged as promising immunotherapies for cancer treatment, harnessing the patient's immune system to fight and eliminate tumor cells. However, despite their potential and proven efficacies, checkpoint inhibitors still face important challenges such as the tumor heterogeneity and resistance mechanisms, and the complex in vitro testing, which limits their widespread applicability and implementation to treat cancer. To address these challenges, we propose a novel analytical technique utilizing biomimetic label-free nanoplasmonic biosensors for rapid and reliable screening and evaluation of checkpoint inhibitors. We have designed and fabricated a low-density nanostructured plasmonic sensor based on gold nanodisks that enables the direct formation of a functional supported lipid bilayer, which acts as an artificial cell membrane for tumor ligand immobilization. With this biomimetic scaffold, our biosensing approach provides real-time, highly sensitive analysis of immune checkpoint pathways and direct assessment of the blocking effects of monoclonal antibodies in less than 20 min/test. We demonstrate the accuracy of our biomimetic sensor for the study of the programmed cell death protein 1 (PD1) checkpoint pathway, achieving a limit of detection of 6.7 ng/mL for direct PD1/PD-L1 interaction monitoring. Besides, we have performed dose-response inhibition curves for an anti-PD1 monoclonal antibody, obtaining a half maximal inhibitory concentration (IC) of 0.43 nM, within the same range than those obtained with conventional techniques. Our biomimetic sensor platform combines the potential of plasmonic technologies for rapid label-free analysis with the reliability of cell-based assay in terms of ligand mobility. The biosensor is integrated in a compact user-friendly device for the straightforward implementation in biomedical and pharmaceutical laboratories. Graphical Abstract: (Figure presented.)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

APPRAISE-RS, Automated, updated, participatory, and personalized treatment recommender systems based on GRADE methodology

  • López, Beatriz|||0000-0001-9210-0073
  • Raya, Oscar|||0000-0002-0420-3038
  • Baykova, Evgenia
  • Saez, Marc|||0000-0003-1882-0157
  • Rigau, David|||0000-0003-0828-4872
  • Cunill, Ruth|||0000-0003-3247-393X
  • Mayoral, Sacramento
  • Carrion, Carme|||0000-0003-1479-7551
  • Serrano, Domènec
  • Castells Cervelló, Xavier|||0000-0002-2619-7273
Clinical practice guidelines (CPGs) have become fundamental tools for evidence-based medicine (EBM). However, CPG suffer from several limitations, including obsolescence, lack of applicability to many patients, and limited patient participation. This paper presents APPRAISE-RS, which is a methodology that we developed to overcome these limitations by automating, extending, and iterating the methodology that is most commonly used for building CPGs: the GRADE methodology. APPRAISE-RS relies on updated information from clinical studies and adapts and automates the GRADE methodology to generate treatment recommendations. APPRAISE-RS provides personalized recommendations because they are based on the patient's individual characteristics. Moreover, both patients and clinicians express their personal preferences for treatment outcomes which are considered when making the recommendation (participatory). Rule-based system approaches are used to manage heuristic knowledge. APPRAISE-RS has been implemented for attention deficit hyperactivity disorder (ADHD) and tested experimentally on 28 simulated patients. The resulting recommender system (APPRAISE-RS/TDApp) shows a higher degree of treatment personalization and patient participation than CPGs, while recommending the most frequent interventions in the largest body of evidence in the literature (EBM). Moreover, a comparison of the results with four blinded psychiatrist prescriptions supports the validation of the proposal. APPRAISE-RS is a valid methodology to build recommender systems that manage updated, personalized and participatory recommendations, which, in the case of ADHD includes at least one intervention that is identical or very similar to other drugs prescribed by psychiatrists.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly

  • Conde-Dusman, María J.|||0000-0001-6841-2181
  • Dey, Partha N.
  • Elía-Zudaire, Óscar|||0000-0002-1396-834X
  • Rabaneda, Luis G 4
  • García-Lira, Carmen
  • Grand, Teddy
  • Briz, Victor|||0000-0001-6936-0918
  • Velasco, Eric R.
  • Andero Galí, Raül|||0000-0003-3641-8903
  • Niñerola, Sergio
  • Barco, Angel|||0000-0002-0653-3751
  • Paoletti, Pierre|||0000-0002-3681-4845
  • Wesseling, John F.
  • Gardoni, Fabrizio|||0000-0003-4598-5563
  • Tavalin, Steven J.|||0000-0001-7169-0932
  • Perez-Otaño, Isabel|||0000-0002-7222-8202
De novo protein synthesis is required for synapse modifications underlying stable memory encoding. Yet neurons are highly compartmentalized cells and how protein synthesis can be regulated at the synapse level is unknown. Here, we characterize neuronal signaling complexes formed by the postsynaptic scaffold GIT1, the mechanistic target of rapamycin (mTOR) kinase, and Raptor that couple synaptic stimuli to mTOR-dependent protein synthesis; and identify NMDA receptors containing GluN3A subunits as key negative regulators of GIT1 binding to mTOR. Disruption of GIT1/mTOR complexes by enhancing GluN3A expression or silencing GIT1 inhibits synaptic mTOR activation and restricts the mTOR-dependent translation of specific activity-regulated mRNAs. Conversely, GluN3A removal enables complex formation, potentiates mTOR-dependent protein synthesis, and facilitates the consolidation of associative and spatial memories in mice. The memory enhancement becomes evident with light or spaced training, can be achieved by selectively deleting GluN3A from excitatory neurons during adulthood, and does not compromise other aspects of cognition such as memory flexibility or extinction. Our findings provide mechanistic insight into synaptic translational control and reveal a potentially selective target for cognitive enhancement.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Correction to 'TMSNP, a web server to predict pathogenesis of missense mutations in the transmembrane region of membrane proteins'

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

PATH classification, a proposal for patients with HNSCC treated with salvage surgery

  • Llansana, Albert
  • Virós Porcuna, David|||0000-0002-2861-3672
  • Vásquez, Rosselin|||0000-0002-2483-9383
  • Parellada, Arnau
  • Valero Mayor, Cristina|||0000-0003-3397-2888
  • Holgado, Anna|||0000-0002-7478-8561
  • León i Vintró, Xavier|||0000-0001-6286-630X
Purpose: The aim of this study is to propose a classification for patients with recurrent head and neck squamous cell carcinoma (HNSCC) treated with salvage surgery based on the location of the primary tumor and data commonly found in the pathological report of the resection. Methods: Retrospective study of 665 patients with HNSCC treated with a salvage surgery after a local and/or regional recurrence of the tumor. Results: We propose a new postoperative classification for patients with recurrent HNSCC treated with salvage surgery. PATH classification stratifies patients into 4 stages based on the glottic or non-glottic location of the primary tumor, the local and regional pathologic extension of the tumor, the status of the surgical margins, and the presence of lymph node metastases with extracapsular spread. The PATH classification was more homogeneous in the prognosis of patients included in each of its stages, and it had a better prognostic discrimination capacity between stages than the rpTNM classification. According to the PATH classification, the 5-year disease-specific survival was: PATH I (n = 306) 82.8%; PATH II (n = 119) 47.1%; PATH III (n = 202) 24.4%; PATH IV (n = 38) 3.7%. For the rpTNM classification, the 5-year disease-specific survival was: stage I (n = 119) 85.1%; stage II (n = 134) 68.4%; stage III (n = 111) 59.5%; stage IV (n = 301) 33.3%. Conclusion: The PATH classification for HNSCC patients with local and/or regional recurrence treated with salvage surgery had a better prognostic capacity than the rpTNM classification. Level of evidence: Level IV.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood DNA Methylation Analysis Reveals a Distinctive Epigenetic Signature of Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Vallverdú-Prats, Marta|||0000-0002-5262-817X
  • Pérez-Giraldo, Alberto
  • Viles-García, Marc
  • Peris-Subiza, Julia
  • Vidal-Notari, Sergio
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Guisado-Alonso, Daniel|||0000-0002-5799-3184
  • Esteller, M.|||0000-0003-4490-6093
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Ois, Angel|||0000-0002-1375-5950
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
Vasospasm is a potentially preventable cause of poor prognosis in patients with aneurysmal subarachnoid hemorrhage (aSAH). Epigenetics might provide insight on its molecular mechanisms. We aimed to analyze the association between differential DNA methylation (DNAm) and development of vasospasm. We conducted an epigenome-wide association study in 282 patients with aSAH admitted to our hospital. DNAm was assessed with the EPIC Illumina chip (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prenatal immune activation in rats and adult exposure to inescapable shocks reveal sex-dependent effects on fear conditioning that might be relevant for schizophrenia

  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Fuentes, Silvia|||0000-0002-8352-1068
  • Visa Bombardo, Joan|||0000-0002-9675-9999
  • Belda, Xavier|||0000-0003-0374-9546
  • Serrano, Sara
  • Labad, Javier|||0000-0003-2214-1886
Prenatal infection is considered a relevant factor for neurodevelopmental alterations and psychiatric diseases. Administration of bacterial and viral components during pregnancy in rodents results in maternal immune activation (MIA), leading to schizophrenia-like neurochemical and behavioral changes. Despite some evidence for abnormal fear conditioning in schizophrenia, only a few animal studies have focused on this issue. Therefore, we addressed the impact of the administration of the viral mimetic polyI:C to pregnant Long-Evans rats on the adult offspring response to inescapable shocks (IS) and contextual fear conditioning. In males, polyI:C induced a greater endocrine (plasma ACTH) response to IS and both polyI:C and IS enhanced fear conditioning and generalization to a completely different novel environment (hole-board), with no additive effects, probably due to a ceiling effect. In contrast, a modest impact of polyI:C and a lower impact of IS on contextual fear conditioning and generalization was observed in females. Thus, the present results demonstrate that polyI:C dramatically affected fear response to IS in adult males and support the hypothesis that males are more sensitive than females to this treatment. This model might allow to explore neurobiological mechanisms underlying abnormal responsiveness to fear conditioning and stressors in schizophrenia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration

  • Fernández-Calvet, Ariadna|||0000-0002-3340-703X
  • Matilla-Cuenca, Leticia|||0000-0003-1822-0151
  • Izco, María|||0000-0003-4807-6779
  • Navarro, Susanna|||0000-0001-8160-9536
  • Serrano, Miriam
  • Ventura, Salvador|||0000-0002-9652-6351
  • Blesa, Javier|||0000-0002-4257-1325
  • Herráiz, Maite
  • Alkorta-Aranburu, Gorka
  • Galera, Sergio
  • Ruiz de los Mozos, Igor|||0000-0003-4097-6422
  • Mansego, María Luisa|||0000-0001-8914-7890
  • Toledo-Arana, Alejandro|||0000-0001-8148-6281
  • Alvarez-Erviti, Lydia|||0000-0002-1238-9442
  • Valle, Jaione|||0000-0003-3115-0207
Age-related neurodegenerative diseases involving amyloid aggregation remain one of the biggest challenges of modern medicine. Alterations in the gastrointestinal microbiome play an active role in the aetiology of neurological disorders. Here, we dissect the amyloidogenic properties of biofilm-associated proteins (BAPs) of the gut microbiota and their implications for synucleinopathies. We demonstrate that BAPs are naturally assembled as amyloid-like fibrils in insoluble fractions isolated from the human gut microbiota. We show that BAP genes are part of the accessory genomes, revealing microbiome variability. Remarkably, the abundance of certain BAP genes in the gut microbiome is correlated with Parkinson's disease (PD) incidence. Using cultured dopaminergic neurons and Caenorhabditis elegans models, we report that BAP-derived amyloids induce α-synuclein aggregation. Our results show that the chaperone-mediated autophagy is compromised by BAP amyloids. Indeed, inoculation of BAP fibrils into the brains of wild-type mice promote key pathological features of PD. Therefore, our findings establish the use of BAP amyloids as potential targets and biomarkers of α-synucleinopathies. The microbiota of the intestinal tract is considered a large biofilm formed by myriads bacteria that have a considerable impact in health and disease. Here, the authors show that biofilm-associated proteins from intestinal microbiota form amyloid-like structures that exacerbate alpha-synuclein pathologies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Geometric, Biomechanic and Haemodynamic Aortic Abnormalities Assessed by 4D Flow Cardiovascular Magnetic Resonance in Patients Treated by TEVAR Following Blunt Traumatic Thoracic Aortic Injury

  • Gil-Sala, Daniel|||0000-0003-4885-5836
  • Guala, Andrea|||0000-0002-5006-8164
  • Garcia Reyes, Marvin
  • Azancot, María A.|||0000-0002-8447-1373
  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Allegue Allegue, Nicolas
  • Teixido-Tura, Gisela|||0000-0003-4714-2420
  • Goncalves Martins, Gabriela
  • Ruiz Muñoz, Aroa|||0000-0002-1138-8528
  • Constenla Garcia, Ivan|||0000-0002-7107-2277
  • Evangelista Masip, Arturo|||0000-0001-8182-1174
  • Tello Díaz, Cristina
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Bellmunt Montoya, Sergi|||0000-0002-2851-720X
Objective: Thoracic endovascular aortic repair (TEVAR) is widely used for the treatment of patients with blunt traumatic thoracic aortic injury (BTAI). However, aortic haemodynamic and biomechanical implications of this intervention are poorly investigated. This study aimed to assess whether patients treated by TEVAR following BTAI have thoracic aortic abnormalities in geometry, stiffness, and haemodynamics. Methods: Patients with BTAI treated by TEVAR at Vall d'Hebron Hospital between 1999 and 2019 were compared with propensity score matched healthy volunteers (HVs). All subjects underwent cardiovascular magnetic resonance (CMR) comprising a 4D flow CMR sequence. Spatially resolved aortic diameter, length, volume, and curvature were assessed. Pulse wave velocity, distensibility, and longitudinal strain (all measurements of aortic stiffness) were determined regionally. Moreover, advanced haemodynamic descriptors were quantified: systolic flow reversal ratio (SFRR), quantifying backward flow during systole, and in plane rotational flow (IRF), measuring in plane strength of helical flow. Results: Twenty-six BTAI patients treated by TEVAR were included and matched with 26 HVs. They did not differ in terms of age, sex, and body surface area. Patients with TEVAR had a larger and longer ascending aorta (AAo) and marked abnormalities in local curvature. Aortic stiffness was greater in the aortic segments proximal and distal to TEVAR compared with controls. Moreover, TEVAR patients presented strongly altered flow dynamics compared with controls: a reduced IRF from the distal AAo to the proximal descending aorta and an increased SFRR in the whole thoracic aorta. These differences persisted adjusting for cardiovascular risk factors and were independent of time elapsed since TEVAR implantation. Conclusion: At long term follow up, previously healthy patients who underwent TEVAR implantation following BTAI had increased diameter, length and volume of the ascending aorta, and increased aortic stiffness and abnormal flow patterns in the whole thoracic aorta compared with matched controls. Further studies should address whether these alterations have clinical implications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Profiling TREM2 expression in amyotrophic lateral sclerosis

  • Jericó-Pascual, Ivonne|||0000-0003-4262-6370
  • Vicuña-Urriza, J.
  • Blanco-Luquin, I.
  • Macias, M.
  • Martinez-Merino, L.
  • Roldán, M.
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • Pagola-Lorz, Inma
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Luna Salva, Noemí de|||0000-0002-4342-794X
  • Zelaya, V.
  • Mendioroz, Maite|||0000-0002-4179-5781
There is growing evidence of the contribution of neuroinflammation, and in particular microglia, in the pathogenesis of amyotrophic lateral sclerosis (ALS). TREM2 gene plays a crucial role in shaping microglia in neurodegenerative conditions. To deepen the understanding of TREM2 in ALS and investigate the performance of TREM2 as a biomarker, we profiled TREM2 expression levels in spinal cord, cerebrospinal fluid and blood of patients with sporadic ALS. We also wanted to investigate whether the combined measurement of sTREM2 in fluids could improve the diagnostic yield of total and phosphorylated TDP-43 levels. We performed a case-control study to profile overall and transcript-specific TREM2 mRNA levels by RT-qPCR and protein expression levels by Western-blot in postmortem specimens of spinal cord from ALS patients and controls. In parallel, we measured soluble TREM2 (sTREM2) protein levels and full length and phosphorylated TDP-43 (tTDP-43 and pTDP-43) by ELISA in CSF and serum from ALS patients vs healthy controls. Patients were prospectively recruited from an ALS unit of a tertiary hospital and fulfilled El Escorial revised criteria. After bivariate analysis, a logistic regression model was developed to identify adjusted estimates of the association of sTREM2 levels in CSF and serum with ALS status. Overall and transcript-specific TREM2 mRNA were upregulated in the spinal cord of ALS patients (n = 21) compared to controls (n = 19). Similar changes were observed in TREM2 protein levels (p < 0.01) in spinal cord of ALS patients vs healthy controls. We also detected significantly higher sTREM2 levels in CSF (p-value < 0.01) of ALS patients (n = 46) vs controls (n = 46) and serum (p-value < 0.001) of ALS patients (n = 100) vs controls (n = 100). In a logistic regression model, both CSF and serum sTREM2 remained independently associated with ALS status with OR = 3.41 (CI 95 %=1.34-8.66) (p-value < 0.05) and OR = 3.38 (CI 95 %: 1.86-6.16) (p-value < 0.001), respectively. We also observed that pTDP-43 levels in CSF is an independent predictor of ALS (p-value < 0.05). Our results support the role of TREM2 in ALS pathophysiology and demonstrates that the three TREM2 transcripts are deregulated in ALS in postmortem human specimens of spinal cord. We hypothesise about the possible influence of systemic-peripheral inflammation in the disease. Finally, we conclude that pTDP-43 levels in CSF could be a biomarker of ALS, and sTREM2 measurement in CSF and blood emerge as potential non-invasive biomarker in ALS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term vascular events after subarachnoid hemorrhage

  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Guimaraens, Leopoldo
  • Vivas, Elio
  • Saldaña, Jesus
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Revert-Barbera, Anna
  • Estragues-Gazquez, Isabel
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Rey-Álvarez, Lucía|||0000-0003-3000-4814
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Ois, Angel|||0000-0002-1375-5950
Background: Spontaneous subarachnoid hemorrhage (SAH) long-term risk is not well known. Our aims are: describing long-term vascular event (VE) incidence rates in SAH survivors; describing VE: ischemic and/or hemorrhagic; identifying independent association of factors related to VE; and analyzing the usefulness of factors to increase predictive ability. Methods: A prospective cohort study of consecutive patients admitted to Hospital del Mar with a diagnosis of SAH (n = 566) between January 2007 and January 2020 was carried out. They were followed up until January 2021. The study endpoint was a new VE in the follow-up. We calculated both incidence rates and cumulative rates at 5 years. Cox regression survival models including vascular risk factors with and without specific data of SAH disease were developed. We analyzed ROC curves of all multivariate models. Results: The analyzed cohort included 423 non-fatal SAH cases. Total patient-years were 2468.16 years. The average follow-up was 70.03 ± 43.14; range: 1-180 months. There were 49 VE detected in 47 patients, as 2 of them had more than 1 VE. Incidence rate was 0.020 events_per_patient/year, cumulative incidence at 5 years was 11.11%. The more frequent VE that we found were cerebrovascular (28/49), mainly ischemic (21/28). Disability after SAH and the presence of multiple aneurysms were independently associated with a VE risk and improved the predictive capacity of multivariate models (AUC 0.679 vs 0.764; p = 0.0062). Conclusions: We reported a low vascular risk after SAH. We have shown the usefulness of SAH factors to identify patients with a higher risk of VE.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden, A Nonrandomized Controlled Trial

  • Provencio Pulla, Mariano|||0000-0001-6315-7919
  • Ortega Granados, Ana Laura|||0000-0002-5727-3371
  • Coves-Sarto, Juan
  • Calvo, Virginia|||0000-0002-3503-4847
  • Marsé-Fabregat, Raquel
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Guirado Risueño, Maria|||0000-0001-9086-204X
  • Carcereny, Enric|||0000-0001-5235-5602
  • Fernández, Natalia
  • Álvarez, Ruth
  • Blanco, Remei|||0000-0001-6748-0326
  • León-Mateos, Luis
  • Sánchez Torres, José Miguel
  • Sullivan, Ivana|||0000-0002-0434-3436
  • Cobo, Manuel|||0000-0003-3402-1144
  • Sánchez Hernández, Alfredo|||0000-0001-5826-8390
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • Sierra Rodero, Belén|||0000-0003-0276-6088
  • Mártinez-Toledo, Cristina
  • Serna-Blasco, Roberto
  • Romero, Atocha|||0000-0002-1634-7397
  • Cruz-Bermúdez, Alberto|||0000-0001-5136-7011
Antiangiogenic drug combinations with anti-programmed cell death 1 protein and anti-programmed cell death 1 ligand 1 (PD-L1) agents are a novel treatment option for lung cancer. However, survival remains limited, and the activity of these combinations for tumors with high tumor mutation burden (TMB) is unknown. To assess the clinical benefits and safety of atezolizumab plus bevacizumab for patients with high-TMB advanced nonsquamous non-small cell lung cancer (NSCLC). This multicenter, single-arm, open-label, phase 2 nonrandomized controlled trial (Atezolizumab Plus Bevacizumab in First-Line NSCLC Patients [TELMA]) included treatment-naive patients aged 18 years or older with confirmed stage IIIB-IV nonsquamous NSCLC with TMB of 10 or more mutations/megabase and no EGFR, ALK, STK11, MDM2, or ROS1 alterations. From May 2019 through January 2021, patients were assessed at 13 sites in Spain, with follow-up until February 28, 2022. Participants were given atezolizumab, 1200 mg, plus bevacizumab, 15 mg/kg, on day 1 of each 21-day cycle. Treatment was continued until documented disease progression, unacceptable toxic effects, patient withdrawal, investigator decision, or death. Main Outcomes and Measures: The primary end point was 12-month progression-free survival (PFS) rate (according to Response Evaluation Criteria in Solid Tumours, version 1.1 criteria); PFS was defined as the time from enrollment to disease progression or death. Adverse events were monitored according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0. A total of 307 patients were assessed for trial eligibility, of whom 266 were ineligible for enrollment. Of the 41 patients enrolled, 3 did not fulfill all inclusion criteria and were excluded. The remaining 38 patients (28 [73.7%] male; mean [SD] age, 63.7 [8.3] years) constituted the per-protocol population. The 12-month PFS rate was 51.3% (95% CI, 34.2%-66.0%), which met the primary end point. The 12-month overall survival (OS) rate was 72.0% (95% CI, 54.1%-83.9%). The median PFS was 13.0 months (95% CI, 7.9-18.0 months), and the median OS was not reached. Of the 38 patients, 16 (42.1%) achieved an objective response and 30 (78.9%) achieved disease control. The median time to response was 2.8 months (IQR, 2.8-3.58 months), with a median duration of response of 11.7 months (range, 3.57-22.4 months; the response was ongoing at cutoff). Of 16 responses, 8 (50.0%) were ongoing. Most adverse events were grade 1 or 2. For atezolizumab, the most common adverse events were fatigue (6 [15.8%]) and pruritus (6 [15.8%]). For bevacizumab, they were hypertension (10 [26.3%]) and proteinuria (4 [10.5%]). Drug discontinuation occurred in 2 patients receiving atezolizumab (5.3%) and 3 patients receiving bevacizumab (7.9%). PD-L1 levels were not associated with response, PFS, or OS. These findings suggest that atezolizumab with bevacizumab is a potential treatment for high-TMB nonsquamous NSCLC. ClinicalTrials.gov Identifier: NCT03836066.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma, Beyond Blood Eosinophils

  • Cosio, Borja G.|||0000-0002-6388-8209
  • Shafiek, Hanaa|||0000-0002-4716-4809
  • Iglesias, Amanda|||0000-0003-2600-351X
  • Mosteiro, Mar
  • Gonzalez-Piñeiro, Ana
  • Rodríguez, Marta
  • García-Cosío, Mónica
  • Busto, Eladio
  • Martin, Javier
  • Mejías, Luis
  • Benito, Amparo
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Gómez Cobo, Cristina|||0000-0002-9776-4730
Blood eosinophil count (BEC) is currently used as a surrogate marker of T2 inflammation in severe asthma but its relationship with tissue T2-related changes is elusive. Bronchial biopsy could add reliable information but lacks standardization. To validate a systematic assessment of the bronchial biopsy for the evaluation of severe uncontrolled asthma (SUA) by standardizing a pathological score. A systematic assessment of submucosal inflammation, tissue eosinophilic count/field (TEC), goblet cells hyperplasia, epithelial changes, basement membrane thickening, prominent airway smooth muscle and submucosal mucous glands was initially agreed and validated in representative bronchial biopsies of 12 patients with SUA by 8 independent pathologists. In a second phase, 62 patients with SUA who were divided according to BEC ≥ 300 cells/mm or less underwent bronchoscopy with bronchial biopsies and the correlations between the pathological findings and the clinical characteristics were investigated. The score yielded good agreement among pathologists regarding submucosal eosinophilia, TEC, goblet cells hyperplasia and mucosal glands (ICC = 0.85, 0.81, 0.85 and 0.87 respectively). There was a statistically significant correlation between BEC and TEC (r = 0.393, p = 0.005) that disappeared after correction by oral corticosteroids (OCS) use (r = 0.170, p = 0.307). However, there was statistically significant correlation between FeNO and TEC (r = 0.481, p = 0.006) that was maintained after correction to OCS use (r = 0.419, p = 0.021). 82.4% of low-BEC had submucosal eosinophilia, 50% of them moderate to severe. A standardized assessment of endobronchial biopsy is feasible and could be useful for a better phenotyping of SUA especially in those receiving OCS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CHARMS and PROBAST at your fingertips, a template for data extraction and risk of bias assessment in systematic reviews of predictive models

  • Fernandez-Felix, Borja M.
  • López Alcalde, Jesús|||0000-0002-1598-8790
  • Roqué i Figuls, Marta|||0000-0003-0043-1364
  • Muriel, Alfonso|||0000-0002-4805-4011
  • Zamora, Javier|||0000-0003-4901-588X
Systematic reviews of studies of clinical prediction models are becoming increasingly abundant in the literature. Data extraction and risk of bias assessment are critical steps in any systematic review. CHARMS and PROBAST are the standard tools used for these steps in these reviews of clinical prediction models. We developed an Excel template for data extraction and risk of bias assessment of clinical prediction models including both recommended tools. The template makes it easier for reviewers to extract data, to assess the risk of bias and applicability, and to produce results tables and figures ready for publication. We hope this template will simplify and standardize the process of conducting a systematic review of prediction models, and promote a better and more comprehensive reporting of these systematic reviews.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Scheeren Brum, Wagner|||0000-0002-9777-0559
  • Molfetta, Guglielmo Di
  • Benedet, Andréa Lessa
  • Arslan, Burak
  • Jonaitis, Erin Mc Mullen
  • Langhough, Rebecca E.
  • Cody, Karly Alex
  • Wilson, Rachael E.
  • Carlsson, Cynthia M.
  • Vanmechelen, Eugeen|||0000-0002-9466-5366
  • Montoliu Gaya, Laia|||0000-0001-7684-6318
  • Lantero Rodríguez, Juan|||0000-0002-7426-678X
  • Rahmouni, Nesrine
  • Tissot, Cécile
  • Stevenson, Jenna
  • Servaes, Stijn|||0000-0002-4431-957X
  • Therriault, Joseph
  • Pascoal, Tharick|||0000-0001-9057-8014
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Johnson, Sterling C.
  • Jeromin, Andreas
  • Blennow, Kaj|||0000-0002-1890-4193
  • Zetterberg, Henrik|||0000-0003-3930-4354
IMPORTANCE Phosphorylated tau (p-tau) is a specific blood biomarker for Alzheimer disease (AD) pathology, with p-tau217 considered to have the most utility. However, availability of p-tau217 tests for research and clinical use has been limited. Expanding access to this highly accurate AD biomarker is crucial for wider evaluation and implementation of AD blood tests. OBJECTIVE To determine the utility of a novel and commercially available immunoassay for plasma p-tau217 to detect AD pathology and evaluate reference ranges for abnormal amyloid β (Aβ) and longitudinal change across 3 selected cohorts. DESIGN, SETTING, AND PARTICIPANTS This cohort study examined data from 3 single-center observational cohorts: cross-sectional and longitudinal data from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort (visits October 2017-August 2021) and Wisconsin Registry for Alzheimer's Prevention (WRAP) cohort (visits February 2007-November 2020) and cross-sectional data from the Sant Pau Initiative on Neurodegeneration (SPIN) cohort (baseline visits March 2009-November 2021). Participants included individuals with and without cognitive impairment grouped by amyloid and tau (AT) status using PET or CSF biomarkers. Data were analyzed from February to June 2023. EXPOSURES Magnetic resonance imaging, Aβ positron emission tomography (PET), tau PET, cerebrospinal fluid (CSF) biomarkers (Aβ42/40 and p-tau immunoassays), and plasma p-tau217 (ALZpath pTau217 assay). MAIN OUTCOMES AND MEASURES Accuracy of plasma p-tau217 in detecting abnormal amyloid and tau pathology, longitudinal p-tau217 change according to baseline pathology status. RESULTS The study included 786 participants (mean [SD] age, 66.3 [9.7] years; 504 females [64.1%] and 282 males [35.9%]). High accuracy was observed in identifying elevated Aβ (area under the curve [AUC], 0.92-0.96; 95% CI, 0.89-0.99) and tau pathology (AUC, 0.93-0.97; 95% CI, 0.84-0.99) across all cohorts. These accuracies were comparable with CSF biomarkers in determining abnormal PET signal. The detection of abnormal Aβ pathology using a 3-range reference yielded reproducible results and reduced confirmatory testing by approximately 80%. Longitudinally, plasma p-tau217 values showed an annual increase only in Aβ-positive individuals, with the highest increase observed in those with tau positivity. CONCLUSIONS AND RELEVANCE This study found that a commercially available plasma p-tau217 immunoassay accurately identified biological AD, comparable with results using CSF biomarkers, with reproducible cut-offs across cohorts. It detected longitudinal changes, including at the preclinical stage.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Male football comedy. A reappraisal of traditional, declassed, toxic masculinity., Ted Lasso as an improved continuation of British television sports series, Comedia futbolística masculina. Reivindicación de la masculinidad tradicional, desclasada y tóxica : Ted Lasso como continuación mejorada de las series de televisión deportivas británicas

  • Tous, Anna|||0000-0003-4519-3793
This research focuses on British television sports sitcoms (2002-2023), which in this study we term 'male football comedy', and their depiction of declassed male characters in what has been termed the 'crisis of masculinity'. It investigates the causes of the comic portrayal of men experiencing professional and personal failure in a reactionary zeitgeist, leading to toxic masculinity, in contrast to the clichéd figure of the 'bossy woman'. The various productions portray class differences and in particular, the abyss between elite soccer and the working class. We conclude that the subgenre and its inherent toxic masculinity have been maintained, criticized and at the same time legitimized, and that American television series Ted Lasso, belonging to the same subgenre, is a conciliatory approach towards a better relationship between genders.Keywords:British sports fiction; football; toxic masculinity; social class, Esta investigación se centra en las sit-coms deportivas británicas (2002-2023), que denominamos "comedia futbolística masculina", y en su representación de personajes masculinos desclasados de la denominada crisis de masculinidad. Se investigan las causas de la representación cómica de los hombres y su fracaso profesional y personal, en un zeitgeist reaccionario, que conduce a la masculinidad tóxica, en contraste con el cliché de la "mujer mandona". Las series retratan la diferencia de clases y, más concretamente, el abismo entre el fútbol de élite y la clase trabajadora. Se concluye que el subgénero y su inherente masculinidad tóxica se han mantenido, criticado y al mismo tiempo legitimado, y que la serie estadounidense Ted Lasso, del mismo subgénero, es una propuesta conciliadora de una mejor relación entre géneros.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genotyping Hepatitis B virus by Next-Generation Sequencing, Detection of Mixed Infections and Analysis of Sequence Conservation

  • Dopico, Eva|||0000-0002-5306-3035
  • Vila, Marta|||0000-0001-9303-5189
  • Tabernero, David|||0000-0002-1146-4084
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Pacín Ruiz, Beatriz|||0000-0001-8718-6589
  • Guerrero, Laura|||0000-0003-1978-9067
  • Ubillos, Itziar|||0000-0002-0993-0058
  • Martínez, Miguel J.|||0000-0002-0682-1075
  • Costa, Josep|||0000-0001-7978-0748
  • Quer, Josep|||0000-0003-0014-084X
  • Pérez Garreta, Javier
  • González Sánchez, Alejandra|||0000-0002-1809-3415
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Buti, Maria|||0000-0002-0732-3078
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Cortese, Maria Francesca|||0000-0002-4318-532X
Our aim was to develop an accurate, highly sensitive method for HBV genotype determination and detection of genotype mixtures. We examined the preS and 5' end of the HBV X gene (5X) regions of the HBV genome using next-generation sequencing (NGS). The 1852 haplotypes obtained were subjected to genotyping via the Distance-Based discrimination method (DB Rule) using two sets of 95 reference sequences of genotypes A-H. In clinical samples from 125 patients, the main genotypes were A, D, F and H in Caucasian, B and C in Asian and A and E in Sub-Saharan patients. Genotype mixtures were identified in 28 (22.40%) cases, and potential intergenotypic recombination was observed in 29 (23.20%) cases. Furthermore, we evaluated sequence conservation among haplotypes classified into genotypes A, C, D, and E by computing the information content. The preS haplotypes exhibited limited shared conserved regions, whereas the 5X haplotypes revealed two groups of conserved regions across the genotypes assessed. In conclusion, we developed an NGS-based HBV genotyping method utilizing the DB Rule for genotype classification. We identified two regions conserved across different genotypes at 5X, offering promising targets for RNA interference-based antiviral therapies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in prelimbic cortex calcium dynamics during stress and fear learning

  • Marin Blasco, Ignacio Javier|||0000-0001-5096-2871
  • Vanzo, Giorgia
  • Rusco-Portabella, Joaquin
  • Perez-Molina, Lucas
  • Romero, Leire R.
  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Andero Galí, Raül|||0000-0003-3641-8903
In recent years, research has progressively increased the importance of considering sex differences in stress and fear memory studies. Many studies have traditionally focused on male subjects, potentially overlooking critical differences with females. Emerging evidence suggests that males and females can exhibit distinct behavioral and neurophysiological responses to stress and fear conditioning. These differences may be attributable to variations in hormone levels, brain structure, and neural circuitry, particularly in regions such as the prefrontal cortex (PFC). In the present study, we explored sex differences in prelimbic cortex (PL) calcium activity in animals submitted to immobilization stress (IMO), fear conditioning (FC), and fear extinction (FE). While no significant sex differences were found in behavioral responses, we did observe differences in several PL calcium activity parameters. To determine whether these results were related to behaviors beyond stress and fear memory, we conducted correlation studies between the movement of the animals and PL activity during IMO and freezing behavior during FC and FE. Our findings revealed a clear correlation between PL calcium activity with movement during stress exposure and freezing behavior, with no sex differences observed in these correlations. These results suggest a significant role for the PL in movement and locomotion, in addition to its involvement in fear-related processes. The inclusion of both female and male subjects is crucial for studies like this to fully understand the role of the PFC and other brain areas in stress and fear responses. Recognizing sex differences enhances our comprehension of brain function and can lead to more personalized and effective approaches in the study and treatment of stress and fear-related conditions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction

  • Planas-Cerezales, Lurdes|||0000-0001-7636-444X
  • Arias-Salgado, Elena G.
  • Berastegui García, Cristina|||0000-0001-9774-9349
  • Montes-Worboys, Ana|||0000-0002-3204-779X
  • González-Montelongo, Rafaela
  • Lorenzo-Salazar, José. M.
  • Vicens-Zygmunt, Vanesa|||0000-0002-0940-3215
  • Garcia-Moyano, Marta
  • Dorca, Jordi|||0000-0002-8137-878X
  • Flores, Carlos|||0000-0001-5352-069X
  • Perona, Rosario|||0000-0002-2973-5153
  • Roman Broto, Antonio|||0000-0002-9417-3484
  • Molina Molina, Maria|||0000-0002-1852-1723
Introduction: Fibrotic interstitial lung diseases (ILDs) are the first indication for lung transplantation (LT). Telomere dysfunction has been associated with poor post-transplant outcomes. The aim of the study was to evaluate the morbi-mortality and quality of life in fibrotic ILDs after lung transplant depending on telomere biology. Methods: Fibrotic ILD patients that underwent lung transplant were allocated to two arms; with or without telomere dysfunction at diagnosis based on the telomere length and telomerase related gene mutations revealed by whole-exome sequencing. Post-transplant evaluation included: (1) short and long-term mortality and complications and (2) quality of life. Results: Fifty-five percent of patients that underwent LT carried rare coding mutations in telomerase-related genes. Patients with telomere shortening more frequently needed extracorporeal circulation and presented a higher rate of early post-transplant hematological complications, longer stay in the intensive care unit (ICU), and a higher number of long-term hospital admissions. However, post-transplant 1-year survival was higher than 80% regardless of telomere dysfunction, with improvement in the quality of life and oxygen therapy withdrawal. Conclusions: Post-transplant morbidity is higher in patients with telomere dysfunction and differs according to elapsed time from transplantation. However, lung transplant improves survival and quality of life and the associated complications are manageable.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population

  • Loste, Cora
  • Trigueros Peña, Macedonia|||0000-0003-4156-1018
  • Muñoz-López, Francisco|||0000-0003-1789-1658
  • Urrea, Víctor|||0000-0002-2577-856X
  • Martínez, Ana
  • González, Sandra
  • Puig, Jordi|||0000-0002-4075-0346
  • Martín Flix, Marta|||0000-0001-7849-3616
  • Bonjoch, Anna|||0000-0002-5343-2881
  • Echeverría, Patricia|||0000-0003-2755-3695
  • Massanella, Marta|||0000-0002-3326-151X
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
This is an observational, cross-sectional, comparative case-control, pilot study aimed at assessing the impact of HIV infection and age on immunological markers in people with HIV (PWH) on antiretroviral therapy (ART). The study included 40 PWH on ART, divided into two age groups (40-45 years vs. ≥60 years), and 30 HIV-uninfected controls matched by sex and age. The results show that older PWH on ART had more comorbidities and a higher frequency of CD8 T cells compared to older controls, with a significant decrease in CD8 naïve T cells with age. Additionally, younger PWH on ART exhibited higher frequencies of activated CD8 T cells and elevated levels of inflammatory markers (sCD14, IL-6) compared to age-matched controls, with values similar to those of older PWH on ART. These findings suggest that younger PWH on ART may experience accelerated immunoaging, highlighting the need for early interventions in this population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular screening of transitional B cells as a prognostic marker of improved graft outcome and reduced rejection risk in kidney transplant

  • Perezpayá, Inés
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Sanroque-Muñoz, Marta|||0009-0004-5197-7708
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Rodríguez-Martínez, Paula|||0000-0002-9001-2501
  • Vila-Santandreu, Anna
  • Bover, Jordi|||0000-0003-3577-2273
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Cañas, Laura
  • Franquesa, Marcella|||0000-0002-1287-8908
Understanding immune cell dynamics in kidney transplantation may provide insight into the mechanisms of rejection and improve patient management. B cells have gained interest with a special relevance of the "regulatory" subsets and their graft outcome prognostic value. In this study, we aimed to prove that the direct immunophenotyping and target gene expression analysis of kidney transplant patients' fresh whole blood will help to identify graft rejection risk and assist in the monitoring of kidney transplanted patients. We employed flow cytometry and qPCR techniques to characterize B and T cell subsets within fresh whole blood samples, with particular emphasis on transitional B cells (TrB) identified as CD19 + CD24 hi CD38 hi. TrB are a relevant population in the context of kidney transplantation and are closely associated with regulatory B cells (Bregs) in humans. Patients were monitored, tracking pertinent clinical parameters and kidney-related events, including alterations in graft function and episodes of biopsy proven rejection. Higher percentages of TrB cells at 3 months after transplantation were positively associated with better graft outcomes and lower biopsy-proven acute rejection risk. Furthermore, a novel panel of B cell regulatory associated genes was validated at 3 months post-transplantation by qPCR analysis of peripheral blood mononuclear cell (PBMC) mRNA, showing high predictive power of graft events and prognostic value. These findings suggest that monitoring TrB may provide interesting patient management information, improve transplant outcomes, and allow for personalized drug regimens to minimize clinical complications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Video conference vs face-to-face group psychotherapy for distressed cancer survivors, A randomized controlled trial

  • Lleras, María|||0000-0002-7767-1625
  • Medina, Joan Carles|||0000-0002-4550-2157
  • Vives Brosa, Jaume|||0000-0001-5412-7275
  • Casellas-Grau, Anna|||0000-0003-2919-0509
  • Marzo, Jose Luis
  • Borras, Josep M|||0000-0001-7330-6308
  • Ochoa, Cristian|||0000-0002-4508-0951
Objective: This study assesses the effectiveness of face-to-face group positive psychotherapy for cancer survivors (PPC) compared to its online adaptation, online group positive psychotherapy for cancer survivors (OPPC), which is held via videoconference. A two-arm, pragmatic randomized controlled trial was conducted to examine the effects of both interventions on emotional distress, post-traumatic stress symptoms (PTSS), and post-traumatic growth (PTG) among cancer survivors and analyze attrition to treatment. Methods: Adult women with a range of cancer diagnoses were invited to participate if they experienced emotional distress at the end of their primary oncological treatment. Emotional distress, PTSS, and PTG were assessed at baseline, immediately after treatment, and 3 months after treatment. Intention-to-treat analyses were carried out using general linear mixed models to test the effect of the interventions overtime. Logistic regressions were performed to test differential adherence to treatment and retention to follow-up. Results: A total of 269 individuals participated. The observed treatment effect was significant in both modalities, PPC and OPPC. Emotional distress (b = -2.24, 95% confidence interval [CI] = -3.15 to -1.33) and PTSS (b = -3.25, 95% CI = -4.97 to -1.53) decreased significantly over time, and PTG (b = 3.08, 95% CI = 0.38-5.78) increased significantly. Treatment gains were sustained across outcomes and over time. Analyses revealed no significant differences between modalities of treatment, after adjusting for baseline differences, finding that OPPC is as effective and engaging as PPC. Conclusions: The OPPC treatment was found to be effective and engaging for female cancer early survivors. These results open the door for psycho-oncology interventions via videoconference, which are likely to lead to greater accessibility and availability of psychotherapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short-term effect of air pollution on attention function in adolescents (ATENC!Ó), A randomized controlled trial in high schools in Barcelona, Spain

  • Gignac, Florence|||0000-0002-1613-3364
  • Barrera-Gómez, José|||0000-0002-2688-6036
  • Persavento, Cecilia|||0000-0003-4665-5945
  • Solé Martín, Caterina|||0000-0002-1542-1487
  • Tena Gallego, Èlia|||0000-0002-8313-1377
  • López-Vicente, Mónica|||0000-0002-5090-7538
  • Foraster, Maria|||0000-0003-4450-4123
  • Amato, Fulvio|||0000-0003-1546-9154
  • Alastuey, Andrés|||0000-0002-5453-5495
  • Querol Carceller, Xavier|||0000-0002-6549-9899
  • Llavador, Humberto|||0000-0003-4058-7486
  • Apesteguia, Jose|||0000-0003-0733-9595
  • Júlvez, Jordi|||0000-0003-0818-4003
  • Couso, Digna|||0000-0003-4253-5049
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Basagaña, X.|||0000-0002-8457-1489
Background: The recent evidence of the short-term impact of air pollution on youth cognitive functions is based primarily on observational studies. Objectives: We conducted a randomized controlled trial to assess whether purifying the air of the classrooms produced short-term changes in attention processes of adolescents. Methods: We recruited a total of 2,123 adolescents (13-16 years old) in 33 high schools in Barcelona metropolitan area (Spain). In each school, adolescents from each class were randomly split into two equal-sized groups and assigned to two different classrooms. A set of two air cleaner devices with the same appearance (one recirculating and filtrating the air and the other only recirculating the air) was used. Each one of the devices was placed at random at one of the two classrooms. Students were masked to intervention allocation and had to complete several computerized activities for 1.5 h, including an attention test (Flanker task) to be performed at baseline and at the end of the intervention. The response speed consistency, expressed as hit reaction time standard error (HRT-SE, in ms), was measured as the primary outcome. Analyses were conducted using conditional linear regressions with classroom as strata, adjusted for variables that may differ from one class to another such as temperature, humidity and carbon dioxide concentration. Results: Average levels of PM2.5 and black carbon throughout the 1.5 h of experiment were 89% and 87%, respectively, lower in the classrooms with air cleaner than in the control classrooms. No differences were found in the median of HRT-SE between classrooms with cleaned air and normal air (percent change: 1.37%, 95% confidence interval: -2.81%, 5.56%). Sensitivity analyses with secondary attention outcomes resulted in similar findings. Conclusions: Cleaning the air of a classroom to reduce exposure to air pollutants for 1.5 h did not have an impact on the attention function of adolescents. Still, in light of previous evidence suggesting an association between air pollution and attention, further experimental studies should explore other short-term timescales of exposure and age ranges.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer

  • Pascual-Reguant, Laura
  • Serra Camprubí, Queralt
  • Datta, Debayan
  • Cianferoni, Damiano
  • Kourtis, Savvas
  • Gañez-Zapater, Antoni|||0000-0002-6852-4834
  • Cannatá, Chiara|||0000-0003-4807-4669
  • Espinar, Lorena|||0000-0003-3881-3886
  • Querol, Jessica|||0000-0002-0527-759X
  • García-López, Laura
  • Musa-Afaneh, Sara
  • Guirola, Maria
  • Gkanogiannis, Anestis|||0000-0002-6441-0688
  • Miró Canturri, Andrea
  • Guzmán, Marta|||0000-0002-0924-9887
  • Rodríguez, Olga|||0000-0002-0123-9975
  • Herencia-Ropero, Andrea|||0009-0002-9448-1484
  • Arribas, Joaquín V.|||0000-0002-0504-0664
  • Serra, Violeta|||0000-0001-6620-1065
  • Serrano, Luis|||0000-0002-5276-1392
  • Tian, Tian|||0000-0002-9906-0980
  • Peiró, Sandra|||0000-0001-9519-3877
  • Sdelci, Sara|||0000-0003-1330-4364
Triple-negative breast cancer (TNBC) often develops resistance to single-agent treatment, which can be circumvented using targeted combinatorial approaches. Here, we demonstrate that the simultaneous inhibition of LOXL2 and BRD4 synergistically limits TNBC proliferation in vitro and in vivo. Mechanistically, LOXL2 interacts in the nucleus with the short isoform of BRD4 (BRD4S), MED1, and the cell cycle transcriptional regulator B-MyB. These interactions sustain the formation of BRD4 and MED1 nuclear transcriptional foci and control cell cycle progression at the gene expression level. The pharmacological co-inhibition of LOXL2 and BRD4 reduces BRD4 nuclear foci, BRD4-MED1 colocalization, and the transcription of cell cycle genes, thus suppressing TNBC cell proliferation. Targeting the interaction between BRD4S and LOXL2 could be a starting point for the development of new anticancer strategies for the treatment of TNBC. Investigation of the molecular mechanisms underlying triple-negative breast cancer (TNBC) proliferation led to the identification of new therapeutic vulnerabilities.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients

  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Taco, Omar|||0000-0001-9081-5665
  • Rodríguez-Martínez, Paula|||0000-0002-9001-2501
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Bover, Jordi|||0000-0003-3577-2273
  • Vila-Santandreu, Anna
  • Franquesa, Marcella|||0000-0002-1287-8908
  • Juega-Mariño, Javier|||0000-0002-9927-9683
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
Interstitial fibrosis and tubular atrophy (IFTA) is a critical factor in the prognosis of kidney health. Currently, IFTA quantitation in kidney biopsy samples is crucial for diagnosis and assessing disease severity, but the available non-invasive biomarkers are not satisfactory. Proteomic studies identified urinary vitronectin (VTN) as a potential biomarker for kidney fibrosis. As mass spectrometry techniques are not practical for use in clinical settings, we tested whether evaluation of urinary VTN levels through enzyme-linked immunosorbent assay (ELISA) can help monitor fibrotic changes in kidney transplant recipients and prove the clinical viability of the assay. A total of 58 kidney transplant (KTx) patients who underwent renal biopsy were included in the study. Patients were categorized into two groups referred as no fibrosis (0%) or with fibrosis (≥ 5%) based on their histological findings. In a subsequent/follow-up analysis, the time elapsed from transplantation was also considered. The urinary levels of VTN were measured using ELISA. VTN (p = 0.0180) and VTN normalized by urinary creatinine levels (p = 0.0037), were significantly increased in patients with fibrotic grafts. When focusing on patients with long-term grafts (> 3 years from transplantation, n = 36), VTN exhibited superior potential in identifying fibrotic grafts compared to albuminuria (VTN p = 0.0040 vs. albuminuria p = 0.0132). Importantly, in this group, while albuminuria correctly identified 71% of fibrotic patients, the combination of VTN plus albuminuria correctly classified 89% of fibrotic grafts detected by renal biopsy. VTN has emerged as a valid indicator of renal fibrosis. Of interest, urinary levels of VTN in combination with conventional clinical parameters (such as albuminuria) significantly improved the non-invasive detection of renal fibrosis in kidney transplant patients. The online version contains supplementary material available at 10.1186/s12967-024-05777-5.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis

  • Villacieros-Álvarez, Javier
  • Espejo, Carmen|||0000-0001-9949-5901
  • Arrambide, Georgina|||0000-0002-2657-5510
  • Castillo Juárez, Mireia|||0000-0001-8979-3219
  • Carbonell-Mirabent, Pere|||0000-0003-1349-9261
  • Rodriguez, Marta
  • Bollo, Luca|||0000-0002-3673-2030
  • Castilló, Joaquín|||0000-0002-8951-6315
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Galan, Ingrid|||0000-0001-5774-4260
  • Midaglia, Luciana|||0000-0001-7981-2228
  • Mongay-Ochoa, Neus|||0000-0002-0338-4797
  • Nos, Carlos|||0000-0002-3830-4910
  • Río, Jordi|||0000-0003-4546-7627
  • Rodríguez Acevedo, Breogán|||0000-0002-0314-753X
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Tur, Carmen|||0000-0003-1849-3184
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Vilaseca, Andreu|||0000-0001-8147-8505
  • Zabalza, Ana|||0000-0003-3860-5251
  • Auger, Cristina|||0000-0001-9846-4767
  • Rovira, Alex|||0000-0002-2132-6750
  • Montalban, Xavier|||0000-0002-0098-9918
  • Tintoré, Mar|||0000-0001-9999-5359
  • Cobo-Calvo, Álvaro|||0000-0002-2574-0721
Objective: Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) distinguish multiple sclerosis (MS) from MOG-associated disease in most cases. However, studies analyzing MOG-Ab at the time of a first demyelinating event suggestive of MS in adults are lacking. We aimed to (1) evaluate the prevalence of MOG-Ab in a first demyelinating event suggestive of MS and (2) compare clinical and paraclinical features between seropositive (MOG-Ab+) and seronegative (MOG-Ab-) patients. Methods: Six hundred thirty adult patients with available serum samples obtained within 6 months from the first event were included. MOG-Ab were analyzed using a live cell-based assay. Statistical analyses included parametric and nonparametric tests, logistic regression, and survival models. Results: MOG-Ab were positive in 17 of 630 (2.7%). Fourteen out of 17 (82.4%) MOG-Ab+ patients presented with optic neuritis (ON) compared to 227of 613 (37.0%) MOG-Ab- patients (p = 0.009). Cerebrospinal fluid-restricted oligoclonal bands (CSF-OBs) were found in 2 of 16 (12.5%) MOG-Ab+ versus 371 of 601 (61.7%) MOG-Ab- subjects (p < 0.001). Baseline brain magnetic resonance imaging (MRI) was normal in 9 of 17 (52.9%) MOG-Ab+ versus 153 of 585 (26.2%) MOG-Ab- patients (p = 0.029). Absence of CSF-OBs and ON at onset were independently associated with MOG-Ab positivity (odds ratio [OR] = 9.03, 95% confidence interval [CI] = 2.04-53.6, p = 0.009; and OR = 4.17, 95% CI = 1.15-19.8, p = 0.042, respectively). Of MOG-Ab+ patients, 22.9% (95% CI = 0.0-42.7) compared to 67.6% (95% CI = 63.3-71.3) of MOG-Ab- patients fulfilled McDonald 2017 criteria at 5 years (log-rank p = 0.003). Interpretation: MOG-Ab are infrequent in adults with a first demyelinating event suggestive of MS. However, based on our results, we suggest to determine these antibodies in those patients with ON and absence of CSF-OBs, as long as the brain MRI is not suggestive of MS. ANN NEUROL 2024;95:116-128.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis, A randomized clinical trial

  • Roman, Eva|||0000-0001-9084-8555
  • Kaur Gill, Naujot|||0009-0007-4184-0398
  • Sánchez, Elisabet|||0000-0002-3280-9301
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Padros i Valls, Josep
  • Nadal, Mª Josepa|||0000-0002-6700-057X
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Alvarado-Tapias, Edilmar|||0000-0003-2036-6133
  • Vidal, Silvia|||0000-0002-3909-6682
  • Ortiz, M. Àngels|||0000-0002-1574-9861
  • Hernández Martínez-Esparza, Elvira|||0000-0002-9736-9052
  • Santesmases Masana, Rosalia|||0000-0002-6890-3279
  • Urgell, Eulàlia|||0000-0003-3519-1022
  • Juanes Borego, Elena|||0000-0001-8910-2123
  • Ferrero-Gregori, Andreu|||0000-0001-6492-2416
  • Escorsell, Àngels|||0000-0001-5083-8467
  • Guarner, Carlos|||0000-0001-5957-9481
  • Soriano, German|||0000-0002-9267-6811
Frailty is a predictive factor of hospitalization, falls, and mortality in patients with cirrhosis, regardless of the degree of liver failure. The aim was to analyze whether a multifactorial intervention consisting of home-based exercise, branched-chain amino acids, and a multistrain probiotic can improve frailty in these patients. Outpatients with cirrhosis were classified according to the Liver Frailty Index (LFI). Prefrail and frail patients were randomized into 2 groups. The intervention group was assigned to a multifactorial intervention consisting of exercise at home, branched-chain amino acid supplements, and a multistrain probiotic for 12 months. The control group received standard care. All patients were prospectively followed up every 3 months for 1 year to determine LFI, incidence of falls, emergency room visits, hospitalizations, and mortality. Thirty-two patients were included: 17 patients were assigned to the intervention group and 15 to the control group. In the intervention group, the baseline LFI decreased at 3, 6, 9, and 12 months (p = 0.019 for overall change with respect to the control group). The change in LFI (ΔLFI) at 12 months was -0.71 ± 0.24 in the intervention group and -0.09 ± 0.32 in the control group (p<0.001). During follow-up, patients in the intervention group had a lower 1-year probability of falls (6% vs. 47%, p = 0.03) and emergency room visits (10% vs. 44%, p = 0.04) than patients in the control group. A long-term multifactorial intervention that included exercise at home, branched-chain amino acids, and a multistrain probiotic improved frailty in outpatients with cirrhosis and was associated with a decrease in the incidence of clinical events such as falls and emergency room visits. 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tumor analysis of MMR genes in Lynch-like syndrome, Challenges associated with results interpretation

  • Rofes, Paula|||0000-0001-6045-7879
  • Dueñas Cid, Nuria|||0000-0001-6624-3265
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Navarro, Matilde
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Tuset, Noemí
  • Castillo, Carmen
  • González, Sara
  • Brunet, Joan|||0000-0003-1945-3512
  • Capella, Gabriel|||0000-0002-4669-7320
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Pineda, Marta|||0000-0002-5403-5845
Up to 70% of suspected Lynch syndrome patients harboring MMR deficient tumors lack identifiable germline pathogenic variants in MMR genes, being referred to as Lynch-like syndrome (LLS). Previous studies have reported biallelic somatic MMR inactivation in a variable range of LLS-associated tumors. Moreover, translating tumor testing results into patient management remains controversial. Our aim is to assess the challenges associated with the implementation of tumoral MMR gene testing in routine workflows. Methods: Here, we present the clinical characterization of 229 LLS patients. MMR gene testing was performed in 39 available tumors, and results were analyzed using two variant allele frequency (VAF) thresholds (≥5% and ≥10%). Results and Discussion: More biallelic somatic events were identified at VAF ≥ 5% than ≥10% (35.9% vs. 25.6%), although the rate of nonconcordant results regarding immunohistochemical pattern increased (30.8% vs. 20.5%). Interpretation difficulties question the current utility of the identification of MMR somatic hits in the diagnostic algorithm of suspected LS cases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Practice matters, The role of mindfulness skills in emotion dysregulation in borderline personality disorder

  • Schmidt, Carlos|||0000-0002-5927-4554
  • Soler, Joaquim|||0000-0001-8077-3641
  • Vega, Daniel|||0000-0002-5621-8987
  • Pascual, Juan Carlos|||0000-0001-8039-9346
Mindfulness skills training constitute a core element of dialectical behavior therapy (DBT) that has been proposed as a key component to improve emotion dysregulation (ED) in borderline personality disorder (BPD). However, the relationship between the time spent practicing mindfulness skills at home and changes in ED is not well-understood. This study aimed to determine whether daily mindfulness practice meaningfully improves ED, and, if so, the minimum dose needed to do so. A total of 75 BPD outpatients participated in a 10-week DBT mindfulness skill training program. We systematically tracked the participants' mindfulness practice and their ED levels throughout the sessions. A total of 499 observations were recorded. We used multilevel modeling with a time-lagged approach to investigate the association between weekly practice and ED over time. Greater mindfulness practice predicted improvements in ED in the following week. A bidirectional relationship was also found; a higher level of ED impaired subsequent mindfulness practice. When accounting for the previous week's ED level, participants who practiced ≥3 days and.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene

  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • Herreros García, Alba|||0009-0003-0451-7568
  • Pybus, Marc|||0000-0002-6195-5738
  • Aza-Carmona, Miriam|||0000-0003-4448-9541
  • Pilco-Teran, Melissa|||0000-0002-1311-0896
  • Furlano, Monica|||0000-0003-1025-3901
  • Garcia Borau, Maria José|||0000-0002-8223-8033
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Ars, Elisabet|||0000-0002-4118-4358
X-linked hypophosphatemia (XLH) is a rare inherited disorder of renal phosphate wasting with a highly variable phenotype caused by loss-of-function variants in the PHEX gene. The diagnosis of individuals with mild phenotypes can be challenging and often delayed. Here, we describe a three-generation family with a very mild clinical presentation of XLH. The diagnosis was unexpectedly found in a 39-year-old woman who was referred for genetic testing due to an unclear childhood diagnosis of a tubulopathy. Genetic testing performed by next-generation sequencing using a kidney disease gene panel identified a novel non-canonical splice site variant in the PHEX gene. Segregation analysis detected that the consultand's father, who presented with hypophosphatemia and decreased tubular phosphate reabsorption, and the consultand's son also carried this variant. RNA studies demonstrated that the non-canonical splice site variant partially altered the splicing of the PHEX gene, as both wild-type and aberrant splicing transcripts were detected in the two male members with only one copy of the PHEX gene. In conclusion, this case contributes to the understanding of the relationship between splicing variants and the variable expressivity of XLH disease. The mild phenotype of this family can be explained by the coexistence of PHEX transcripts with aberrant and wild-type splicing.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

  • Torres Esquius, Sara|||0000-0001-7540-7284
  • Llop Guevara, Alba|||0000-0002-7913-9472
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Romey, Marcel
  • Teule, Alex|||0000-0003-0028-7200
  • Llort, Gemma|||0000-0001-9987-7862
  • Herrero, Ana
  • Sánchez-Henarejos, Pilar
  • Vallmajó, Anna
  • González-Santiago, Santiago|||0000-0002-4787-0236
  • Chirivella, Isabel|||0000-0002-0733-3276
  • Cano, Juana María|||0000-0002-2493-0988
  • Graña, Begoña|||0000-0003-2008-8188
  • Simonetti, Sara|||0000-0003-2406-030X
  • Díaz de Corcuera, Isabel
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Sanz, Judit
  • Serrano, Sara
  • Otero, Andrea
  • Churruca, Cristina
  • Sánchez-Heras, Ana Beatriz|||0000-0003-1742-5374
  • Servitja, Sonia|||0000-0001-6988-4519
  • Guillén-Ponce, Carmen
  • Brunet, Joan|||0000-0003-1945-3512
  • Denkert, Carsten
  • Serra, Violeta|||0000-0001-6620-1065
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
IMPORTANCE RAD51C and RAD51D are involved in DNA repair by homologous recombination. Germline pathogenic variants (PVs) in these genes are associated with an increased risk of ovarian and breast cancer. Understanding the homologous recombination deficiency (HRD) status of tumors from patients with germline PVs in RAD51C/D could guide therapeutic decision-making and improve survival. OBJECTIVE To characterize the clinical and tumor characteristics of germline RAD51C/D PV carriers, including the evaluation of HRD status. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included 91 index patients plus 90 relatives carrying germline RAD51C/D PV (n = 181) in Spanish hospitals from January 1, 2014, to December 31, 2021. Genomic and functional HRD biomarkers were assessed in untreated breast and ovarian tumor samples (n = 45) from June 2022 to February 2023. MAIN OUTCOMES AND MEASURES Clinical and pathologic characteristics were assessed using descriptive statistics. Genomic HRD by genomic instability scores, functional HRD by RAD51, and gene-specific loss of heterozygosity were analyzed. Associations between HRD status and tumor subtype, age at diagnosis, and gene-specific loss of heterozygosity in RAD51C/D were investigated using logistic regression or the t test. RESULTS A total of 9507 index patients were reviewed, and 91 patients (1.0%) were found to carry a PV in RAD51C/D; 90 family members with a germline PV in RAD51C/D were also included. A total of 157 of carriers (86.7%) were women and 181 (55.8%) had received a diagnosis of cancer, mainly breast cancer or ovarian cancer. The most prevalent PVs were c.1026+5_1026+7del (11 of 56 [19.6%]) and c.709C.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Symptom profile in suicide attempters during the COVID-19 pandemic, Relationships with suicide outcomes

  • Díaz-Carracedo, Patricia|||0000-0001-6595-2377
  • Marín, Carolina|||0000-0001-6628-9669
  • Díaz-Marsá, Marina|||0000-0003-1364-3163
  • Borges, Guilherme|||0000-0002-3269-0507
  • Torre-Luque, Alejandro de la|||0000-0003-0595-6127
  • Elices, M.|||0000-0002-7034-4242
  • Toll, Alba|||0000-0003-2399-5250
  • Grande, Iria|||0000-0002-0137-0666
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Vázquez, Mireia
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Ruiz-Veguilla, Miguel|||0000-0002-5790-7346
  • Canal-Rivero, Manuel|||0000-0002-5818-5103
  • Cebrià, Ana Isabel|||0000-0002-2632-8130
  • Palao, Diego|||0000-0002-3323-6568
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Jiménez-Treviño, Luis|||0000-0002-9551-8587
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • Andreo Jover, Jorge|||0000-0002-6703-8017
  • March, Katya B.
  • Palao Tarrero, Ángela|||0000-0003-2717-5807
  • Pérez Solà, Víctor|||0000-0002-5825-2337
Suicidal behavior constitutes a multi-cause phenomenon that may also be present in people without a mental disorder. This study aims to analyze suicidal behavior outcomes in a sample of attempters, from a symptom-based approach. The sample comprised 673 patients (72% female; M = 40.9 years) who attended a hospital emergency department due to a suicide attempt. A wide range of clinical factors (e.g., psychopathology symptoms, psychiatric diagnoses, impulsivity, acquired capability), was administered within 15 days after the index attempt. Nine psychopathology domains were explored to identify the profile of symptoms, using latent profile analysis. The relationship between the profile membership and suicide outcome (i.e., intensity of suicidal ideation, number of suicide behaviors, and medical injury derived from index attempt) was also studied, using linear and logistic regression. Three psychopathology profiles were identified: high-symptom profile (45.02% of participants), moderate-symptom profile (42.50%), and low-symptom profile (12.48%). High-symptom profile members were more likely to show higher risk of non-suicidal self-injury, acquired capability for suicide, and more severe suicide behavior and ideation. On the other hand, a more severe physical injury was associated with low-symptom profile membership in comparison to membership from the other profiles (OR < 0.45, p <.05). A symptom-based approach may be useful to monitor patients and determine the risk of attempt repetition in the future and potential medical injury, and to optimize prevention and intervention strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A phenome-wide association and Mendelian randomisation study of alcohol use variants in a diverse cohort comprising over 3 million individuals

  • Jennings, Mariela V.
  • Martínez-Magaña, José Jaime
  • Courchesne-Krak, Natasia S.
  • Cupertino , Renata B.
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Bianchi, Sevim B.
  • Hatoum, Alexander S.
  • Atkinson, Elizabeth G.
  • Giusti-Rodriguez, Paola
  • Montalvo-Ortiz, Janitza L.|||0000-0002-7657-8365
  • Gelernter, Joel|||0000-0002-4067-1859
  • Soler Artigas, María|||0000-0002-3213-1107
  • Elson, Sarah L.
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Fontanillas, Pierre
  • Palmer, Abraham A.
  • Sánchez Roige, Sandra|||0000-0001-6137-5699
Alcohol consumption is associated with numerous negative social and health outcomes. These associations may be direct consequences of drinking, or they may reflect common genetic factors that influence both alcohol consumption and other outcomes. We performed exploratory phenome-wide association studies (PheWAS) of three of the best studied protective single nucleotide polymorphisms (SNPs) in genes encoding ethanol metabolising enzymes (ADH1B : rs1229984-T, rs2066702-A; ADH1C : rs698-T) using up to 1109 health outcomes across 28 phenotypic categories (e.g., substance-use, mental health, sleep, immune, cardiovascular, metabolic) from a diverse 23andMe cohort, including European (N ≤ 2,619,939), Latin American (N ≤ 446,646) and African American (N ≤ 146,776) populations to uncover new and perhaps unexpected associations. These SNPs have been consistently implicated by both candidate gene studies and genome-wide association studies of alcohol-related behaviours but have not been investigated in detail for other relevant phenotypes in a hypothesis-free approach in such a large cohort of multiple ancestries. To provide insight into potential causal effects of alcohol consumption on the outcomes significant in the PheWAS, we performed univariable two-sample and one-sample Mendelian randomisation (MR) analyses. The minor allele rs1229984-T, which is protective against alcohol behaviours, showed the highest number of PheWAS associations across the three cohorts (N = 232, European; N = 29, Latin American; N = 7, African American). rs1229984-T influenced multiple domains of health. We replicated associations with alcohol-related behaviours, mental and sleep conditions, and cardio-metabolic health. We also found associations with understudied traits related to neurological (migraines, epilepsy), immune (allergies), musculoskeletal (fibromyalgia), and reproductive health (preeclampsia). MR analyses identified evidence of causal effects of alcohol consumption on liability for 35 of these outcomes in the European cohort. Our work demonstrates that polymorphisms in genes encoding alcohol metabolising enzymes affect multiple domains of health beyond alcohol-related behaviours. Understanding the underlying mechanisms of these effects could have implications for treatments and preventative medicine. MVJ, NCK, SBB, SSR and AAP were supported by T32IR5226 and 28IR-0070. SSR was also supported by DP1DA054394. NCK and RBC were also supported by R25MH081482. ASH was supported by funds from NIAAA K01AA030083. JLMO was supported by VA 1IK2CX002095. JLMO and JJMM were also supported by R21DA050160. JJMM was also supported by the for Academic Diversity. EGA was supported by K01MH121659 from the /, the and the at . MSA was supported by the and co-funded by the : (FSE+) (P19/01224, PI22/00464 and CP22/00128).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Precise Targeting of Autoantigen-Specific B Cells in Lupus Nephritis with Chimeric Autoantibody Receptor T Cells

  • Solé Marcé, Cristina|||0000-0002-4870-2824
  • Royo, Maria|||0000-0003-3289-2624
  • Sandoval, Sebastian
  • Moliné, Teresa|||0000-0003-4912-5114
  • Gabaldón, Alejandra
  • Cortés Hernández, Josefina|||0000-0003-4538-3538
Despite conventional therapy, lupus nephritis (LN) remains a significant contributor to short- and long-term morbidity and mortality. B cell abnormalities and the production of autoantibodies against nuclear complexes like anti-dsDNA are recognised as key players in the pathogenesis of LN. To address the challenges of chronic immunosuppression associated with current therapies, we have engineered T cells to express chimeric autoantibody receptors (DNA-CAART) for the precise targeting of B cells expressing anti-dsDNA autoantibodies. T cells from LN patients were transduced using six different CAAR vectors based on their antigen specificity, including alpha-actinin, histone-1, heparan sulphate, or C1q. The cytotoxicity, cytokine production, and cell-cell contact of DNA-CAART were thoroughly investigated in co-culture experiments with B cells isolated from patients, both with and without anti-dsDNA positivity. The therapeutic effects were further evaluated using an in vitro immune kidney LN organoid. Among the six proposed DNA-CAART, DNA4 and DNA6 demonstrated superior selectively cytotoxic activity against anti-dsDNA + B cells. Notably, DNA4-CAART exhibited improvements in organoid morphology, apoptosis, and the inflammatory process in the presence of IFNα-stimulated anti-dsDNA + B cells. Based on these findings, DNA4-CAART emerge as promising candidates for modulating autoimmunity and represent a novel approach for the treatment of LN.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Women's neuroplasticity during gestation, childbirth and postpartum

  • Paternina-Die, María|||0000-0002-5100-4955
  • Martínez-García, Magdalena|||0000-0002-5054-9427
  • Martín de Blas, Daniel|||0000-0001-6985-9460
  • Noguero, Inés
  • Servin-Barthet, Camila|||0000-0002-4771-898X
  • Pretus, Clara|||0000-0003-2172-1184
  • Soler, Anna
  • López-Montoya, Gonzalo
  • Desco, Manuel|||0000-0003-0989-3231
  • Carmona Cañabate, Susana|||0000-0001-5853-6527
Pregnancy is a unique neuroplastic period in adult life. This longitudinal study tracked brain cortical changes during the peripartum period and explored how the type of childbirth affects these changes. We collected neuroanatomic, obstetric and neuropsychological data from 110 first-time mothers during late pregnancy and early postpartum, as well as from 34 nulliparous women evaluated at similar time points. During late pregnancy, mothers showed lower cortical volume than controls across all functional networks. These cortical differences attenuated in the early postpartum session. Default mode and frontoparietal networks showed below-expected volume increases during peripartum, suggesting that their reductions may persist longer. Results also pointed to different cortical trajectories in mothers who delivered by scheduled C-section. The main findings were replicated in an independent sample of 29 mothers and 24 nulliparous women. These data suggest a dynamic trajectory of cortical decreases during pregnancy that attenuates in the postpartum period, at a different rate depending on the brain network and childbirth type. This longitudinal study tracked the brains of 139 first-time mothers. Mothers showed lower cortical volume before childbirth that attenuated during the postpartum, with a distinct recovery rate as a function of the brain network and birth type.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

  • Carreño Gago, Lidia
  • Juarez-Flores, Diana Luz|||0000-0003-3615-7803
  • Grau, Josep M.|||0000-0001-7560-224X
  • Ramón, Javier|||0000-0002-0673-9338
  • Lozano, Ester|||0000-0002-6307-9807
  • Vila-Julià, Ferran
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Garrabou, Glòria|||0000-0001-8973-9933
  • García Arumí, Elena|||0000-0003-1848-005X
Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MptpB Inhibitor Improves the Action of Antibiotics against Mycobacterium tuberculosis and Nontuberculous Mycobacterium avium Infections

  • Rodríguez-Fernández, Pablo|||0000-0003-1273-0548
  • Botella, Laure
  • Cavet, Jennifer S.
  • Domínguez, José|||0000-0001-7888-0309
  • Gutierrez, Maximiliano G.|||0000-0003-3199-0337
  • Suckling, Colin J.
  • Scott, Fraser J.|||0000-0003-0229-3698
  • Tabernero, Lydia|||0000-0001-8867-455X
Treatment of Mycobacterium tuberculosis and Mycobacterium avium infections requires multiple drugs for long time periods. Mycobacterium protein-tyrosine-phosphatase B (MptpB) is a key M. tuberculosis virulence factor that subverts host antimicrobial activity to promote intracellular survival. Inhibition of MptpB reduces the infection burden in vivo and offers new opportunities to improve current treatments. Here, we demonstrate that M. avium produces an MptpB orthologue and that the MptpB inhibitor C13 reduces the M. avium infection burden in macrophages. Combining C13 with the antibiotics rifampicin or bedaquiline showed an additive effect, reducing intracellular infection of both M. tuberculosis and M. avium by 50%, compared to monotreatment with antibiotics alone. This additive effect was not observed with pretomanid. Combining C13 with the minor groove-binding compounds S-MGB-362 and S-MGB-363 also reduced the M. tuberculosis intracellular burden. Similar additive effects of C13 and antibiotics were confirmed in vivo using Galleria mellonella infections. We demonstrate that the reduced mycobacterial burden in macrophages observed with C13 treatments is due to the increased trafficking to lysosomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Trait anxiety is associated with attentional brain networks

  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Chavarría-Elizondo, Pamela|||0000-0002-8177-3771
  • Juaneda-Seguí, Asier|||0000-0003-1662-1605
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Morgado, Pedro|||0000-0003-3880-3258
  • Manuel Menchón, José
  • Picó-Pérez, Maria|||0000-0002-1573-2445
  • Fullana, Miguel|||0000-0003-3863-5223
  • Soriano-Mas, Carles|||0000-0003-4574-6597
Trait anxiety is a well-established risk factor for anxiety and depressive disorders, yet its neural correlates are not clearly understood. In this study, we investigated the neural correlates of trait anxiety in a large sample (n = 179) of individuals who completed the trait and state versions of the State-Trait Anxiety Inventory and underwent resting-state functional magnetic resonance imaging. We used independent component analysis to characterize individual resting-state networks (RSNs), and multiple regression analyses to assess the relationship between trait anxiety and intrinsic connectivity. Trait anxiety was significantly associated with intrinsic connectivity in different regions of three RSNs (dorsal attention network, default mode network, and auditory network) when controlling for state anxiety. These RSNs primarily support attentional processes. Notably, when state anxiety was not controlled for, a different pattern of results emerged, highlighting the importance of considering this factor in assessing the neural correlates of trait anxiety. Our findings suggest that trait anxiety is uniquely associated with resting-state brain connectivity in networks mainly supporting attentional processes. Moreover, controlling for state anxiety is crucial when assessing the neural correlates of trait anxiety. These insights may help refine current neurobiological models of anxiety and identify potential targets for neurobiologically-based interventions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Care-related quality of life of informal caregivers of stroke survivors, Cross-sectional analysis of a randomized clinical trial

  • Villa-García, Lorena|||0000-0003-0828-2260
  • Salvat-Plana, Mercè|||0000-0003-0994-6567
  • Slof, Eric John|||0000-0002-0576-8161
  • Pérez de la Ossa, Natalia|||0000-0002-6063-211X
  • Abilleira i Castells, Sònia|||0000-0002-5587-128X
  • Ribo, Marc|||0000-0001-9242-043X
  • Hidalgo-Benítez, Verónica
  • Inzitari, Marco|||0000-0002-3796-0625
  • Ribera, A.|||0000-0002-2604-6328
We aimed to describe the intensity of care and its consequences on informal caregivers of stroke survivors according to the degree of care receivers' functional dependence for activities of daily living; and to identify the factors associated with caregivers' care-related quality of life. Cross-sectional analysis of prospective data collected in a cost-utility study alongside the RACECAT trial in Catalonia (Spain). One-hundred and thirty-two care receiver-caregiver pairs were interviewed six months after stroke. Functional dependence for activities of daily living was measured with the Barthel index. We assessed caregivers care-related quality of life with the CarerQoL, which measures seven dimensions of subjective burden (CarerQoL-7D) and a happiness score (CarerQoL-VAS). We evaluated the association between characteristics of informal caregivers, characteristics of care receivers, and intensity of care, and the caregiver's care-related quality of life (subjective burden and happiness) in a hypothesized model using a structural equation model. Of the 132 caregivers, 74,2% were women with an average age of 59.4 ± 12.5 years. The 56.8% of them were spouses. The care intensity ranged from a mean of 24h/week for mild to 40h/week for severe dependence. Most caregivers (76.3%) were satisfied with their task, regardless of dependence, but showed increasing problems in caring for severely dependent persons. Being a woman (coeff. -0.23; 95%CI: -0.40, -0.07), spending more time in care tasks (coeff -0.37; -0.53, -0.21) and care receiver need of constant supervision (coeff 0.31; -0.47, -0.14) were associated with higher burden of care, irrespective of the degree of dependence. Caregiver burden (coeff 0.46; 0.30-0.61) and care receiver anxiety or depression (coeff -0.19; -0.34, -0.03) were associated with lower caregiver happiness. The findings suggest the importance of developing mainly two types of support interventions for caregivers: respite and psychosocial support. Especially for women with high caring burden and/or caring for persons with high levels of anxiety or depression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Implications for Long COVID

  • Jurek, Joanna Michalina|||0000-0002-7319-0672
  • Castro-Marrero, Jesús|||0000-0002-2481-3052
Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and long COVID are complex, multisystemic and long-term disabling conditions characterized by debilitating post-exertional malaise and other core symptoms related to immune dysregulation resultant from post-viral infection, including mitochondrial dysfunction, chronic neuroinflammation and gut dysbiosis. The reported associations between altered microbiota composition and cardinal symptoms of ME/CFS and long COVID suggest that the use of microbial preparations, such as probiotics, by restoring the homeostasis of the brain-immune-gut axis, may help in the management of symptoms in both conditions. Therefore, this review aims to investigate the implications of alerted gut microbiome and assess the evidence supporting use of microbial-based preparations, including probiotics, synbiotics, postbiotics alone and/or in combination with other nutraceuticals in the management of fatigue, inflammation and neuropsychiatric and gastrointestinal symptoms among patients with ME/CFS and long COVID.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Spontaneous and perturbation-based EEG cortical excitability markers are associated with plasma p-tau181 concentration in healthy middle-aged adults

  • Perellón-Alfonso, Ruben|||0000-0001-8647-3703
  • Abellaneda Pérez, Kilian|||0000-0001-6447-1248
  • Pileckyte, Indre
  • Cabello-Toscano, María|||0000-0001-5066-3476
  • Mulet-Pons, Lídia|||0000-0002-8884-136X
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Cattaneo, Gabriele|||0000-0002-7411-6829
  • Redondo-Camós, María|||0000-0002-3890-5070
  • España-Irla, Goretti|||0000-0003-2525-6523
  • Delgado-Gallen, Selma
  • Solana Sánchez, Javier|||0000-0003-0880-7856
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Tormos, Jose M.|||0000-0002-8764-2289
  • Franzmeier, Nicolai
  • Pascual Leone, Álvaro|||0000-0001-8975-0382
  • Bartrés-Faz, David|||0000-0001-6020-4118
In early-stage Alzheimer's disease (AD) amyloid-β (Aβ) deposition can induce neuronal hyperactivity, thereby potentially triggering activity-dependent neuronal secretion of phosphorylated tau (p-tau), ensuing tau aggregation and spread. Therefore, cortical excitability is a candidate biomarker for early AD detection. Moreover, lowering neuronal excitability could potentially complement strategies to reduce Aβ and tau buildup. There is, however, a lack of understanding of the relationship between cortical excitability and p-tau increase in vivo. Therefore, in a sample of 658 healthy middle-aged (between the ages of 40 and 65) participants of the Barcelona Brain Health Initiative cohort study, we examined the relation of blood-based tau, phosphorylated at amino acid 181 (p-tau181), reflecting neuronal p-tau secretion; neurofilament light chain (NfL), as a passively released control for p-tau181; and electroencephalography (EEG) markers of cortical excitability. A subsample of 47 participants also completed a controlled brain perturbation approach via transcranial magnetic stimulation (TMS) with concurrent EEG. Results show that both spontaneous (i.e., resting-state) and perturbation-based TMS-EEG markers, are associated with blood p-tau181, particularly in older individuals. The perturbation-based marker was a significantly more sensitive predictor of p-tau181 concentration than the spontaneous resting state EEG-based marker. The relationships observed are not present for the NfL control. These results show that relationships between p-tau181 and cortical excitability are present in healthy middle-aged subjects and that p-tau181 increases may reflect activity-dependent secretion.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis

  • Sena, Elena|||0000-0003-1220-5639
  • Tacke, Frank|||0000-0001-6206-0226
  • Anstee, Quentin M.|||0000-0002-9518-0088
  • Di Prospero, Nicholas
  • Skalshøi- Kjær, Mette
  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Rivera Esteban, Jesús|||0000-0003-4357-8817
  • Jiménez-Masip, Alba
  • Bañales, Jesús M.
  • Martínez-Gómez, María
  • Koenig, Franz
  • Genescà Ferrer, Joan|||0000-0002-0831-8422
  • Ratziu, Vlad
  • Pericàs, Juan M.|||0000-0002-3645-3293
The EU Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) project (IMI2-853966) aimed to develop tools to establish integrated research platforms (IRP) for conducting adaptive-design trials in various diseases, including metabolic-dysfunction associated steatohepatitis (MASH). One essential component of a successful MASH IRP is a robust and reliable Clinical Research Network (CRN). Herein, we outline the required elements and anticipated steps to set-up such a CRN. We identified European clinical research sites that could potentially serve as the foundation for MASH IRP and a CRN. A survey was sent to sites to assess their interest in joining a CRN, their familiarity with platform trials, and their capacity to participate in a future MASH IRP. A total of 141 investigators were invited to participate in the survey, and 40% responded. More than half of the answers (52%) identify MASH with advanced fibrosis (F3-4) as the subpopulation with the greatest unmet need. Regarding the difficulty in identifying candidates for trials, 65% find it is moderately difficult and 30% very difficult. Most respondents (94%) believe that a platform trial could offer substantial benefits to patients. Nearly all researchers express interest in participating in a platform trial (78%), with 22% indicating their interest would be contingent on initial industry funding. While preliminary, our findings on responding sites are encouraging for the potential establishment of a CRN for a MASH IRP. However, funding schemes and sustainability strategies to provide proof-of-platform in MASH seem key in the short-term scenario. Metabolic dysfunction-associated steatohepatitis (MASH) occurs when the liver becomes damaged due to the build up of fat, which is often related to obesity and diabetes. There is a lack of effective drug treatments for MASH, so strategies to strengthen clinical research in this area are needed. Here, we survey key European experts on MASH to assess their interest in joining a network of MASH researchers and their interest in participating in a new type of clinical trial called a platform trial, where multiple drugs can be tested simultaneously. Researchers largely agree that these are promising approaches to boost drug development in the field, although have concerns regarding funding and sustainability strategies. Our findings may inform the creation of a network of MASH researchers capable of running a platform trial, which in turn may speed up research into treatments for MASH. Sena et al. survey European clinical research sites that could potentially serve as the foundation for a MASH integrated research platform and clinical research network. Respondents generally believe that a MASH platform trial could benefit patients and are interested in participating, though securing industry funding is identified as a priority.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Ferrer Pérez, Rosa|||0009-0004-9477-699X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Alcolea, Daniel|||0000-0002-3819-3245
Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown. We analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A+) or negative (A-) according to CSF Aβ/Aβ ratio. Plasma pTau, pTau, Aβ and Aβ were measured in the fully-automated LUMIPULSE platform. We used linear regression to compare plasma biomarkers concentrations between A + and A- groups, evaluated Spearman's correlation between plasma and CSF and performed ROC analyses to assess their diagnostic accuracy to detect brain amyloidosis as determined by CSF Aβ/Aβ ratio. We analyzed the potential of pTau to predict amyloidosis in CSF. Plasma pTau and pTau concentration were higher in A + than A- while the plasma Aβ/Aβ ratio was lower in A + compared to A-. pTau and the Aβ/Aβ ratio showed moderate correlation between plasma and CSF (Rho = 0.66 and 0.69, respectively). The areas under the ROC curve to discriminate A + from A- participants were 0.94 (95% CI 0.92-0.97) for pTau, and 0.88 (95% CI 0.84-0.92) for both pTau and Aβ/Aβ. Chronic kidney disease (CKD) was related to increased plasma biomarker concentrations, but ratios were less affected. Plasma pTau had the highest fold change (x4.2) and showed high predictive capability in discriminating A + from A-, having 4-7% misclassification rate. The global accuracy of plasma pTau using a two-threshold approach was robust in symptomatic groups, exceeding 90%. The evaluation of blood biomarkers on an automated platform exhibited high diagnostic accuracy for AD pathophysiology, and pTau showed excellent diagnostic accuracy to identify participants with AD in a consecutive sample representing the routine clinical practice in a specialized memory unit.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biomarkers for Psychosis, Are We There Yet? Umbrella Review of 1478 Biomarkers

  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Estradé, Andrés|||0000-0001-6871-5932
  • Solanes, Aleix|||0000-0002-2491-200X
  • Ramella-Cravaro, Valentina
  • Garcia-Leon, Maria Angeles
  • Diego-Adeliño, Javier de|||0000-0001-9708-2441
  • Molins, Conrad
  • Fung, Eric
  • Valentí, Marc
  • Anmella, Gerard|||0000-0002-6798-4054
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Oliver, Dominic|||0000-0002-8920-3407
  • Vieta, Eduard|||0000-0002-0548-0053
  • Radua, Joaquim|||0000-0003-1240-5438
  • Fusar-Poli, Paolo|||0000-0003-3582-6788
This umbrella review aims to comprehensively synthesize the evidence of association between peripheral, electrophysiological, neuroimaging, neuropathological, and other biomarkers and diagnosis of psychotic disorders. We selected systematic reviews and meta-analyses of observational studies on diagnostic biomarkers for psychotic disorders, published until February 1, 2018. Data extraction was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Evidence of association between biomarkers and psychotic disorders was classified as convincing, highly suggestive, suggestive, weak, or non-significant, using a standardized classification. Quality analyses used the Assessment of Multiple Systematic Reviews (AMSTAR) tool. The umbrella review included 110 meta-analyses or systematic reviews corresponding to 3892 individual studies, 1478 biomarkers, and 392 210 participants. No factor showed a convincing level of evidence. Highly suggestive evidence was observed for transglutaminase autoantibodies levels (odds ratio [OR] = 7.32; 95% CI: 3.36, 15.94), mismatch negativity in auditory event-related potentials (standardized mean difference [SMD] = 0.73; 95% CI: 0.5, 0.96), P300 component latency (SMD = -0.6; 95% CI: -0.83, -0.38), ventricle-brain ratio (SMD = 0.61; 95% CI: 0.5, 0.71), and minor physical anomalies (SMD = 0.99; 95% CI: 0.64, 1.34). Suggestive evidence was observed for folate, malondialdehyde, brain-derived neurotrophic factor, homocysteine, P50 sensory gating (P50 S2/S1 ratio), frontal N -acetyl-aspartate, and high-frequency heart rate variability. Among the remaining biomarkers, weak evidence was found for 626 and a non-significant association for 833 factors. While several biomarkers present highly suggestive or suggestive evidence of association with psychotic disorders, methodological biases, and underpowered studies call for future higher-quality research.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interface Engineering in All-Oxide Photovoltaic Devices Based on Photoferroelectric BiFeCoO Thin Films

  • Machado, Pamela|||0000-0002-4235-0370
  • Sallés Perramon, Pol|||0000-0003-1426-611X
  • Frebel, Alexander
  • De Luca, Gabriele|||0000-0003-3757-3761
  • Ros, Eloi|||0000-0002-1952-6614
  • Hagendorf, Christian
  • Fina, Ignasi|||0000-0003-4182-6194
  • Puigdollers, Joaquim|||0000-0002-1834-2565
  • Coll, Mariona|||0000-0001-5157-7764
Photoferroelectric BiFeO (BFO) has attracted renewed interest to be integrated into thin film photovoltaic (PV) devices as a stable, lead-free, and versatile photoabsorber with simplified architecture. While significant efforts have been dedicated toward the exploration of strategies to tailor the properties of this photoabsorber to improve the device performance, efficiencies still remain low. The modification of the BFO interface by the incorporation of transport-selective layers can offer fresh opportunities to modify the properties of the device. Identifying an optical and electrically suitable selective layer while ensuring easy device processing and controlled film properties is challenging. In this work, we determine the influence of incorporating a ZnO layer on the ferroelectric and photoresponse behavior of an epitaxial BiFeCoO (BFCO)-based heterostructure. The device is completed with Sn-doped InO (ITO) and LaSrMnO (LSMO) electrodes. This all-oxide system is stable under ambient conditions and displays robust ferroelectricity. The coupled ferroelectricity-photoresponse measurements demonstrate that the short circuit current can be modulated by ferroelectric polarization in up to 68% under blue monochromatic light. Also, the responsivity of the system with the ZnO-modified interface is larger than that of the system with no ZnO. Complementary band energy alignment studies reveal that the observed increase in the short circuit current density of the device with ZnO is attributed to lower Fermi level energy at the ZnO/BFCO interface compared to the ITO/BFCO interface, which reduces charge recombination. Therefore, this study provides useful insights into the role of the ZnO interface layer in stable BFO-based devices to further explore their viability for potential optoelectronic applications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing and correcting neighborhood socioeconomic spatial sampling biases in citizen science mosquito data collection

  • Padilla-Pozo, Álvaro
  • Bartumeus, Frederic|||0000-0001-6908-3797
  • Montalvo Porro, Tomas|||0000-0002-9060-3205
  • Sanpera-Calbet, Isis|||0000-0001-7004-4293
  • Valsecchi, Andrea
  • Palmer, John R. B.|||0000-0002-2648-7860
Climatic, ecological, and socioeconomic factors are facilitating the spread of mosquito-borne diseases, heightening the importance of vector surveillance and control. Citizen science is proving to be an effective tool to track mosquito populations, but methods are needed to detect and account for small scale sampling biases in citizen science surveillance. In this article we combine two types of traditional mosquito surveillance records with data from the Mosquito Alert citizen science system to explore the ways in which the socioeconomic characteristics of urban neighborhoods result in sampling biases in citizen scientists' mosquito reports, while also shaping the spatial distribution of mosquito populations themselves. We use Barcelona, Spain, as an example, and focus on Aedes albopictus, an invasive vector species of concern worldwide. Our results suggest citizen scientists' sampling effort is focused more in Barcelona's lower and middle income census tracts than in its higher income ones, whereas Ae. albopictus populations are concentrated in the city's upper-middle income tracts. High resolution estimates of the spatial distribution of Ae. albopictus risk can be improved by controlling for citizen scientists' sampling effort, making it possible to provide better insights for efficiently targeting control efforts. Our methodology can be replicated in other cities faced with vector mosquitoes to improve public health responses to mosquito-borne diseases, which impose massive burdens on communities worldwide.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MYC, there is more to it than cancer

  • Zacarías-Fluck, Mariano F.|||0000-0002-7171-4268
  • Soucek, Laura|||0000-0002-4750-7971
  • Whitfield, Jonathan R.|||0000-0002-4925-7283
MYC is a pleiotropic transcription factor involved in multiple cellular processes. While its mechanism of action and targets are not completely elucidated, it has a fundamental role in cellular proliferation, differentiation, metabolism, ribogenesis, and bone and vascular development. Over 4 decades of research and some 10,000 publications linking it to tumorigenesis (by searching PubMed for "MYC oncogene") have led to MYC becoming a most-wanted target for the treatment of cancer, where many of MYC's physiological functions become co-opted for tumour initiation and maintenance. In this context, an abundance of reviews describes strategies for potentially targeting MYC in the oncology field. However, its multiple roles in different aspects of cellular biology suggest that it may also play a role in many additional diseases, and other publications are indeed linking MYC to pathologies beyond cancer. Here, we review these physiological functions and the current literature linking MYC to non-oncological diseases. The intense efforts towards developing MYC inhibitors as a cancer therapy will potentially have huge implications for the treatment of other diseases. In addition, with a complementary approach, we discuss some diseases and conditions where MYC appears to play a protective role and hence its increased expression or activation could be therapeutic.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prognostic value of single-subject grey matter networks in early multiple sclerosis

  • Fleischer, Vinzenz
  • González-Escamilla, Gabriel|||0000-0002-7209-1736
  • Pareto, Deborah|||0000-0001-7356-3769
  • Rovira, Alex|||0000-0002-2132-6750
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Høgestøl, Einar A.|||0000-0001-8446-2111
  • Harbo, Hanne F.
  • Bellenberg, Barbara|||0000-0001-7484-6787
  • Ruggieri, Serena|||0000-0001-5287-3290
  • Gasperini, Claudio|||0000-0002-3959-4067
  • Uher, Tomas|||0000-0003-3160-9022
  • Vaneckova, Manuela|||0000-0002-8784-7997
  • Bittner, Stefan|||0000-0003-2179-3655
  • Othman, Ahmed E.
  • Collorone, Sara|||0000-0003-1506-8983
  • Toosy, Ahmed T.|||0000-0002-4441-3750
  • Meuth, Sven G.
  • Zipp, Frauke|||0000-0002-1231-1928
  • Barkhof, Frederik|||0000-0003-3543-3706
  • Ciccarelli, Olga|||0000-0001-7485-1367
  • Groppa, Sergiu|||0000-0002-2551-5655
The identification of prognostic markers in early multiple sclerosis (MS) is challenging and requires reliable measures that robustly predict future disease trajectories. Ideally, such measures should make inferences at the individual level to inform clinical decisions. This study investigated the prognostic value of longitudinal structural networks to predict 5-year Expanded Disability Status Scale (EDSS) progression in patients with relapsing-remitting MS (RRMS). We hypothesized that network measures, derived from MRI, outperform conventional MRI measurements at identifying patients at risk of developing disability progression. This longitudinal, multicentre study within the Magnetic Resonance Imaging in MS (MAGNIMS) network included 406 patients with RRMS (mean age = 35.7 ± 9.1 years) followed up for 5 years (mean follow-up = 5.0 ± 0.6 years). EDSS was determined to track disability accumulation. A group of 153 healthy subjects (mean age = 35.0 ± 10.1 years) with longitudinal MRI served as controls. All subjects underwent MRI at baseline and again 1 year after baseline. Grey matter atrophy over 1 year and white matter lesion load were determined. A single-subject brain network was reconstructed from T1-weighted scans based on grey matter atrophy measures derived from a statistical parameter mapping-based segmentation pipeline. Key topological measures, including network degree, global efficiency and transitivity, were calculated at single-subject level to quantify network properties related to EDSS progression. Areas under receiver operator characteristic (ROC) curves were constructed for grey matter atrophy and white matter lesion load, and the network measures and comparisons between ROC curves were conducted. The applied network analyses differentiated patients with RRMS who experience EDSS progression over 5 years through lower values for network degree [H(2) = 30.0, P < 0.001] and global efficiency [H(2) = 31.3, P < 0.001] from healthy controls but also from patients without progression. For transitivity, the comparisons showed no difference between the groups [H(2) = 1.5, P = 0.474]. Most notably, changes in network degree and global efficiency were detected independent of disease activity in the first year. The described network reorganization in patients experiencing EDSS progression was evident in the absence of grey matter atrophy. Network degree and global efficiency measurements demonstrated superiority of network measures in the ROC analyses over grey matter atrophy and white matter lesion load in predicting EDSS worsening (all P -values < 0.05). Our findings provide evidence that grey matter network reorganization over 1 year discloses relevant information about subsequent clinical worsening in RRMS. Early grey matter restructuring towards lower network efficiency predicts disability accumulation and outperforms conventional MRI predictors. Fleischer et al. examine the prognostic value of brain networks derived from MRI for predicting disability progression in patients with multiple sclerosis. They conclude that early brain network alterations identify clinical deterioration in multiple sclerosis and outperform classical MRI predictors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice

  • Verberk, I.M.W.
  • Jutte, J.
  • Kingma, M.Y.
  • Vigneswaran, S.
  • Gouda, M.M.T.E.E.
  • van Engelen, M.P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Chevalier, C.
  • Marizzoni, M.
  • van de Giessen, E.M.
  • Lemstra, A.W.
  • Pijnenburg, Y.A.L.
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • den Braber, A.
  • Wilson, D.
  • Schut, M.C.
  • van Harten, A.C.
  • Teunissen, C.E.
INTRODUCTION: We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P-)tau181, amyloid-beta (Abeta)42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). METHODS: We measured the plasma biomarkers with Simoa (n = 1199), applied LASSO regression for biomarker selection and receiver operating characteristics (ROC) analyses to determine diagnostic accuracy. We validated our findings in two independent cohorts and constructed a visualization approach. RESULTS: P-tau181, GFAP, and NfL were selected. This combination had area under the curve (AUC) = 83% to identify amyloid positivity in pre-dementia stages, AUC = 87%-89% to differentiate Alzheimer's or controls from frontotemporal dementia, AUC = 74%-76% to differentiate Alzheimer's or controls from dementia with Lewy bodies. Highly reproducible AUCs were obtained in independent cohorts. The resulting visualization tool includes UpSet plots to visualize the stand-alone biomarker results and density plots to visualize the biomarker results combined. DISCUSSION: Our multimarker blood test interpretation tool is ready for testing in real-world clinical dementia settings. Highlights: We developed a multimarker blood test interpretation tool for clinical dementia practice. Our interpretation tool includes plasma biomarkers P-tau, GFAP, and NfL. Our tool is particularly useful for Alzheimer's and frontotemporal dementia diagnosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection

  • Suades, Rosa|||0000-0002-0193-3115
  • Greco, M.F.|||0000-0003-3613-5516
  • Prieto, P.
  • Padró, Teresa|||0000-0003-1921-954X
  • Devaux, Yvan|||0000-0002-5321-8543
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Badimon, Lina|||0000-0002-9162-2459
Coronavirus disease 2019 (COVID-19) has been a major public health burden. We hypothesised that circulating extracellular vesicles (cEVs), key players in health and disease, could trace the cell changes during COVID-19 infection and recovery. Therefore, we studied the temporal trend of cEV and inflammatory marker levels in plasma samples of COVID-19 patients that were collected within 24 h of patient admission (baseline, n = 80) and after hospital discharge at day-90 post-admission (n = 59). Inflammatory markers were measured by standard biochemical methods. cEVs were quantitatively and phenotypically characterized by high-sensitivity nano flow cytometry. In patients recovered from COVID-19 lower levels of inflammatory markers were detected. cEVs from vascular (endothelial cells) and blood (platelets, distinct immune subsets) cells were significantly reduced at day-90 compared to admission levels, a pattern also observed for cEVs from progenitor, perivascular and epithelial cells. The best discriminatory power for COVID-19 severity was found for inflammatory markers lactate dehydrogenase and neutrophil-to-lymphocyte ratio and for granulocyte/macrophage-released CD66b/CD68-cEVs. Albeit inflammatory markers were good indicators of systemic inflammatory response and discriminators of COVID-19 remission, they do not completely reveal cell stress and organ damage states. cEVs reaching baseline pre-infection levels at 90 days post-infection in recovered patients discriminate parental cells affected by disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in neural projections of fear memory processing in mice and humans

  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Romero, Leire R.
  • Acharya, Neha|||0000-0002-1024-3351
  • Marin Blasco, Ignacio Javier|||0000-0001-5096-2871
  • Fabregat Nabás, Jaime|||0000-0002-5040-0913
  • Perez-Caballero, Laura|||0000-0002-2315-2213
  • Rivero, Guadalupe|||0000-0002-2537-4047
  • Olabarrieta, Estibaliz|||0000-0001-7842-3298
  • Nuñez-delMoral, Amaia|||0000-0002-1749-7055
  • González-Parra, Jose A.
  • Porta-Casteràs, Daniel|||0000-0002-3921-3607
  • Cano, Marta|||0000-0003-0675-9483
  • Steward, Trevor|||0000-0003-3116-8175
  • Antony, Monica S.
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Torrúbia, Rafael|||0000-0002-6826-6572
  • Jackson, Alexander|||0000-0001-7489-3946
  • Fullana, Miguel|||0000-0003-3863-5223
  • Andero Galí, Raül|||0000-0003-3641-8903
It remains unexplored in the field of fear memory whether functional neuronal connectivity between two brain areas is necessary for one sex but not the other. Here, we show that chemogenetic silencing of centromedial (CeM)-Tac2 fibers in the lateral posterior BNST (BNSTpl) decreased fear memory consolidation in male mice but not females. Optogenetic excitation of CeM-Tac2 fibers in the BNSTpl exhibited enhanced inhibitory postsynaptic currents in males compared to females. In vivo calcium imaging analysis revealed a sex-dimorphic fear memory engram in the BNSTpl. Furthermore, in humans, the single-nucleotide polymorphism (SNP) in the Tac2 receptor (rs2765) (TAC3R) decreased CeM-BNST connectivity in a fear task, impaired fear memory consolidation, and increased the expression of the TAC3R mRNA in AA-carrier men but not in women. These sex differences in critical neuronal circuits underlying fear memory formation may be relevant to human neuropsychiatric disorders with fear memory alterations such as posttraumatic stress disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SpadaHC, a database to improve the classification of variants in hereditary cancer genes in the Spanish population

  • Moreno-Cabrera, José Marcos|||0000-0001-8570-0345
  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Pineda, Marta|||0000-0002-5403-5845
  • Prada Dacasa, Patricia|||0000-0003-0689-9072
  • Ramos-Muntada, Mireia|||0000-0002-5531-1442
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Brunet, Joan|||0000-0003-1945-3512
  • Gel, Bernat|||0000-0001-8878-349X
  • Currás-Freixes, M.
  • Calsina Pla Giribert, Bruna|||0000-0002-6922-9415
  • Salazar-Hidalgo, Milton E.
  • Rodríguez-Balada, M.
  • Roig, Bàrbara
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Durán, Mercedes|||0000-0002-6301-9732
  • Arranz Ledo, Mónica
  • Infante, Mar
  • Castillejo Castillo, Adela|||0000-0002-9581-6285
  • Dámaso, Estela|||0000-0002-9650-7791
  • Soto, José Luis
  • de Miguel, Montserrat
  • Hidalgo Calero, Beatriz
  • Sánchez-Zapardiel, José M.
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Lasa, Adriana|||0000-0001-9957-9646
  • Gisbert-Beamud, Alexandra|||0000-0001-6515-3081
  • López Novo, Anael
  • Ruiz-Ponte, C.
  • Potrony, Miriam|||0000-0003-2766-0765
  • Álvarez Mora, María Isabel|||0000-0003-3788-8915
  • Osorio, Ana|||0000-0001-8124-3984
  • Lorda Sánchez, Isabel
  • Robledo, Mercedes|||0000-0001-6256-5902
  • Cascón, Alberto|||0000-0003-2119-891X
  • Ruiz, Anna|||0000-0001-7314-5962
  • Spataro, Nino|||0000-0002-2127-2238
  • Hernán Sendra, Imma
  • Borràs, Emma
  • Moles-Fernández, Alejandro|||0000-0003-0252-6084
  • Earl, Julie
  • Cadiñanos, J.
  • Sánchez-Heras, Ana Beatriz|||0000-0003-1742-5374
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Capella, Gabriel|||0000-0002-4669-7320
  • Lázaro, C.
Accurate classification of genetic variants is crucial for clinical decision-making in hereditary cancer. In Spain, genetic diagnostic laboratories have traditionally approached this task independently due to the lack of a dedicated resource. Here we present SpadaHC, a web-based database for sharing variants in hereditary cancer genes in the Spanish population. SpadaHC is implemented using a three-tier architecture consisting of a relational database, a web tool and a bioinformatics pipeline. Contributing laboratories can share variant classifications and variants from individuals in Variant Calling Format (VCF) format. The platform supports open and restricted access, flexible dataset submissions, automatic pseudo-anonymization, VCF quality control, variant normalization and liftover between genome builds. Users can flexibly explore and search data, receive automatic discrepancy notifications and access SpadaHC population frequencies based on many criteria. In February 2024, SpadaHC included 18 laboratory members, storing 1.17 million variants from 4306 patients and 16 343 laboratory classifications. In the first analysis of the shared data, we identified 84 genetic variants with clinically relevant discrepancies in their classifications and addressed them through a three-phase resolution strategy. This work highlights the importance of data sharing to promote consistency in variant classifications among laboratories, so patients and family members can benefit from more accurate clinical management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hypoxia Increases Nitric Oxide-Dependent Inhibition of Angiogenic Growth

  • Arce, Cristina
  • Vicente, Diana
  • Monto, Fermí
  • González, Laura
  • Nuñez, Cristina
  • Victor, Victor Manuel|||0000-0002-3027-3945
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • D'Ocon, Pilar|||0000-0001-8544-7124
Nitric oxide (NO) is a proangiogenic factor acting through the soluble guanylate cyclase (sGC) pathway. However, angiogenic growth increases energy demand, which may be hampered by NO inhibition of cytochrome c oxidase (CcO). Then, NO activity would be the balanced result of sGC activation (pro-angiogenic) and CcO inhibition (anti-angiogenic). NO activity in a rat and eNOS mice aortic ring angiogenic model and in a tube formation assay (human aortic endothelial cells) were analyzed in parallel with mitochondrial O consumption. Studies were performed with NO donor (DETA-NO), sGC inhibitor (ODQ), and NOS or nNOS inhibitors (L-NAME or SMTC, respectively). Experiments were performed under different O concentrations (0-21%). Key findings were: (i) eNOS-derived NO inhibits angiogenic growth by a mechanism independent on sGC pathway and related to inhibition of mitochondrial O consumption; (ii) NO inhibition of the angiogenic growth is more evident in hypoxic vessels; (iii) in the absence of eNOS-derived NO, the modulation of angiogenic growth, related to hypoxia, disappears. Therefore, NO, but not lower O levels, decreases the angiogenic response in hypoxia through competitive inhibition of CcO. This anti-angiogenic activity could be a promising target to impair pathological angiogenesis in hypoxic conditions, as it occurs in tumors or ischemic diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Surpassing protein specificity in biomimetics of bacterial amyloids

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
In nature, nontoxic protein amyloids serve as dynamic, protein-specific depots, exemplified by both bacterial inclusion bodies and secretory granules from the endocrine system. Inspired by these systems, chemically defined and regulatory-compliant artificial protein microgranules have been developed for clinical applications as endocrine-like protein repositories. This has been achieved by exploiting the reversible coordination between histidine residues and divalent cations such as Zn, that promotes protein-protein interactions. While stereospecificity is a main architectonic feature of natural amyloids, the potential for synthetic approaches to create hybrid protein materials remains unexplored. Such materials could enable the occurrence and synchronized local application of diverse proteins in predefined molar ratios, for coupled enzymatic reactions or delivery of synergistically acting polypeptides. Here, we report on the fabrication of artificial protein granules with amyloidal architecture formed by combining two structurally distinct polypeptides. Specifically, we tested co-aggregation of the pairs GFP/IRFP and GFP/β-galactosidase. The formation of hybrid microparticles was confirmed through FRET and complementary methodologies, demonstrating that the His-Zn clustering technology does not require sequential or structural homologies between aggregating polypeptides. This approach opens new avenues for the development of functional depots that capitalize on synergistic protein functionalities, paving the way for next-generation functional materials.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pig nasal and rectal microbiotas are involved in the antibody response to Glaesserella parasuis

  • Obregon-Gutierrez, Pau|||0000-0002-6897-2792
  • Mahmmod, Yasser|||0000-0002-1975-3454
  • Barba-Vidal, Emili|||0000-0001-8639-0895
  • Sibila Vidal, Rosa Marina|||0000-0003-3867-1988
  • Correa-Fiz, Florencia|||0000-0002-9459-5871
  • Aragón, Virginia|||0000-0002-3470-6015
Vaccination stands as one of the most sustainable and promising strategies to control infectious diseases in animal production. Nevertheless, the causes for antibody response variation among individuals are poorly understood. The animal microbiota has been shown to be involved in the correct development and function of the host immunity, including the antibody response. Here, we studied the nasal and rectal microbiota composition in association with the antibody response against the pathobiont Glaesserella parasuis. The nasal and rectal microbiotas of 24 piglets were sampled in two farms before vaccination and in one unvaccinated farm (naturally exposed to the pathobiont) at similar time. Microbiota composition was inferred by V3V4 16S rRNA gene sequencing and bioinformatics analysis, and the antibody response was quantified using the variation between the levels before and after vaccination (normalized per farm). Piglets with higher antibody responses showed more diverse nasal and rectal microbial communities compared to piglets with lower responses. Moreover, swine nasal core microbiota colonizers were associated with higher antibody levels, such as several members from Bacteroidales and Clostridiales orders and genera including Moraxella, Staphylococcus, Fusobacterium and Neisseria. Regarding taxa found in the rectal microbiota, associations with antibody responses were detected only at order level, pointing towards a positive role for Clostridiales while negative for Enterobacteriales. Altogether, these results suggest that the microbiota is associated with the antibody response to G. parasuis (and probably to other pathogens) and serves as starting point to understand the factors that contribute to immunization in pigs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics

  • Laghi, Luca|||0000-0003-1593-7376
  • Ortiz, M. Àngels|||0000-0002-1574-9861
  • Rossi, Giacomo|||0000-0001-8617-5984
  • Roman, Eva|||0000-0001-9084-8555
  • Mengucci, C.|||0000-0003-0602-3003
  • Cantó, Elisabet|||0000-0002-1782-1855
  • Biagini, L.|||0000-0001-5990-1514
  • Sánchez, Elisabet|||0000-0002-3280-9301
  • Mulet Gual, Maria|||0000-0003-3639-3291
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Urgell, Eulàlia|||0000-0003-3519-1022
  • Kaur Gill, Naujot|||0009-0007-4184-0398
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Padros i Valls, Josep
  • Nadal, Mª Josepa|||0000-0002-6700-057X
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Alvarado-Tapias, Edilmar|||0000-0003-2036-6133
  • Vidal, Silvia|||0000-0002-3909-6682
  • Juanes Borego, Elena|||0000-0001-8910-2123
  • Ferrero-Gregori, Andreu|||0000-0001-6492-2416
  • Escorsell, Àngels|||0000-0001-5083-8467
  • Soriano, German|||0000-0002-9267-6811
Frailty in cirrhosis or advanced chronic liver disease (ACLD) is a relevant prognostic factor. In the present study, we aimed to analyze potential biomarkers associated with frailty and its improvement in patients with ACLD. We analyzed the serum of outpatients with ACLD who participated in a previous study (Román, Hepatol Commun 2024) in which frailty was assessed using the liver frailty index (LFI), and patients who were frail or prefrail were randomized to a multifactorial intervention (home exercise, branched-chain amino acids, and probiotics) or control for 12 months. We determined a biomarker battery of inflammation, bacterial translocation, and liver damage in blood and urine and blood metabolomics by H-NMR. Thirty-seven patients were included. According to the LFI, 32 patients were frail or prefrail, and 5 were robust. At baseline, LFI correlated with LBP, sCD163, mtDNA, FGF-21, urinary NGAL, urinary claudin-3, and the metabolites mannose, ethanol, and isoleucine. During the study, patients in the intervention group showed an improvement in LFI and a decrease in CRP, LBP, sCD163, and ccK18 compared to the control group. Metabolomics showed a decrease in dimethyl sulfone and creatinine and an increase in malonate, ornithine, isoleucine, and valine in the intervention group. We conclude that frailty in patients with ACLD is associated with biomarkers of systemic inflammation, bacterial translocation, and liver damage, and alterations of amino acid and short-chain fatty acid metabolism.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Contextual-compassion training for borderline personality disorder with long lasting symptoms, A randomized clinical trial

  • Casellas Pujol, Elisabet|||0000-0001-8496-0719
  • Soler, Joaquim|||0000-0001-8077-3641
  • Schmidt, C.
  • Soria-Madrid, A.
  • Elices, M.|||0000-0002-7034-4242
  • Pascual, J.C.
Long-term follow-up studies have shown that the symptoms of borderline personality disorder (BPD) tend to remit over time. However, many patients present long lasting symptoms (LLS), including low mood, emptiness, and persistent impairment in psychosocial adjustment. Given the high rate of LLS in BPD patients, new treatment strategies are needed. We conducted a randomized clinical trial (RCT) to evaluate the efficacy of a novel intervention that combines self-compassion and contextual-based skills for patients with persistent symptoms. Sixty BPD individuals with LLS who had received dialectical behavior therapy skills training (DBT-ST) in the previous six months were recruited and randomized to receive the experimental intervention or treatment as usual (TAU) for 12 weeks. All participants were evaluated pre- and post-intervention and at 3-months follow-up. The primary outcome measure was self-reported well-being. Other clinical variables were also evaluated, including depressive symptoms, BPD symptoms, functionality, self-compassion, and self-criticism. Participants in the experimental arm showed a significant increase in indicators of well-being (e.g., happiness and quality of life) and a significant decrease in depressive symptoms. These results were sustained-and even continued to improve-at the three-month follow-up. No significant changes were observed in BPD severity, self-criticism, or self-compassion. More RCTs are needed to test the efficacy of new interventions targeting this population with persistent symptoms, not only to reduce symptoms but also to promote well-being and personal recovery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nasal microbial diversity is associated with survival in piglets infected by a highly virulent PRRSV-1 strain

  • Obregon-Gutierrez, Pau|||0000-0002-6897-2792
  • Cortey, Martí|||0000-0003-1126-3423
  • Martin-Valls, Gerard|||0000-0003-3302-0692
  • Clilverd, Hepzibar|||0000-0002-4309-7506
  • Correa-Fiz, Florencia|||0000-0002-9459-5871
  • Aragón, Virginia|||0000-0002-3470-6015
  • Mateu de Antonio, Enrique María|||0000-0003-2715-6032
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major threat to swine industry worldwide, especially virulent variants arising during the last years, such as Spanish PRRSV-1 Rosalia strain. The role of the nasal microbiota in respiratory viral infections is still to be unveiled but may be promisingly related with the health status of the animals and thus, their susceptibility. The goal of this project was to study the nasal microbiota composition of piglets during a highly virulent PRRSV-1 outbreak comparing animals that died due to the infection with animals that survived it. The microbiota composition was inferred by V3-V4 regions of the 16S rRNA gene sequencing and bioinformatics analysis. To deepen the analysis, we added samples taken from piglets before the outbreak as well as from the sows giving birth to piglets under study. Piglets that survived the PRRSV-1 outbreak reported a more diverse and different nasal microbiota at three weeks of age compared to piglets dying, which was highly related with the litter of origin and the sow of the piglets. In addition, a high abundance of classical swine nasal colonizers belonging to genera such as Bergeyella, Glaesserella, Neisseria and Moraxella (among others), was related with good outcome. On the other hand, a dysbiotic community dominated by Escherichia and a different clade of Moraxella was found in piglets with bad outcome. Moreover, samples taken before the outbreak showed similar dynamics prior to virulent PRRSV-1 arrival, suggesting that microbiota-related susceptibility was already occurring in the animals and that the increase in mortality seen was related to the new highly virulent strain. Our study suggests that the susceptibility to an infection such as PRRSV could be related to the nasal microbiota composition at the moment of infection and may serve as starting point to explore animal resilience. Since the dysbiosis detected as an initial response to infection may be not specific for this virus, further investigations should explore this phenomenon in the context of other viral infections. The online version contains supplementary material available at 10.1186/s42523-024-00371-y.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Atherogenic circulating lipoproteins in ischemic stroke

  • Benitez, Sonia|||0000-0003-3565-0743
  • Puig Grifol, Núria|||0000-0002-4699-3162
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
The fundamental role of qualitative alterations of lipoproteins in the early development of atherosclerosis has been widely demonstrated. Modified low-density lipoproteins (LDL), such as oxidized LDL (oxLDL), small dense LDL (sdLDL), and electronegative LDL [LDL(-)], are capable of triggering the atherogenic process, favoring the subendothelial accumulation of cholesterol and promoting inflammatory, proliferative, and apoptotic processes characteristic of atherosclerotic lesions. In contrast, high-density lipoprotein (HDL) prevents and/or reverses these atherogenic effects. However, LDL's atherogenic and HDL's anti-atherogenic actions may result altered in certain pathological conditions. The molecular mechanisms underlying the impaired effects of altered lipoproteins have been studied in numerous in vitro and in vivo studies, and have been extensively analyzed in coronary atherosclerosis, especially in the context of pathologies such as dyslipidemia, diabetes, obesity, and metabolic syndrome. However, the corresponding studies are scarcer in the field of ischemic stroke, despite carotid arteriosclerosis progression underlies at least 20% of ischemic strokes. The present review relates qualitative alterations of LDL and HDL with the development of carotid arteriosclerosis and the occurrence of ischemic stroke.